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Abstract 
Mesenchymal stem cells (MSC) are multipotent stem cells that have much 
potential for application in regenerative medicine, with their ability to self-
renew and to undergo differentiation into several lineages, including those that 
comprise fat, bone, and cartilage. Studies on MSCs have mainly focused on 
exploiting their capacity to differentiate, rather than self-renewal, yet 
understanding of the latter process is pivotal for the expansion of these cells to 
sufficient numbers for use in future clinical treatments. 
 
Aspects of MSC behaviour can be induced by culture on nanopatterned 
substrates, known as nanotopography. Use of established nanopit features, in 
arrangements known to maintain MSC multipotency over long periods in culture 
(SQ), in addition to an osteogenic promoting arrangement (NSQ), were used as a 
tool to study self-renewal in MSCs, and begin to elucidate some of the potential 
mechanisms underlying the effects of the nanotopographies on stem cell fate.    
 
This study utilised patient-specific primary MSCs derived from bone marrow, 
which were optimised in terms of initial seeding density, to make efficient use 
of our nanotopographies. Once the fundamental details pertaining to optimal 
conditions for use of the substrates and cells were established, exploration of 
changes in metabolism, cell cycle and gene expression were carried out. Results 
indicated that MSCs on SQ contained more unsaturated metabolites, and that 
cell cycle may be altered, which warranted further investigation. Further study 
identified some differences in cell cycle regulatory proteins when compared to 
NSQ and flat controls. Further inferences were achieved by analysis of transcript 
abundances and differential expression, supporting the hypothesis of a 
heterogeneous population existing on NSQ, and activation of pathways linked to 
differentiation, consistent with previous work. A greater percentage of MSCs on 
SQ were shown to be in the early G0/G1 stages of the cell cycle in comparison to 
those on flat, suggesting that cell cycle is altered and further establishes a link 
between self-renewal and cell cycle regulation.   
 
Nanotopography was assessed for a novel application, namely the potential of SQ 
to reprogram differentiating MSCs.  Nanotopography was used to induce and 
 iii 
reverse the onset of osteogenic differentiation, and evaluated in conjunction 
with the addition of an epigenetic modifier, valproic acid. Results did not 
indicate that nanotopographical cues were able to reprogram MSCs. However, 
promising indications that stem cell marker STRO-1 levels increased, is 
consistent with SQ being a surface that maintains ‘stemness’ and multipotency 
of MSCs with culture in vitro. 
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1  General Introduction 
 
1.1 Tissue engineering and regenerative medicine 
 
The concept of tissue engineering developed from an idea to create new tissue 
with the aim of repairing failing or damaged tissue and restoring its associated 
function (Langer and Vacanti, 1993). Materials have been used to make 
templates or scaffolds to cultivate cells for eventual tissue formation (Langer 
and Tirrell, 2004). Several promising studies identified aspects of the tested 
materials that were sufficient to induce changes in cell behaviour, including 
differentiation, growth and proliferation (Engler et al., 2006, Dalby et al., 2007, 
McMurray et al., 2011, Lee et al., 2014a). Tissue engineering commonly applies 
the strategy of mimicking a cell’s natural environment, often bringing together 
cells, scaffolds and biochemical factors (Langer and Vacanti, 1993, Shah et al., 
2014, Zhang et al., 2014). With a trend towards a largely aging population, such 
research is becoming increasingly important, leading to the evolution of the field 
of regenerative medicine (Haseltine, 2003). Regenerative medicine incorporates 
tissue engineering with the additional aim of advancing research on the 
induction of self-repair (regeneration) of tissues and organs, presenting some 
truly revolutionary approaches in the treatment of disease (Salgado et al., 
2013).  
 
Examples of particularly well-publicised and promising preliminary work for 
potential future clinical treatments range from the implant of vascular grafts 
(Dahl et al., 2011) to the transplantation of a tissue-engineered trachea 
(Macchiarini et al., 2008). The derivation and subsequent development of tissue 
engineering constructs has now become commonly utilised to overcome issues 
with organ replacement, particularly during the last decade. Expansion of cells 
from the patient themselves, and generating autologous tissues, may reduce the 
likelihood of rejection (Boehler et al., 2011).  
 
The basis of these types of clinical therapy are studies illustrating that cells in 
the body require supporting mechanical structures for their establishment and 
orientation, as well as instructional cues that influence their behaviour (Melchels 
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et al., 2010, Gee et al., 2012, Evans and Gentleman, 2014). Normally these 
would be obtained from the extracellular matrix (ECM), which is produced and 
secreted by the cells themselves. However, the structural aspect of the ECM can 
be provided artificially by building a substrate from materials such as a polymer 
or using natural materials (Ma et al., 2001, Chastain et al., 2006, Geckil et al., 
2010). Such substrates are commonly referred to as ‘biomaterials’, designed to 
mimic the native composition and arrangement of the ECM, attempting to 
recapitulate the microenvironment as closely as possible (Navarro et al., 2008, 
Damanik et al., 2014). Subsequent supplementation of cells and additional 
growth factors to the material construct or ‘scaffold’ can then lead to support of 
other cell types and successful formation of tissues for use in medical 
applications (Cenni et al., 2011, Chen et al., 2014a).  
 
Stem cells will likely underpin regenerative medicine, with biomaterials also 
being recognised as useful tools. The former are important, due largely to the 
unique ability of stem cells to self-renew and their versatility in differentiating 
into many cell types (potentially complex tissues) (Yao et al., 2006, Abdallah 
and Kassem, 2007, Wilson et al., 2008, Sarugaser et al., 2009, Blin et al., 2010). 
Stem cells are complemented by the potential of next-generation biomaterials in 
directing stimulation of stem cells without the need for chemical intervention 
(Dalby et al., 2007, McMurray et al., 2011). The combination of advantages 
offered by both biomaterials and stem cells could lead to a workable platform in 
the treatment of degenerative diseases, such as future implants for bone 
conditions such as osteoarthritis (Sjöström et al., 2009, Sjöström et al., 2013), 
and vascular grafts to overcome cardiovascular complications (Matsumura et al., 
2003, Zhao, 2013), which are affecting increasing numbers of people in modern 
society. Tissue engineering now encompasses both in vitro (Friedenstein et al., 
1987, Ma et al., 2001) and in situ (Ko et al., 2013, Andreas et al., 2014) 
strategies that allow even greater potential for regenerative medicine.  
 
Individual aspects that comprise the foundations for tissue engineering and 
regenerative medicine will be discussed in further detail in the following 
sections.  
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1.2 The extracellular matrix 
 
The extracellular space between cells in tissues is known as the extracellular 
matrix (ECM). The ECM contains a vast network of glycoproteins, 
polysaccharides, proteoglycans and macromolecules, and their spatial 
arrangement gives rise to the distinct physical attributes of numerous tissues of 
the body (Mouw et al., 2014). Some examples of ECM proteins include 
fibronectin, vitronectin, collagen and laminin (Frantz et al., 2010). These are 
important scaffolding proteins necessary for cell-matrix adhesion and structural 
organisation (Woods et al., 1986, Steele et al., 1992, Heino, 2007, Frantz et al., 
2010, Marthiens et al., 2010).  
 
The ECM does not merely offer structural support and stability within a tissue or 
scaffolding for cell anchorage; changes in ECM composition have influence on 
migration, proliferation, morphology and other aspects of cellular function and 
behaviour (Bhadriraju and Hansen, 2002, Barker, 2011, Charras and Sahai, 2014, 
Nakamura et al., 2014). A decrease in effective anchorage of cell adhesion 
related molecules in the ECM is associated with diseases such as osteoporosis 
(Perinpanayagam et al., 2001), cancer (Mason et al.) and asthma (Vanderslice et 
al., 2004). This outlines the importance of regulation, reorganisation and 
remodelling of the constituents of the ECM to maintain a state of homeostasis 
within tissues in response to external pressures from their microenvironment. 
Moreover, these findings underline the fact that the ECM must be highly 
adaptable at any given point in time, so that it may respond as cells are 
undergoing changes themselves.  
 
In the context of this thesis, the term ECM will be used as reference to the 
extracellular environment, inclusive of the substrate biomaterial utilised in this 
study, rather than solely the macromolecules secreted by other cells.  
 
1.3 The evolution of biomaterials for tissue engineering   
 
Interaction of cells with the ECM has been well established as being important in 
influencing subsequent cell development and behaviour (Lukashev and Werb, 
1998). Extending this knowledge towards investigating the interaction of cells 
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and tissues with the surfaces of synthesized substrates forms the basis of 
biomaterials research. This research is critical as medical implants and devices 
require an understanding of the properties of cells and tissues in order to 
provide a safe and feasible means of treatment in the body (Uluda!, 2014). Over 
time, the definition of the term ‘biomaterial’ has undergone changes to 
encompass the increasing number of materials, chemistries and multi-
component systems that are now being studied (Williams, 2009). A biomaterial 
can be considered as an engineered substance that can be used in isolation or in 
conjunction with other substances, to regulate entities and thereby processes of 
living systems for medical purposes (Williams, 2009).  
 
A wide range of biomaterials can be selected to produce a scaffold or substrate, 
dependent on the property deemed most important for a specific aim or 
function. In general terms, the classically used materials fall into the broad 
categories of metals (Dolder et al., 2003, Wall et al., 2009, McNamara et al., 
2011), ceramics (Saikia et al., 2008, Lin et al., 2009), and synthetic or naturally 
derived single or blended polymers (Di Martino et al., 2005, He et al., 2005), 
which all present their own advantages and disadvantages. As there is often not 
an ideal ‘gold standard material’ that can meet all the requirements, distinct 
properties and complexities of native tissue, a compromise of these factors must 
be decided upon. The evolution in the design of biomaterials appears to have 
progressed across three distinct stages, or ‘generations’ up to the turn of the 
century, as outlined by Hench and Polak (Hench and Polak, 2002) (!"#$%&'()().  
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The design focus of the earliest biomedical materials was to emulate native 
mechanical properties such as that of bone, which then shifted to achieve 
biological ‘inertness’, and reduction in the likelihood of an immune response 
from the host (Hench, 1980, Navarro et al., 2008); example materials include 
metals and ceramics. This was particularly important in surgical prostheses and 
the rule still holds true to date. Nevertheless, use of nearly inert materials in 
isolation did not prove an ideal solution, as insufficient adhesion and cellular 
interaction with these types of implants meant that often a thin fibrous area of 
tissue developed in the region between the implant and the native tissue 
(Hench, 1980, Anderson et al., 2008). In contrast, use of materials that induced 
greater immune reaction also typically resulted in the formation of a fibrous 
capsule around such materials, (observed to be of increased thickness due partly 
to inflammation), which, in turn, would apply a degree of stress to surrounding 
tissues (Anderson et al., 2008). Moreover, the lack of blood supply would mean 
that white blood cells would not be available to fight off any developing 
infection (Hench, 1980). It was therefore understood that biocompatibility alone 
was not enough to elicit the desired responses of tissue repair in the body 
(Williams, 2008).    
 
Second-generation biomaterials developed the concept of localized bioactivity, 
in that the substrate itself could generate a physiological response from the 
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tissue surrounding it (Navarro et al., 2008). Bioactive glasses and bioactive 
ceramics such as hydroxyapatite were reported as being able to facilitate 
formation of bone (Reilly et al., 2007). There was additionally an increasing 
emphasis on biodegradability, such that a scaffold would be gradually removed 
over time (Nair and Laurencin, 2007). Polymers approved by the Food and Drug 
Administration (FDA) for use in the body, such as polyglycolic acid (PGA), which 
is bioresorbable, poly(lactic-co-glycolic acid) (PLGA) and polycaprolactone (PCL) 
which are biodegradable polymers, were utilised as they were regarded as being 
both biocompatible and removable in the long-term (Gunatillake and Adhikari, 
2003). Once the scaffold or construct biomaterial is resorbed, this would leave 
the cells that were seeded within the scaffold to interact with those located in 
the surrounding environment, eventually aspiring to incorporate a blood system 
and nerves from the recipient.  However, it was increasingly recognised that 
specific cell-material interactions must take place to give rise to the most 
benefits for the patient (McBeath et al., 2004, Chen et al., 2014b). 
 
This led to the development of ‘third generation’ biomaterials, which progressed 
towards surfaces that would involve bioactive components for the support and 
regeneration of tissue (Hench and Polak, 2002). They aimed to induce changes at 
a molecular level, inhibiting or activating cellular activities or inducing 
expression of specific genes to aid the regeneration process. To this end, 
biomaterials must mimic a cell’s natural environment at a molecular level (Lutolf 
et al., 2009). One strategy has been to incorporate features emulating the ECM 
onto the material surface, often at a micro- or nanoscale range (topography) 
(Arnold et al., 2004, Bettinger et al., 2009, Albuschies and Vogel, 2013). 
Advances have already been made with examples of biomaterials having 
influence on a range of cellular processes such as cell migration (Cavalcanti-
Adam et al., 2007), proliferation (Ali et al., 2014) and differentiation (Dalby et 
al., 2007, Teo et al., 2013). Cellular responses have been reported for a range of 
cell types including fibroblasts (Loesberg et al., 2007), osteoblasts (Lamers et 
al., 2010), endothelial cells (Dreier et al., 2013), neuronal cells (Micholt et al., 
2013) and stem cells (Chen et al., 2012). Stem cells present an exciting prospect 
in regenerative medicine as they can differentiate into many cell types.  
With regards to the control of stem cells with biomaterials, the next challenge 
herein lies in determining how to elicit beneficial stem cell self-renewal or guide 
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differentiation to a particular cell lineage (Hench and Polak, 2002). Strategies 
employed include the use of different topographies over several scales 
(Wilkinson et al., 2002), varying chemistries (Lutolf et al., 2009) and elastic 
modulus (Engler et al., 2006). All of these studies are linked in their attempt at 
provision of a tailored method of stimulation to gain a specific functional 
cellular response. The next step would be to generate complex tissues such as 
bone tissue, which are distinguished by their unique physical, chemical and 
structural topographical features (Stevens and George, 2005), and to develop 
systems in three-dimensions (Baker and Chen, 2012) to allow for incorporation of 
aspects of geometric positioning. 
 
1.4 Stem cells  
 
Stem cells are defined by the possession of two distinctive properties: that of 
self-renewal in an undifferentiated state, and a potential to differentiate into a 
range of specialized cell lineages, known as potency (Blanpain et al., 2004). 
There are several degrees of potency, namely unipotency (differentiation into a 
single cell type) pluripotency (the ability to differentiate into all three germ 
layers; endoderm, mesoderm or ectoderm) multipotency (able to differentiate 
into a number of cell types) or totipotency (can form all cell types) (Kolios and 
Moodley, 2013).  
 
Embryonic stem cells (ESCs) are pluripotent and are derived from the inner cell 
mass of a blastocyst from an embryo (Nichols and Smith, 2012), which makes 
human ESCs difficult to obtain due to a number of ethical factors pertaining to 
the donation of in vitro fertilized eggs for research (Wert and Mummery, 2003). 
ESCs were initially cultured with a ‘feeder layer’ of mouse (Thomson et al., 
1998, Reubinoff et al., 2000) or human derived (non-dividing) fibroblasts (Amit 
et al., 2003) to supply nutrients to the ESCs, however, use of foreign cells from 
another species and the risk of virus transmission would prevent ESC treatments 
from being successfully transferred to the clinic. With the advent of new 
technologies, xeno and feeder-free culturing methods are being investigated 
(Jang et al., 2013).    
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An alternative source of stem cells can be extracted from adult tissue such as 
bone marrow, adipose and brain tissue (Friedenstein et al., 1987, Meirelles et 
al., 2006, Bunnell et al., 2008). These cells are referred to as somatic stem cells 
or adult stem cells, and those derived from bone marrow, are commonly termed 
mesenchymal stem cells (MSCs) (Abdallah and Kassem, 2007). MSCs also possess 
the capacity to self-renew, though they possess a limited differentiation 
capacity in comparison to ESCs (Blau et al., 2001). MSCs exhibit multipotency 
which means that they can differentiate into a small number of lineages 
(Pittenger et al., 1999). The discovery and history of MSCs will be expanded 
upon in the following section.  
 
Induced pluripotent stem cells (iPSCs) are derived from successful 
reprogramming of somatic cells to once again ascribe them ESC-like properties. 
The initial discoveries were attributed to Yamanaka and collaborators, who 
reported reprogramming of mouse cells (Takahashi and Yamanaka, 2006), 
followed by reprogramming of human cells shortly thereafter (Takahashi et al., 
2007). Intriguingly, the retroviral delivery of the same four transcription factors 
(Oct3/4, Sox2, Klf4, and c-Myc) to both mouse and human fibroblasts resulted in 
the generation of iPSC cells (Takahashi and Yamanaka, 2006, Takahashi et al., 
2007). The generation of human iPSCs was thought to be a groundbreaking 
discovery as it opened up the potential for large quantities of autologous patient 
stem cells to be created for regenerative medicine (!"#$%&'()9). However, a 
caveat to creating these cells is that there is no screening method to ensure that 
complete nuclear reprogramming has taken place. Partially reprogrammed iPSCs 
will not exhibit all the desired ESC-like characteristics, and aberrations in 
reprogramming may impair differentiation potential and pose a higher risk of 
teratoma formation (Yamanaka, 2009). Indeed, a study by Okita et al. reported 
that expression of c-myc could be reactivated and cause formation of tumours 
(Okita et al., 2007) with additionally safety concerns due to the uncontrolled 
and random nature of integration of DNA into the host genome (Takahashi et al., 
2007).  
 
Chapter 1: General Introduction 
 
 10 
 
!"#$%&'()9*':&1&%50".1'51;';"22&%&10"50".1'.2'"<=>68'R&/"-&%A'.2'2.$%'2570.%6'$6"1#'%&0%.-"%$6&6'751'
%&B%.#%54'5'6.450"7'7&//'05G&1'2%.4'5'B50"&10Y'6$7,'56'5'2"3%.3/560'7&//Y'51;'#&1&%50&'51'"1;$7&;'
B/$%"B.0&10'60&4'7&//8'+,&6&'751'0,&1'3&';"22&%&10"50&;'"10.'5'1$43&%'.2'7&//'0AB&6Y'51;'%&)
"4B/510&;'"10.'0,&'B50"&10'2.%'0,&'B$%B.6&6'.2'%&#&1&%50"-&'4&;"7"1&8'E;5B0&;'2%.4'i54515G5Y'
9OON8'(
 
 
1.4.1 Mesenchymal stem cells 
 
In 1970, Friedenstein and colleagues described cells from the bone marrow, 
which included a small population that were adherent, similar to fibroblasts in 
morphology, and exhibited clonal growth. These were shown to be progenitor 
cells, with the ability to differentiate into osteoblasts (Friedenstein et al., 
1970). At the time, Friedenstein called them ‘colony forming units’, and these 
were, in fact, stem cells. Caplan eventually assigned the term ‘mesenchymal 
stem cells’ to the subpopulation in bone marrow that exhibited an ability to 
differentiate into cartilage and bone (Caplan, 1991). 
 
Amongst the mixture of MSCs isolated from bone marrow are osteoprogenitors, 
chondrogenic progenitors and adipocyte progenitors (Muraglia et al., 2000) that 
can be viewed as partially defined in terms of their stem cell fate. MSCs are 
multipotential, and have been reported to differentiate into a number of cell 
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types including adipocytes, osteoblasts, chrondrocytes, myoblasts, and 
fibroblasts; cells comprising fat, bone, cartilage, muscle and skin respectively 
(!"#$%&'()?)(Pittenger et al., 1999, Barry et al., 2001, Gang et al., 2004). Aside 
from these widely accepted cell types, some studies controversially report cases 
of trans-differentiation across tissue types, for example into neuronal cells, 
hepatocytes and endothelial cells, though these are mostly considered rare 
events and that trans-differentiation would be more achievable through 
reprogramming (Orlic, 2003, Song and Tuan, 2004, Jopling et al., 2011).!!
MSCs, along with other stem cell types, therefore offer great therapeutic 
potential for use in future clinical therapies, which is dependent on furthering 
our understanding of the regulation of self-renewal and lineage commitment. 
This will allow MSCs to be expanded and directed as necessary to meet the 
needs of particular patients. It is likely that MSCs will first be exploited for 
trophic effects related to immune and inflammatory modulation properties, to 
assist with transplant survival (Caplan and Dennis, 2006, Wu et al., 2011, Yoo et 
al., 2013). Expanded MSCs would offer immune protection for the initial stages 
of transplant and then dwindle over time (Wu et al., 2011).  
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Current methods to isolate MSCs remain largely based on detection of the 
presence or absence of certain cell surface markers (Baddoo et al., 2003). A 
number of MSC-specific markers have been identified which can be exploited in 
the selection of particular MSC subpopulations from human tissue samples (Jones 
et al., 2002, Boxall and Jones, 2012, Gothard et al., 2014). These can be cell 
adhesion molecules or surface antigens for example. No universal marker has 
been identified that can be used in isolation for all MSCs, however, one of the 
most highly published and widely known is the STRO-1 antigen (Simmons and 
Torok-Storb, 1991). Recently, CD271 (low-affinity nerve growth factor receptor, 
also known as p75 neurotrophic receptor) has emerged as a strong marker for 
isolating MSCs from human bone marrow aspirate (Bühring et al., 2007, Jones et 
al., 2010)  (!"#$%&'()D). STRO-1 and CD271 have been reported to be highly 
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expressed in bone marrow-derived MSCs, and absent in fibroblasts, supporting 
their use as markers for selection (Jones et al., 2002).  
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With the use of markers, a higher purity population of multipotent MSCs may be 
isolated from the mixture of adherent bone marrow cells. These markers can 
also be exploited for characterisation purposes, quantifying their expression 
levels with and without treatments in order to show stem or differentiation 
status (Qian et al., 2012). STRO-1 and CD271 can therefore be used as indicators 
of ‘stemness’. This surface profile at the gene or protein level can be compared 
to markers associated with differentiated states, such as those related to 
osteogenesis, for example osteopontin and osteocalcin (Kulterer et al., 2007). 
ALCAM (CD166) is another marker used as an indicator of stem cell state 
(McMurray et al., 2011), however, it is believed to define a population of MSCs 
that are beginning to commit to differentiation.  
 
 A summary of the markers used in this study is shown in Table 1-1. 
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Name Description Marker type 
CD271/p75NTR Surface antigen MSC marker 
STRO-1 Surface antigen MSC marker 
CD166/ALCAM Surface antigen  MSC and early 
progenitor marker 
Osteocalcin (OCN) Bone mineralisation Osteogenic marker 
Osteopontin (OPN) Bone mineralisation Osteogenic marker 
CD63 Surface antigen  MSC marker 
Nestin Intermediate filament 
protein 
Bone marrow niche 
marker  
Table 1-1: MSC and differentiation cell surface markers used in the study.  
 
 
Bone marrow-derived MSCs offer the advantage of being relatively easily sourced 
from patients undergoing routine (orthopaedic) knee/hip arthroplasty (Al-
Nbaheen et al., 2013, Gothard et al., 2014). Isolated cells can be further 
expanded in vitro and have formed the basis of many studies into their potential 
use in regenerative medicine. Although MSCs can now be derived from 
alternative sources such as dental pulp, olfactory mucosa and adipose tissue 
(Bunnell et al., 2008, Tomé et al., 2009, Johnstone et al., 2011, Pisciotta et al., 
2015), historically, much work has been carried out on bone marrow-derived 
MSCs, and thus the latter source is used throughout this thesis. The abbreviation 
MSCs will be used from herein to refer to bone marrow-derived mesenchymal 
stem cells.   
 
1.4.2 The role of the niche in regulation of stem cells 
 
MSC division must be subjected to strict regulation in order to maintain 
adequate pools of non-differentiated cells and to provide the required 
committed progenitor cell types to surrounding tissues when necessary as a 
response to injury (Ehninger and Trumpp, 2011). The supporting 
microenvironments of stem cells in the body are often referred to as a ‘niche’; 
Schofield proposed the concept in 1978 which has been widely accepted as the 
method by which different types of stem cells are maintained and regulated 
(Schofield, 1978). The niche incorporates the progeny stem cells, supporting 
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cells and structures that immediately surround the stem cell populations that 
reside there (!"#$%&'()H). Stem cells within the niche are exposed to growth 
factors, have interactions with cells within the same localized vicinity, as well as 
with their extracellular environment in the formation of cell contacts, all of 
which have influence on eventual stem cell fate (Kerever et al., 2007). Thus the 
environments in which MSC populations reside contain components that provide 
instructional cues in directing stem cell differentiation or maintenance of 
phenotype, and that additionally serve to regulate the processes of cell growth 
and survival.  
 
Aside from eliciting specific cell growth and differentiation behaviours, many 
stem cells in their niche enter a state of quiescence that prevents their 
progression through the cell cycle (Kunisaki et al., 2013). When required, stem 
cells will integrate into tissues via the production of progeny or ‘transit 
amplifying’ cells (Hsu et al., 2014). For example, in response to injury or 
disease, homing of these cells will occur, followed by terminal differentiation 
into the required cell type (Rustad and Gurtner, 2012, Eseonu and De Bari, 
2015). However, despite the extensive research on stem cells, which spans many 
years, mammalian stem cell niches are poorly understood, and the precise 
location of the stem cell niches are often widely debated (Meirelles et al., 2006, 
Ehninger and Trumpp, 2011, Lander et al., 2012). Although, MSCs can be found 
in several different sites in the body, these do not necessarily constitute a niche 
unless there is evidence that the environment contributes both anatomically and 
functionally to preserve the stem cells that reside there.  
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Our knowledge of stem cell niches is thus far limited to several types, including 
that of the germline stem cell niche in Drosophila melanogaster, the neural 
stem cell niches in the brain, the epidermal stem cell niche in the hair follicle 
and HSCs in the bone marrow niche (Song et al., 2002, Doetsch, 2003, Blanpain 
et al., 2004, Mendez-Ferrer et al., 2010). In recent years, more evidence 
pertaining to the bone marrow niche has come to light, clarifying some of the 
implicated components and describing a number of residing cell types, each 
commanding functionalities to maintain homeostasis within the 
microenvironment. It has been suggested that a self-renewing population of 
MSCs in the bone marrow, characterised by their positive nestin expression, act 
as supporting cells of HSCs (Mendez-Ferrer et al., 2010). When the number of 
nestin+ MSCs was decreased, this had a detrimental impact on the ability of HSCs 
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to ‘home’ towards the MSCs, and instead they migrated towards the spleen 
(Mendez-Ferrer et al., 2010). Evidence points to MSCs being located in the 
endosteum and on the sinusoidal vessels (as part of the perivascular niche) 
perforating the marrow (Ehninger and Trumpp, 2011). Their placement within 
the niche brings them into close proximity to interact with neighbouring cells 
and to support and regulate other stem cells, such as in their interaction with 
HSCs (Ehninger and Trumpp, 2011).  
 
The understanding that the multitude of localised physical, chemical and 
cellular components in a cell’s microenvironment all have influence on cell 
behaviour, have both inspired and influenced research and design concepts in 
tissue engineering (Burdick and Vunjak-Novakovic, 2008, Ma, 2008). Scientists 
have attempted to replicate characteristic properties of stem cell niches in 
order to study stem cell behaviour in an environment that more closely 
resembles that which is observed in vivo (Ko and Cho, 2013, Mano, 2015). This 
can sometimes pose a challenge, as biological niches can be very complex, and 
require 3D geometric positioning of multiple cell types and molecules (Saleh et 
al., 2012), which is difficult to recapitulate in vitro. An example of such a study 
is the spatial positioning of MSCs and endothelial cells to investigate their 
migration relative to each other using tunable hydrogel shapes (Eng et al., 
2013). Nevertheless, creating culture systems that resemble physical attributes 
of a cell’s native environment appears to be of benefit to preserving the self-
renewal capacity of stem cells: an example being muscle stem cells which were 
cultured on a softer hydrogel instead of tissue culture plastic, recapitulating the 
characteristic physiological tissue rigidity, were successfully propagated in an 
undifferentiated state and subsequently regenerated muscle following 
transplantation (Gilbert et al., 2010).   
 
Hypotheses have been proposed that suggest the niche has a role in orientation 
of both the cell and spindle that define whether stem cell division will be 
symmetric or asymmetric (Quyn et al., 2010, Yadlapalli and Yamashita, 2012). 
Symmetric division can either result in two daughter stem cells (self-renewal) or 
two differentiated cells (lineage commitment), whilst a stem cell dividing 
asymmetrically will produce a daughter stem cell and a differentiated cell 
(Morrison and Kimble, 2006).  Details about how this ‘decision process’ of 
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division takes place remains unclear. This may involve spatial positioning of 
differentiation or stem cell retention factors such that the daughter cell will 
either be committed to overcome its ‘stemness’ state, or used to maintain the 
stem cell pool. In a hypothetical model proposed by Fuchs et al. (!"#$%&'()J), the 
polarity of a stem cell will be determined by its interaction with neighbouring 
stem cells within the niche as well as its contact with the basal surface (such as 
the basal lamina)(Fuchs et al., 2004). These two determinants will in turn affect 
the distribution of internal cell fate determinant molecules, and alter mitotic 
spindle orientation into an arrangement favourable for asymmetric renewal 
(determinants at the apical region) or symmetric renewal (determinants located 
at the lateral region) (Fuchs et al., 2004).      
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1.5 Topography: from micro to nano 
 
Introducing patterned features (topography) to the surface of a biomaterial is a 
simple way to integrate physical stimulating cues to a base substance. The 
earliest study of cell response to physical cues was in 1914 when Harrison 
observed that frog embryonic cells showed a response when grown on strands of 
spider silk (Harrison, 1914). It appeared that the mechanical stiffness of the 
fibres was the key factor that allowed the cells to extend and spread in a 
unidirectional manner (Harrison, 1914). Following his initial discovery, other cell 
types (such as fibroblasts, osteoblasts, and neuronal cells) were have been 
shown to be affected by topographical features such as grooves, which had 
visible effects on cell morphology and behaviour (Hsu et al., 2007, Biggs et al., 
2008, Biggs et al., 2009b, Brydone et al., 2011). Early pioneering work described 
observations such as these as exhibition of ‘contact guidance’, defined as 
alignment with substrate features (Weiss, 1945). Curtis and Varde attributed 
these cellular changes to a reaction to aspects of the topographical features 
themselves (Curtis and Varde, 1964). The idea here being that cells must be 
sensitive to their microenvironment due to the size of physical features being of 
the same scale as the cell. This means that interaction between proteins and 
structural features can feasibly occur.  
 
Early research identified that cells respond to patterning at a micro-level with 
the use of photolithographic techniques employed in the microelectronics 
industry in the construction of simple topographies. The foremost topographical 
substrates made use of features such as steps (Clark et al., 1987), ridges, fibres 
and grooves (Clark et al., 1990), the majority of which were of micron scale due 
to limitations in fabrication technologies at the time. A microtopography 
consisting of a series of heightened steps impeded cell movement across the 
features and thereby cell alignment (contact guidance) (Clark et al., 1987), and 
in a continuing study, increasing depth of parallel grooves caused increase in the 
degree of cell alignment (Clark et al., 1990). Research findings largely agreed 
with Dunn and Heath’s hypothesis, and demonstrated that the shape of substrate 
features would physically restrict microfilaments, requiring the cell to alter its 
morphology to accommodate the substrate. In Dunn and Heath’s original study, 
fibroblasts were observed to develop shorter protrusions at the cell edges if the 
curvature of the substrate had a steeper angle, which contributed to the 
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changes in overall cell morphology (Dunn and Heath, 1976). These observations 
formed the foundations of our understanding of the effects of topography on cell 
function, and led to exploration into the use of biomaterials to recapitulate this 
natural phenomenon in cell regulation.   
 
Furthermore, the influence of geometry of substrates was exhibited with 
fibroblasts seeded on regular arrays of pits of microscale diameters and spacing 
(Berry et al., 2004). The cells appeared to move into the pits or respond to the 
grooves. The largest diameter of pit tested allowed the cells to enter or exit the 
pits and form large focal adhesions, whereas the smallest diameter of pit 
appeared to promote motility and allow cells to form smaller focal adhesions 
(Berry et al., 2004). A common theme of these prior studies is an indication that 
the underlying effect of topographies is dependent in the resultant ability of a 
cell to form outreaching protrusions, leading to the development of focal 
contacts and adhesions on the substratum.  
 
As tools and techniques in the electronics and semiconductor industries began to 
become more advanced and refined, scientists have exploited these technologies 
to further reduce topography feature sizes from the microscale to the nanoscale 
level (Gadegaard et al., 2006, Bettinger et al., 2009) (!"#$%&'()L). Advantages 
arise in the regularity conferred by use of electron beam lithography, used to 
‘write’ the pattern shapes onto a master silicon wafer.  Production of features 
with precise positioning and size can be achieved (Altissimo, 2010). It is 
important to maintain this degree of uniformity as it has previously been shown 
that cells respond differently if the spacing of nanotopographical features varies 
(Dalby et al., 2007, Gadegaard et al., 2008, McMurray et al., 2011). The silicon 
wafers with the master pattern can then be sputter coated with nickel and 
further electroplated with nickel. The metallic ‘shim’ can then be removed from 
the silicon master to provide a negative of the pattern in a hard material. This 
shim can then be used for embossing and injection moulding of thermoplastics 
down to 5 nm fidelity (Gadegaard et al., 2003). 
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These smaller nanoscale features can now be produced at the same scale as cell 
receptors (for example the human fibronectin receptor is approximately 8 nm in 
diameter)(Nermut et al., 1988), to allow for interactions between intrinsic 
protein and molecular components and nanotopography (Dalby et al., 2014). 
Consistent with the possibility that nanotopographies possess the capability to 
regulate cellular processes through activation of membrane receptors and 
signalling pathways, many cell types indeed show specific responses to particular 
nanoscale fabrications that fall within a size range (Gallagher et al., 2002, Curtis 
et al., 2004, McNamara et al., 2011).  Through replication of characteristics of 
the ECM, alterations at the nanoscale level should allow for changes at greater 
magnitudes, affecting cellular processes, thereby having a wider influence over 
the entire cell.  
 
Direction of stem cell behaviour with nanotopography has shown a degree of 
promise. Proliferation and differentiation of neural stem cells was affected 
following culture on polyethersulfone fibre meshes in comparison to standard 
tissue culture plastic (Christopherson et al., 2009). A trend for decreasing 
proliferation rates with increasing mesh fibre diameters was noted, and 
different diameters were seen to allow cells to differentiate preferably to glial 
or to neuronal lineages (Christopherson et al., 2009). Chen et al. demonstrated 
that human ESCs could undergo self-renewal over long periods on vitronectin-
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coated smooth glass (exhibiting lots of filopodial protrusions), whereas 
vitronectin-coated nanorough glass surfaces (with a low degree filopodial 
extensions) induced spontaneous differentiation (Chen et al., 2012). Response of 
MSCs to nanotopography has also garnered significant attention; studies have 
reported the direction of MSCs to undergo differentiation (Dalby et al., 2006b) 
and self-renewal (McMurray et al., 2011). Examples whereby nanotopographical 
induction of osteogenic differentiation in MSCs was achieved include culture on 
titanium substrates patterned with nanopillars (McNamara et al., 2011), and 
using disordered nanopit poly(methyl methacrylate) substrates (Dalby et al., 
2007). Although some success has been reached with regards to promoting MSC 
differentiation, it is the continuation of the self-renewal process that presents 
the greater challenge.  
 
1.5.1 Directing MSC phenotype with nanotopography 
 
MSC differentiation to a particular lineage can be achieved with the use of 
differentiation media containing a cocktail of soluble chemical factors, however, 
the use of nanotopography confers a distinct advantage. Physical cues on the 
substrate can direct MSC behaviour without having to control the release of any 
soluble factors or molecules. Previous work had shown that nanotopography 
alone was effective in promoting MSC differentiation to an osteoblastic lineage 
(Dalby et al., 2007) and in maintaining a stem cell self-renewing state (McMurray 
et al., 2011). In these cases, the nanopit features on each surface were 
identical, with only the degree of disorder being changed between them; thus it 
appears that distribution of the nanotopographical features is of importance to 
the eventual behaviour of the cells. A highly ordered square lattice arrangement 
(SQ) of nanoscale pits (120 nm diameter, 100 nm depth and 300 nm centre-
centre spacing) was shown to promote self-renewal of MSCs (McMurray et al., 
2011). However, a slightly disordered ‘near square’ arrangement (NSQ, similar to 
SQ, but with a random, up to ±50 nm offset in the X and Y position of the pit 
from the centre position) having geometry similar to collagen X (Kwan et al., 
1991), swayed MSCs in favour of osteogenesis (Dalby et al., 2007). As mentioned 
in the previous section, it has been demonstrated that nanotopography can 
promote osteogenic differentiation of MSCs (Zouani et al., 2012), with further 
studies showing enhanced induction of chondrogenesis (on polycaprolactone 
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fibres, though cultured in the presence of transforming growth factor beta 1; 
TGF-"1)(Wise et al., 2008), neural differentiation (Yim et al., 2007), and 
myogenesis (Teo et al., 2013). 
 
It has been observed that grooved nanotopography caused alignment of MSCs 
with decreased expression of integrin subunits, suggesting that nanotopography 
is a principal factor that affects the distribution and clustering of focal 
adhesions (Yim et al., 2010). Moreover, previous work on nanopitted surfaces 
has indicated that the number and size of focal adhesions vary between MSCs 
cultured on nanotopographical substrates compared to planar controls (Biggs et 
al., 2009a). McMurray et al. further highlighted that a Rho-associated kinase 
(ROCK) is important in creating the high degree of intracellular tension 
(conferred by the ECM) that favours MSC differentiation to osteoblasts and the 
low tension state that drives differentiation to an adipocyte lineage, with tensile 
force also likely to have a part in the maintenance of MSC multipotency 
(McMurray et al., 2011). Therefore, the transmission of physical forces from the 
ECM to the nucleus by means of the cytoskeleton (direct mechanotransduction) 
is one mechanism that may explain how a cell adapts expression of genes in 
response to topographical cues (Alenghat and Ingber, 2002). In turn, this notion 
correlates with the ‘tensegrity’ (tensional integrity) theory, which assumes that 
a continuous state of tension exists, generated by microfilaments and 
intermediate filaments, which is resisted by microtubules (Ingber, 1993). Any 
mechanical stress on the cell could therefore result in deformation of the 
nucleus and rearrangement of chromosomes to evoke changes in gene expression 
(Dalby, 2005).    
 
The scale of nanofeatures confers an exciting ability to manipulate the spatial 
arrangement of integrin clustering and focal adhesion formation, with larger 
focal adhesions being detected in MSCs cultured on the disordered NSQ 
nanotopography that stimulated differentiation to osteoblasts (Dalby et al., 
2007). The process of indirect mechanotransduction, involving integrin receptors 
and focal adhesions in the activation of intracellular signalling cascades and 
chemical messengers could be another mechanism at work (Dalby, 2005). 
Interestingly, nanotopographies appear to enhance the sensitivity of MSCs to 
mechanical signals, effectively increasing the degree of mechanotransduction 
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(Salvi et al., 2010), likely to be caused by certain regions of the surface being 
conducive to promoting or impeding cell attachment (Cavalcanti-Adam et al., 
2008). Focal adhesion kinase (FAK) is associated with the cytoplasmic tails of 
integrins, ideally placed for signal transduction upon activation by the integrins 
themselves. It has been shown that FAK and signalling mediator c-Src can 
activate extracellular signal-related kinase ERK2 (Schlaepfer et al., 1998), which 
is involved in proliferation. Inactivation or downregulation of cascades such as 
the extracellular signal-related kinase (ERK) and p38-mitogen activated protein 
kinase (MAPK) pathways leads to a decrease in transcription factors such as Runt 
related transcription factor (Runx2) which are crucial for osteogenesis (Artigas 
et al., 2014), and may offer a potential explanation as to how the 
aforementioned SQ nanotopography maintains MSC self-renewal (McMurray et 
al., 2011).  
 
These themes of adhesion, cytoskeleton and mechanotransduction will be 
explored in more detail in subsequent sections. 
     
1.6 Control of MSC growth 
 
Several studies report that MSCs undergo spontaneous differentiation when 
cultured over time on standard tissue culture plastic-ware (Naruse et al., 2004). 
Long periods of culture and passaging in vitro cause MSCs to become senescent 
(Cheng, 2011), which restricts the window at which they can be effectively used 
for clinical applications. To date, limited work has been carried out on MSC self-
renewal because it has been difficult to control this process until now, and much 
of the existing literature on self-renewal is based on studies that have been 
carried out on pluripotent stem cells. However, the precise mechanisms 
implicated in self-renewal remain largely unknown, however, some possible 
regulators have been suggested from results of related studies. Though mouse 
ESCs could be continuously expanded in culture by provision of leukaemia 
inhibitory factor (LIF), which induces STAT3 signalling (Williams et al., 1988), 
contradictory results report LIF having little effect on human ESCs (Thomson et 
al., 1998, Dahéron et al., 2004), showing that there must be differences in 
mechanisms between ESCs between different species.  
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MicroRNAs (non-coding RNAs) and transcription factors influence ESC self-
renewal and differentiation. MicroRNAs suppress or reinforce cellular processes, 
therefore can enhance or impede self-renewal (Melton and Blelloch, 2010). 
Melton et al. proposed that ESC cell cycle regulating (ESCC) miRNAs and the let-
7 miRNA family have opposing effects on each other, with the ESCC miRNAs 
acting to prevent the suppressive action of let-7 on self-renewal (Melton et al., 
2010). Balance of transcription factors is also pivotal to preservation of self-
renewal. The presence of transcription factor Nanog was associated with 
maintenance of ESC state whilst depletion increased endoderm differentiation 
(Mitsui et al., 2003).The self-renewal aspects of Nanog were attributed to an 
ability to repress differentiation-promoting genes, such as gata4 and gata6 
(Mitsui et al., 2003).  
 
Regulation and coordination of the cell cycle is likely to be implicated in stem 
cell self-renewal, and has been explored in ESCs and HSCs (Orford and Scadden, 
2008). Cell cycle will be discussed in further detail in section 1.8. Finally, self-
renewal can be promoted by culture on synthetic substrates. Deng et al. 
cultured human iPSCs on a synthetic substrate tethered with peptide ‘brushes’, 
which allowed for long-term self-renewal and expansion of the cells up to ten 
serial passages. This was evidenced by maintenance of characteristic morphology 
and pluripotency markers, and observations of cell adherence and proliferation, 
suggesting that physical cues have a role (Deng et al., 2013).  
 
1.6.1 Mechanotransduction 
 
Physical cues and mechanical stimuli from the ECM or surface of a substrate are 
converted to biochemical signals through the process of mechanotransduction. 
The key initiation point of mechanotransduction is located at the interface 
between the cell and ECM. This is where integrins and protein receptors are 
found, which means that they are ideally placed for cell sensing of their 
environment, to form focal adhesions (FAs) to assist adhesion, and to transduce 
external signals into the cell.  
These biochemical signals in turn lead to alterations in gene expression and cell 
signalling pathways, that can result in functional changes as an adaptive 
response to the initial stimulus. Mechanical stimuli may consist of external 
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forces conferred on the cell such as tension or fluid shear stress, or internal 
forces arising from intracellular adjustments of cellular stiffness in response to 
alterations in stiffness of the ECM (Dahl et al., 2008). Mechanotransduction can 
be either direct or indirect, depending on how the signal is relayed to the 
nucleus (McNamara et al., 2010). Signal propagation through direct 
mechanotransduction is achieved through force-induced adjustments in 
cytoskeletal conformation and cellular morphology that in turn, cause 
deformations in the nucleus and redistribution of chromatin or conformation 
changes in DNA (Dahl et al., 2008, Wang et al., 2009).  
 
Indirect mechanotransduction is achieved through activation of signalling 
pathways to transfer information to the nucleus, primarily the extracellular-
signal-regulated kinase/mitogen-activated protein kinase (ERK/MAPK) signalling 
cascade, induced at the level of focal adhesions and integrins (Dalby et al., 
2014). The ERK/MAPK pathway has been implicated in proliferation and 
differentiation, and is therefore of particular interest with regards to 
understanding the regulation of stem cells (Li et al., 2007, Gharibi et al., 2012, 
Michailovici et al., 2014). Studies on the interaction between cells and 
biomaterial substrates have additionally indicated that focal adhesion kinase 
(FAK) and integrin-linked kinase (ILK) have roles in mechanotransduction (Sun et 
al., 2012). 
 
Integrins and focal adhesions, the adhesion components that work together in 
tandem to initiate the process of mechanotransduction will be discussed in the 
following sections.  
 
1.6.2 Integrins 
 
Integrins are a large family of cell surface, heterodimeric transmembrane 
receptors, involved in cellular adhesion and bidirectional signalling between the 
ECM and from within the cell itself. This allows a direct association between the 
intracellular and extracellular environments to be established. Integrins can 
simultaneously bind proteins in the extracellular matrix such as fibronectin, 
vitronectin, collagen and laminin, whilst the inner cytoplasmic domain connects 
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to the actin cytoskeleton (Selhuber-Unkel et al., 2010) via linker proteins 
including #-actinin, paxillin, talin and vinculin (Zamir and Geiger, 2001). 
They are composed of alpha (#) and beta (") subunits. There are 18 # and 8 " 
subunits thus far known to exist in mammalian cells, which combine and 
assemble into 24 different integrins, each with a distinct functionality and 
binding specificity to particular extracellular proteins (Hynes, 2002, Humphries 
et al., 2006).  This means that varied responses can be induced from each type 
of integrin (Zaidel-Bar et al., 2007). Each (heterodimer) subunit spans the 
membrane once, and possesses a large extracellular ‘head’ domain (>1600 amino 
acids), and two shorter cytoplasmic ‘tail’ domains (20-50 residues) (Hynes, 
2002). The crystal structure of integrin #V"3 ‘at rest’ and its structure when 
bound to a ligand, revealed a ‘bent’ inactive conformation when no ligand was 
bound (Xiong et al., 2001, Xiong et al., 2002). Upon ligand binding, the structure 
exhibits an extended and open conformation to allow interaction between the 
integrin and focal adhesion proteins. Thus the open form exhibits high affinity 
for the ligand, whereas the closed form has low affinity for the ligand (Shimaoka 
et al., 2001). In general, integrins recognise ligand motifs, which can be 
exploited to facilitate ligand binding, such as the widely recognised arginine, 
glycine, aspartic acid (RGD) peptide sequence (Humphries et al., 2006).  
 
Ligand binding to the extracellular domain establishes a direct link from the ECM 
to the nucleus via the cytoskeleton and associated proteins, allowing for 
integrin-mediated signalling to take place (Hynes, 2002). ‘Inside-out’ signalling 
describes the intracellular regulation of binding activity in the extracellular 
domains of the receptor (Calderwood, 2004). ‘Outside-in’ signalling refers to 
binding of ligands in the ECM which produces signals that are subsequently 
transferred into the cell via focal adhesions and the cytoskeleton (Hynes, 2002). 
Integrins have pivotal roles in mediating interactions from cell-to-cell, in 
addition to those between the cell and extracellular environment, making them 
essential to maintenance of cellular integrity (Raducanu et al., 2009, Watson et 
al., 2010). Furthermore, contraction of the cytoskeleton pulls clusters of 
integrins together (integrin gathering) to assemble growing adhesions; this 
means that larger adhesions form in response to a higher degree of tension in 
the cytoskeleton (Dalby et al., 2014).   
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Integrins appear to be a crucial element of cell response to nanotopography (Teo 
et al., 2013). For osteogenic commitment from MSCs, high degrees of adhesion 
and resultant increase in intracellular tension have been shown to be critical 
(McBeath et al., 2004, Kilian et al., 2010). Indeed, on the osteogenic, NSQ, 
nanotopography, adhesion size was noted to be much larger on the planar 
controls (Biggs et al., 2007b).  
!
1.6.3 Cell-extracellular matrix adhesions  
 
Adhesions between the cell and the extracellular matrix assist anchoring of the 
cell in addition to acting as bridging sites between the actin cytoskeleton and 
the ECM for integrin-mediated signal transduction (Alenghat and Ingber, 2002). 
Furthermore, adhesions are important in the processes of migration and 
spreading (Aplin and Juliano, 1999, Ballestrem et al., 2001).  Different types of 
cell adhesions are characterized by their size, location and constituent 
components. The smallest are focal complexes (of approximately 1 µm 
diameter), which are located primarily around the cell periphery, near the 
lamellipodia at the leading edge of the cell (Nobes and Hall, 1995, Galbraith et 
al., 2002). Focal contacts or focal adhesions are larger and can be found within 
the cell in addition to the periphery, typically measuring 1-5 µm in length (Zamir 
and Geiger, 2001, Biggs and Dalby, 2010)(!"#$%&'()M). Fibrillar or supermature 
adhesions compose the largest size of adhesions (>5 µm) and extend from focal 
adhesions in the central region of the cell (Wozniak et al., 2004).  
 
During initial adherence of a cell to a surface, membrane protrusions are 
stabilised as integrins bind to the ECM and begin to cluster together (Wozniak et 
al., 2004). The integrin receptors involved will be largely dictated by the 
constituents of the ECM as integrins demonstrate specificity for particular ligand 
motifs.  
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One of the main ECM adhesion proteins, fibronectin, leads to the development of 
focal adhesions containing integrin #v"1 (Zhang et al., 1993), while vitronectin in 
the ECM will drive formation of focal adhesions containing integrin #V"3 (Horton, 
1997). Consequently, the smallest adhesions, focal complexes are formed, and 
mature into focal adhesions in response to subsequent changes in intracellular 
tension (Bershadsky et al., 1985, Riveline et al., 2001). Due to the fact that 
focal adhesions are formed as a result of protein clustering, they comprise an 
assembly of proteins, of which focal adhesion kinase (FAK) and adaptor proteins 
#-actinin, paxillin, talin, tensin and vinculin are usually present, as well as Src 
tyrosine kinases (Calalb et al., 1995, Miyamoto et al., 1995, Chen and Lo, 2003, 
Lawson et al., 2012). Larger mature adhesions can be distinguished by the 
additional recruitment of zyxin (Zaidel-Bar et al., 2004). In particular, vinculin is 
an important adaptor protein that translocates to focal adhesions and is involved 
in regulating cell adhesion and force transduction (Humphries et al., 2007). 
Depletion of vinculin is detrimental to adhesion and motility as vinculin is 
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thought to link actin filaments to integrins, together with #-actinin and talin 
(Coll et al., 1995).   
 
Members of the ras-related GTPase family (Rho, Rac and cdc42) are pivotal to 
the formation of stress fibres, focal adhesions, lamellipodia and filopodia (Ridley 
and Hall, 1992, Ridley et al., 1992, Nobes and Hall, 1995). Focal adhesion 
formation is dependent on myosin II contractility, activated by Rho-associated 
kinase (known as Rho-kinase or ROCK), a downstream target of Rho GTPase 
(Riveline et al., 2001). When localized tension was applied to GFP tagged-
vinculin-containing focal complexes, they developed into focal adhesions within 
the vicinity of the applied stress, with Rho inhibition suppressing this observed 
effect (Riveline et al., 2001). Rho and Rac proteins are additionally established 
as having actions downstream from surface receptors, being involved in diverse 
signalling pathways (Schwartz, 2004). A hierarchical relationship exists between 
cdc42, Rac and Rho, where activation of cdc42 leads to activation of Rac, which 
stimulates Rho (Nobes and Hall, 1995). Following activation of Rho, actin 
polymerisation is initiated, resulting in the development of stress fibres (Ridley 
and Hall, 1992, Nobes and Hall, 1995, Chrzanowska-Wodnicka and Burridge, 
1996). In turn, stress fibres are attached to the plasma membrane by way of the 
aforementioned focal contacts (Naumanen et al., 2008).   
 
The spatial distribution of ligands and subsequent gathering of integrin receptors 
is pivotal to focal adhesion formation. A distance of 58-73 nm between ligands 
was proposed by Arnold et al as being optimal for successful receptor 
accumulation (Arnold et al., 2004). Distance between integrin ligands (local 
ligand density), and whether the required ligand distribution is spread 
throughout the surface or confined to localised regions (global ligand density), 
has been investigated for integrin #V"3 (Deeg et al., 2011). It was demonstrated 
that the local density was the more dominant factor in influencing formation of 
focal adhesions (Deeg et al., 2011). Focal adhesions can alternatively form 
through adhesion bridging, whereby structural proteins vinculin and zyxin can 
stretch to span patches of vitronectin or fibronectin to form a focal adhesion 
bridge with another adhesion (Malmström et al., 2011). As integrins did not 
undergo adhesion bridging, this suggests that an excess of adhesion is not 
required for focal adhesion formation. Furthermore, the concept of bridging can 
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be applied to nanopatterned substrates, where it is likely there will be regions 
of a surface that will encourage larger adhesions in addition to areas where it 
will be difficult for adhesions to develop.  
 
FAK is a tyrosine kinase and a crucial downstream constituent of integrin-
mediated signalling, that has been shown to be important for cell migration 
(Wang et al., 2001) and in promoting adhesion maturation. FAK is activated by 
auto-phosphorylation of tyrosine residues following clustering of integrins. 
Tyrosine-397 (Tyr397) is the most documented activation site, with other 
phosphorylation sites being identified as tyrosine-407, -576 (Tyr576), -577 
(Tyr577), -861 and -925 (Ciccimaro et al., 2006). Tyrosine phosphorylation 
appears to only occur following recruitment of vinculin, paxillin and FAK to the 
focal adhesions themselves (Kirchner et al., 2003). Following phosphorylation at 
Tyr397, Src is able to bind to FAK via the Src-homology 2 (SH2) domain, 
facilitating phosphorylation at Tyr576 and Tyr577.  FAK can subsequently 
interact with phosphatidylinositol kinase (PI3K) to achieve cell adhesion (Chen et 
al., 1996) and migration (Reiske et al., 1999). 
 
The notion of focal adhesions acting as mechanosensors, and integrins as process 
regulators, provides a mechanism as to how cells respond to changes in substrate 
mechanical stiffness and tension (Cavalcanti-Adam et al., 2008, Selhuber-Unkel 
et al., 2010, Prager-Khoutorsky et al., 2011). Cell spreading is limited on a soft 
collagen gel in comparison to a stiff gel or glass substrate (Engler et al., 2004). 
Stress fibres are typically observed to be well ordered throughout the cell 
together with the presence of defined focal adhesions on the rigid substrates 
(Engler et al., 2004). Interestingly, stem cell differentiation can be directed 
through culture in gels of differing elasticities, with differentiation to an 
osteogenic phenotype being observed with stiffer gels, and differentiation to 
myogenic and neuronal lineages being observed with softer gels (Engler et al., 
2006). This may be due to the substrates allowing focal adhesions of sufficient 
size and stability to be formed; for example, osteoblasts typically possess many 
supermature adhesions (Biggs et al., 2008). 
 
Furthermore, cell morphology has been indicated as affecting MSC 
differentiation, as constraining MSCs within geometric features that increase 
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actomyosin contractility favoured osteogenic differentiation (Kilian et al., 2010). 
Prominent F-actin stress fibres were found at the edges of cells cultured on the 
differentiation-promoting star-shaped micropattern, with concomitant 
concentration of vinculin, and thereby focal adhesions, at the points of the 
shape (Kilian et al., 2010). Moreover, ERK signalling cascades can be activated 
following maturation and elongation of focal adhesions, which may influence 
proliferation and differentiation (Fincham et al., 2000, Biggs et al., 2009b). 
Thus, there is evidence that focal adhesion signalling can affect eventual stem 
cell fate (Kilian et al., 2010, Gautrot et al., 2014). However, as the assembly 
and turnover of focal adhesions is complex and dynamic (Ballestrem et al., 
2001), all the details pertaining to the mechanisms of these processes are 
difficult to ascertain. A further insight into the complexity of focal adhesions can 
be observed with the plethora of known interacting proteins and components 
that comprise the focal adhesion assembly, connecting integrins to the actin 
microfilament network (collated from published experimental data), which 
currently stands at 156 associated components with 690 modifying interactions 
(Zaidel-Bar et al., 2007).  
 
Whilst adhesion requirements for osteogenesis are becoming well known, for 
self-renewal this is less explored. Assessment of focal adhesions on the SQ and 
NSQ nanotopographies after three days culture revealed that a greater number 
of longer adhesions and higher levels of phospho-myosin were detected on the 
differentiating NSQ surface in comparison to SQ (Tsimbouri et al., 2012, 
Tsimbouri et al., 2014). Furthermore, pharmacological inhibition of ERK1/2 
caused a drop in stem cell marker gene expression (Tsimbouri et al., 2012). 
Together, this indicates that differences in adhesion and tension profile of MSCs 
are associated with differentiating and self-renewing phenotypes. Changes in 
adhesion and downstream signalling will impact on ERK cascades and suggests 
potential control of cell growth in a way that could mediate self-renewal.  
 
1.7 The cytoskeleton 
 
Protein filaments and molecular motor proteins mesh together in a network to 
form the cytoskeleton in eukaryotic cells (Pollard, 2003). The cytoskeleton 
carries out an array of fundamental and diverse functions, assisting the cell in 
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retaining its rigidity and shape when faced with mechanical stresses (Luna and 
Hitt, 1992), being involved in cell motility and migration (Pollard, 2003), and 
reorganising the cell to undergo morphological adaptations (Sims et al., 1992). 
Furthermore, the cytoskeleton facilitates transport and positioning of organelles 
and small molecules, utilising motor proteins, kinesin, dynein and myosin 
(Hirokawa et al., 2009). The three major constituents that are involved in 
shaping the cell architecture are cytoskeletal protein filaments; actin filaments 
(microfilaments), intermediate filaments and microtubules (Fuchs and Weber, 
1994)(!"#$%&'()N). Dynamic assembly and disassembly of these components takes 
place within the cytoskeleton, corresponding to fluctuations in the requirements 
of the cell (Vadlamudi et al., 2002, Iwasa and Mullins, 2007).  
 
Actin filaments (F-actin) are made from monomeric units of globular G-actin 
(Oda et al., 2009). Assembled actin bundles are described as microfilaments, 
and actin filaments can join with motor proteins to form the actin cytoskeleton 
(Bremer and Aebi, 1992, Dos Remedios et al., 2003). Intermediate filaments are 
assembled from several types of proteins, and therefore vary in their subunit 
composition (Fuchs and Weber, 1994). They are structurally stable, and provide 
support to tubulin in conjunction with microtubules (Fletcher and Mullins, 2010). 
Some intermediate filaments are specific to certain cell types, and others, such 
as vimentin, are found in all cells (Cooper, 1985).  
Microtubules are hollow tube-like filaments formed from basic units of 
polymerised # and " tubulin heterodimers (Kadavath et al., 2015). These are the 
largest of the three types of filaments in the cytoskeleton, having a diameter of 
25 nm (Murphy et al., 2001, Mikhaylova et al., 2015).  
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1.7.1 The role of the cytoskeleton in mechanotransduction and 
cell sensing  
 
The dynamic nature of the cytoskeleton indicates the degree of responsiveness it 
must have to changes in the cell microenvironment. Firstly, cells must probe the 
physical and chemical composition of its surroundings to adapt accordingly to 
extracellular conditions (Albrecht-Buehler, 1979). Cells utilise numerous 
projected extensions, called lamellipodia, to explore the space and surface at 
which it inhabits (Albrecht-Buehler, 1976). Filopodia, are smaller actin-rich 
finger-like projections that have been implicated in ‘sensing’ of the 
microenvironment (Albuschies and Vogel, 2013). These structures are formed 
when actin polymerization is directed against cell membrane, generating force 
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(DeMali and Burridge, 2003). Actin filaments can also produce contractile forces, 
through formation of contraction bundles in conjunction with myosin II 
filaments, #-actinin and tropomyosin (Weber and Groeschel-Stewart, 1974, 
Lazarides, 1976). The energy derived from adenosine triphosphate (ATP) drives 
the motor domains of myosin II along the actin filament, generating contraction 
of the actin-myosin (actomyosin) bundle (Thoresen et al., 2011). Collections of 
actomyosin bundles in non-muscle cells are termed stress fibres (Chrzanowska-
Wodnicka and Burridge, 1996). Stress fibres tend to be less in number and 
thinner in structure in highly motile cells, whilst conversely, they are more 
numerous and larger in cells that do not migrate readily (Hotulainen and 
Lappalainen, 2006). Additionally, the formation of stress fibres appears to be 
more apparent on rigid substrates in comparison to soft surfaces (Prager-
Khoutorsky et al., 2011).       
 
The cytoskeleton is also known to have a role in mechanotransduction (Alenghat 
and Ingber, 2002). Any applied forces or mechanical stresses will be transferred 
to the cytoskeletal architecture, and many cell types have been shown to be 
mechanosensitive, ranging from osteoblasts to smooth muscle (Tang et al., 1999, 
Nomura and Takano-Yamamoto, 2000). The cytoskeleton itself can generate 
forces and relay them to adhesion sites. This coupling of the cytoskeleton with 
focal adhesions is central to the process of mechanotransduction as growth of 
focal adhesions can be induced by tension, demonstrated by the application of 
external forces (Pelham and Wang, 1997, Riveline et al., 2001). Changes in 
tension will additionally alter the distribution of the cytoskeleton and therefore 
impact on associated proteins. One identified mechanism that results from this 
is the exposure of protein binding sites in response to increased tension. An 
increase in binding could bring key proteins together and lead to activation of 
downstream signalling cascades (del Rio et al., 2009). Tension affects the 
conformation of fibronectin, and when released, promotes unfolding of the 
protein, which in turn exposes hidden binding sites (Baneyx et al., 2002). 
Alternatively, the arrangement of proteins will change if the cytoskeletal 
organization has been affected (Kubler et al., 1991), meaning that the 
interaction proximity of binding partners may become more favourable. These 
observations indicate that numerous mechanisms are likely to be occurring to 
facilitate mechanotransduction via the actin cytoskeleton.  
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If nanotopography can be used to increase the lifespan of MSCs, whilst 
preserving their differentiation potential, this would be of great benefit to the 
future of MSC treatments. This may be achievable by use of appropriately 
arranged mechanical cues to create an intermediate degree of intracellular 
tension, one that could be said to maintain a stem cell phenotype, and to allow 
sufficient interaction with integrins to trigger desired downstream pathways via 
the cytoskeleton.  
!
1.8 The cell cycle and its potential role in stem cell self-
renewal 
 
The cell cycle consists of a series of highly regulated phases resulting in cell 
division and production of two daughter cells. There are two growth phases, 
termed Gap 1 (G1) and Gap 2 (G2), a synthesis phase (S) and a mitotic phase 
(M). Cells that are not actively cycling (quiescent) exit G1 and are described as 
being in resting state, termed the G0 phase (Orford and Scadden, 2008, Cheung 
and Rando, 2013)(!"#$%&'()(O).  
 
The classic model of the cell cycle describes cyclin-dependent kinases (CDKs), 
having regulatory roles during specific phases (Malumbres and Barbacid, 2005). 
During early G1, D-type cyclins (D1, D2, and D3) bind to their respective cyclin-
dependent kinases (CDK4 and CDK6) forming complexes (Sherr and Roberts, 
1999). The resultant cyclin D-CDK complexes then initiate phosphorylation of 
retinoblastoma protein (Rb), thereby removing its repressive action on the E2F 
family of transcription factors (Matsumoto and Nakayama, 2013). These 
transcription factors become free to induce expression of cyclins E and A and 
other genes required to progress into S phase (Sherr and Roberts, 1999). The 
classical model has been challenged with the advent of knockout experiments 
with mice (Satyanarayana and Kaldis, 2009). These studies revealed that 
progression through the cell cycle was still possible without all of the CDKs being 
functional, due to compensatory mechanisms between cyclins and CDKs 
(Satyanarayana and Kaldis, 2009). For example, the ablation of CDK2 function 
was compensated for, by CDK1 and CDK4 (Barrière et al., 2007). Intriguingly, it 
has since been shown that the master regulator of the mammalian cell cycle is 
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CDK1, which can solely guide the cycle to completion, working in isolation from 
the other CDKs (Santamaria et al., 2007). 
 
The cell cycle is considered to be a prominent factor in the self-renewal of stem 
cells. Supporting evidence includes observations that bone marrow 
haematopoietic stem cells (HSCs) maintain their cell population and preserve 
their self-renewal capabilities by continuously switching between a state of 
quiescence and self-renewal, entering and exiting the cell cycle (Cheshier et al., 
1999, Wilson et al., 2008). The activities of CDKs are controlled by CDK 
inhibitors (Sherr and Roberts, 1999) and recent studies have suggested that 
inhibitor p57KIP2 (p57) has a role in both quiescence and self-renewal of HSCs 
(Tesio and Trumpp, 2011). Collectively, this evidence supports a theory that 
prevention of entry into G1 will preserve the self-renewal characteristic of stem 
cells.   
 
In trying to decipher MSC self-renewal, the G1 phase of the cycle is of particular 
interest. This is due to the fact that G1 is mitogen-dependent for progression to 
S phase (Matsushime et al., 1994). The G1/S checkpoint divides G1 into early 
and late phases. Once the cell passes this checkpoint and enters the late G1 
phase, any external stimuli will no longer have any effects, and the cell is 
committed to progression through the cell cycle (Tesio and Trumpp, 2011). 
Mouse embryonic stem cells have a shortened G1 phase, allowing them to 
progress through the cycle and proliferate quickly. This is due to sustained 
activation of the cyclin E-CDK2 complex, which deactivates the R checkpoint 
that separates early and late stages of G1 (Orford and Scadden, 2008). Induced 
pluripotent stem cells have also been reported to have a shortened G1 phase and 
faster proliferation rate (Ghule et al., 2011). As MSCs will garner instructional 
cues from the surface topography, this external stimulus may have strong effects 
during G1, in parallel with observations that G1 is important in HSCs and ESCs.  
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Integrin-related signalling could lead to changes in activation of ERK1/2, and 
studies have shown that ERK is critical for S-phase progression. Specifically, the 
presence of ERK2 protein maintains expression of cyclin-D1 during G1 (Cárcamo-
Orive et al., 2008). ERK also appears to have a role in down-regulating genes 
that are associated with suppression of S-phase entry, with down-regulation 
occurring when ERK is continuously activated (Yamamoto et al., 2006). 
Additionally, a link has been identified between the cell cycle and integrin-
mediated signalling, in that members of the Rho-family GTPases which regulate 
changes in the actin cytoskeleton and activate ROCK, are also implicated in 
continuous ERK activation (Welsh et al., 2001). Previous work showed that 
ERK1/2 was downregulated in MSCs on SQ nanotopography (Biggs et al., 2009b).  
However, the precise mechanisms underlying MSC self-renewal remain unclear. A 
model for stem cell self-renewal was suggested by Li and Clevers, (Li and 
Clevers, 2010) which consisted of populations of both quiescent and active state 
stem cells in contrast with the previous idea that an individual stem cell would 
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be able to support the whole tissue. For example, HSCs are directed to enter or 
exit into a quiescent state by their niche, in order to preserve a store of HSCs 
(Wilson et al., 2008).  
 
There is a link between cell shape, cytoskeletal tension and cell cycle 
progression, which could be at work in the niche and when cells are cultured on 
biomaterial substrates. More rounded and less well spread cells appear to be 
impeded in their progression past G1 into S phase (Huang et al., 1998). 
Moreover, fibroblasts that were unable to form stable attachments exhibited a 
downregulation of cyclin D1 and increase in expression of CDK inhibitors (Fringer 
and Grinnell, 2001).   
 
1.9 Thesis aims 
 
There is great potential for implementing the use of MSCs together with specific 
phenotype-inducing biomaterials for future medical applications. Furthermore, 
nanotopography has emerged as an important modulator of MSC processes in 
recent years. However, the caveats to wide-scale use of MSCs in regenerative 
medicine to-date are (i) limitations due to the low number of native cells, and 
(ii) a requirement for a method of effective expansion that maintains long-term 
symmetrical self-renewal.  
 
This work builds on the initial research into the SQ nanotopography, which 
showed much promise for providing long-term self-renewing physical 
instructional cues for bone marrow-derived MSCs. McMurray and colleagues 
demonstrated the ability of SQ nanotopography to maintain STRO-1 selected 
skeletal stem cells over a period of 8 weeks whilst retaining multipotency. 
Conversely, standard culture plastics do not allow MSC populations to be 
maintained, resulting in rapid differentiation of the cells reminiscent of a 
fibroblast-like phenotype. Having identified the nanocues that elicit stem cell 
self-renewal in addition to stimulating osteogenic differentiation, it is now 
possible to begin detailing the mechanistic processes that allow direction of the 
cells into particular phenotypes.  
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This work attempts to clarify MSC self-renewal induced on nanotopography. The 
NSQ surface will be used as a control for comparison, as a differentiating 
surface.   
 
The main aims of this study are: 
• To optimise culture and seeding conditions for best use of the SQ 
polycarbonate nanotopography, in order to maximise self-renewal of 
primary MSCs without the addition of chemical factors, and to investigate 
differences in the metabolism of cells cultured on different 
nanotopographies. 
• To assess levels of different cell cycle-related proteins and gene 
expression in synchronised MSCs cultured on SQ as they progress through 
the cycle, and look for wider networks and pathways through analysis of 
sequencing data. 
• To explore the potential application of SQ nanotopography for MSC 
reprogramming, using a wholly nanotopography-based system for 
investigation. 
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2  Chapter 2 
2.1 Materials and reagents 
 
2.1.1 Cell culture reagents 
Name  Supplier 
Dulbecco’s Modified Eagles Medium  Sigma-Aldrich 
Foetal bovine serum Sigma-Aldrich 
Minimum Essential Medium Non-Essential 
Amino Acids 
Gibco by Life Technologies 
L-Glutamine 200mM (100x stock) Gibco by Life Technologies 
Fungizone® Amphotericin B (250µg/ml) Gibco by Life Technologies 
Sodium Pyruvate (100mM)  Sigma Life Science 
Penicillin-Streptomycin (10mg/ml stock) Sigma-Aldrich 
1xTrypLETM Select cell dissociation 
solution 
Gibco by Life Technologies 
Trypsin 10x solution Sigma-Aldrich 
Versene* Made in house 
Hepes Saline* Made in house 
Phosphate buffered saline  Sigma-Aldrich 
Sodium chloride VWR Chemicals 
Potassium chloride VWR Chemicals 
Glucose Fisher Scientific 
HEPES Fisher Scientific 
Ethylenediaminetetraacetic acid (EDTA) Sigma-Aldrich 
Phenol Red indicator solution (0.5%) Sigma-Aldrich 
Ficoll-Paque PREMIUM density gradient 
media 
GE Healthcare Life Sciences 
EasySepTM Human CD271 Selection Kit  Stemcell Technologies 
Dimethyl sulfoxide (DMSO) Fisher Scientific UK 
Cdc42/Rac1 GTPase Inhibitor, ML141 Calbiochem, Merck Millipore 
 
2.1.2 Induction media reagents 
Name  Supplier 
Insulin  Sigma-Aldrich 
Isobutylmethylxanthine (IBMX) Sigma-Aldrich 
Dexamethasone Sigma-Aldrich 
Ascorbate-2-phosphate Sigma-Aldrich 
Indomethacin Sigma-Aldrich 
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2.1.3 Immunostaining reagents 
Name Supplier 
Formaldehyde (38%) Fisher Scientific UK 
Sucrose Fisher Scientific UK 
Sodium Chloride VWR Chemicals 
4-(2-hydroxyethyl)-1-piperazine-
ethanesulphonic acid (HEPES) 
Fisher Scientific UK 
Triton X-100 Sigma-Aldrich 
Magnesium chloride hexahydrate Sigma-Aldrich 
Bovine serum albumin Sigma-Aldrich 
Phosphate buffered saline Sigma-Aldrich 
Tween 20 Sigma-Aldrich 
Rhodamine Phalloidin  Molecular Probes, Life 
Technologies 
Horse Biotinylated anti-rabbit IgG Vector Laboratories 
Horse Biotinylated anti-mouse IgG Vector Laboratories 
Fluorescein streptavidin Vector Laboratories 
Texas Red streptavidin Vector Laboratories 
Vectashield Mounting Medium with DAPI Vector Laboratories 
 
2.1.4 Western blotting reagents 
Name Supplier 
Sodium dodecyl sulphate  Sigma-Aldrich 
Sodium deoxycholate Sigma-Aldrich 
Phosphatase inhibitor cocktail Roche 
Protease inhibitor cocktail Roche 
Bradford’s reagent Bio-Rad 
Polyvinylidene difluoride (PVDF) 
membrane  
Immobilon P, Millipore  
ECL solutions Thermo Scientific, Pierce 
HRP linked anti-rabbit IgG Sigma-Aldrich 
HRP linked anti-mouse IgG Sigma-Aldrich 
4-12% NuPAGE bis-tris acrylamide gels  Novex; Life Technologies 
NuPAGE 20x running buffer Novex; Life Technologies 
NuPAGE 20x transfer buffer Novex; Life Technologies 
Methanol Fisher Scientific UK 
Dried skimmed milk powder Marvel 
Medical X-ray film Kodak 
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2.1.5 Cell staining reagents 
Name Supplier 
Coomassie Blue G250 Sigma-Aldrich 
Acetic acid Fisher Scientific  
Methanol Fisher Scientific 
Oil Red O Sigma-Aldrich 
Triethyl phosphate Sigma-Aldrich 
Mayer Haematoxylin solution Sigma-Aldrich 
ImmunoHistoMount Sigma-Aldrich 
Silver nitrate Sigma-Aldrich 
Sodium thiosulphate BDH Biosciences 
Nuclear Fast Red Sigma-Aldrich 
Anti-BrdU kit GE Healthcare 
LIVE/DEAD® Viability/Cytotoxicity kit Invitrogen 
 
 
2.1.6 In-cell western reagents 
Name Supplier 
Odyssey Blocking Buffer  LI-COR 
IRDye conjugated goat anti-mouse 
secondary antibody  
LI-COR 
IRDye conjugated goat anti-rabbit 
secondary antibody  
LI-COR 
CellTag 700 Stain  LI-COR 
Tween 20 Sigma-Aldrich 
Phosphate buffered saline Sigma-Aldrich 
 
2.1.7 Scanning electron microscopy reagents 
Name Supplier 
Glutaraldehyde  Sigma-Aldrich 
Sodium cacodylate Agar Scientific 
Osmium tetroxide OxKem 
Uranyl acetate Sigma-Aldrich 
Hexamethyldisilazane Fluka Analytical 
Double-sided conductive carbon tape Agar Scientific  
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2.1.8 Primary antibodies  
Name Supplier 
Anti-CD271 antibody Abcam, UK/Cell Signaling 
Technology, USA 
Anti-CD63 antibody Santa Cruz, USA 
Anti-STRO-1 antibody Santa Cruz, USA 
Anti-ALCAM antibody Epitomics/Abcam, UK 
Anti-Osteocalcin antibody Santa Cruz, USA 
Anti-Osteopontin antibody Santa Cruz, USA 
Anti-Bromodeoxyuridine (BrdU) antibody GE Healthcare, UK 
Anti-CDK6 antibody Cell Signaling Technology, USA 
Anti-E2F-1 antibody Cell Signaling Technology, USA 
Anti-Phosphorylated ERK antibody Cell Signaling Technology, USA 
Anti-Total ERK1/2 antibody Cell Signaling Technology, USA 
Anti-Cyclin D1 antibody Cell Signaling Technology, USA 
Anti-Phosphorylated Rb antibody Cell Signaling Technology, USA 
Anti-Total Rb antibody Cell Signaling Technology, USA 
Anti-Cdc25 antibody Cell Signaling Technology, USA 
Anti-p27kip antibody Cell Signaling Technology, USA 
Anti-GAPDH antibody Abcam, UK/Millipore, Germany 
 
2.1.9 Metabolomics sample preparation  
Name Supplier 
Acetonitrile Sigma-Aldrich, UK 
Chloroform Sigma-Aldrich, UK 
Formic acid Sigma-Aldrich, UK 
Methanol Fisher Scientific, UK 
 
2.1.10 Collagen gel reagents 
Name Supplier 
Rat tail collagen solution First Link, UK 
10X MEM First Link, UK 
FBS Sigma Aldrich, UK 
0.1M sodium hydroxide  Sigma Aldrich, UK 
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2.2 Solutions for cell culture 
 
HEPES-saline solution  
HEPES-saline was used to wash cells prior to detachment with trypsin/versene.  
150 mM NaCl, 5 mM KCl, 5 mM glucose, 10 mM HEPES, 0.5% (v/v) phenol red 
solution. The pH was adjusted to 7.5. Solutions were autoclaved prior to use to 
ensure sterility for use in cell culture.  
 
Trypsin-versene solution  
Trypsin/versene was used to assist detachment of cells from substrates. 
150 mM NaCl, 5 mM KCl, 5 mM glucose, 10 mM HEPES, 1 mM EDTA, 0.5% (v/v) 
phenol red indicator solution, adjusted to pH 7.5 and autoclaved prior to use to 
ensure sterility for cell culture. Trypsin stock (10x) was added as appropriate to 
produce a final working solution for detachment of cells.  
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2.3 Methods 
 
2.3.1 Primary cell culture 
 
All primary cells were maintained in a complete media consisting of a base of 
Dulbecco’s Modified Eagles Medium (DMEM) supplemented with 10% foetal bovine 
serum (FBS), 10% antibiotic-antimycotic-glutamine mix (1% penicillin-
streptomycin, 0.8 mM L-glutamine, 5% (v/v) Fungizone® amphotericin B) and 1% 
non-essential amino acids. Media changes were carried out twice weekly. All 
cells were kept in a humidified incubator at 37°C with an atmosphere of 5% CO2. 
Passaging of cells, and detachment for the purposes of selection and expansion, 
was achieved by washing cells with sterile PBS and incubating with TrypLETM 
Select (a mild detachment reagent) at 37°C for 5 minutes.   
 
2.3.1.1  Extraction of osteoprogenitors from bone marrow  
 
Human mesenchymal stem cells were derived upon purification of bone marrow 
obtained from patients undergoing routine orthopaedic (hip/knee replacement) 
surgery at the Southern General hospital, Glasgow. Bone marrow aspirate was 
transferred into sterile transport media (0.6g EDTA, 5% (v/v) antibiotic-
antimycotic-glutamine mix in 200ml PBS, pH 7.2) and stored at 4°C upon arrival. 
After removal of visible blood clots, bone fragments and fat, processing of the 
marrow sample commenced with initial washes with complete media containing 
10% FBS (as outlined in section 1.3.1 ‘primary cell culture’). This involved 
centrifugation of the aspirate at 345g for 10 minutes to pellet all cells and 
resuspending the resulting pellet with fresh media, with these steps being 
repeated twice. The cleaned cell suspension was layered carefully onto Ficoll-
PaqueTM PREMIUM (GE Healthcare) density gradient media and subjected to a 
period of 45 minutes centrifugation at 445g to remove blood cells and isolate the 
mononuclear cell fraction.   
 
The interface between the clear Ficoll-PaqueTM and the red coloured DMEM 
complete media defines the region where mononuclear cells can be found (!"#$%&'
9)().  
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The mononuclear cell fraction was extracted into a new tube and washed in 
DMEM complete media three times after successive centrifugation at 345g and 
resuspension of the cell pellet in fresh DMEM complete media. The resulting cells 
were transferred into culture flasks and the adherent population (hereby 
referred to as ‘adherent bone marrow-derived cells’) were then cultured to as 
near to 70-80% confluency for several weeks prior to further selection. 
 
2.3.1.2  Magnetic activated cell sorting for CD271+ mesenchymal stem cells 
 
Magnetic-activated cell sorting (MACS) was carried out on the adherent bone 
marrow-derived cells using a CD271 positive selection kit (STEMCELL 
technologies). This additional step was implemented to isolate a CD271+ 
subpopulation, and thereby increase the purity and heterogeneity of the cells 
used in the study (!"#$%&'9)9).  
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Adherent bone marrow-derived cells were detached using TrypLETM Select cell 
dissociation reagent prior to carrying out magnetic sorting. Cells were washed 
with sterile PBS and incubated with the dissociation reagent for 5 minutes at 
37°C. Upon agitation, the cells were observed to detach from the surface of the 
flasks and a volume of complete media was added to stop the action of the 
enzyme. 
 
The cell suspension was sedimented by centrifugation at 345g for 5 minutes, and 
after removal of the supernatant, the cell pellet was resuspended in 500 µl of 
recommended medium (2% FBS in PBS) as per the manufacturers guidelines, and 
subsequently transferred to a sterile round-bottomed tube. All incubations were 
carried out at room temperature unless stated otherwise. 12.5 µL of Fc blocking 
solution was added and mixed by pipetting, followed by 25 µl of CD271 positive 
selection cocktail. The solution was incubated with the antibody for 15 minutes, 
followed by addition of 25 µl of nanoparticles for a further 15 minutes 
incubation. The volume of solution was made up to 2.5 ml with recommended 
medium and mixed by pipetting up and down before each tube was placed inside 
a magnet for 5 minutes. This allowed sufficient time for the positively marked 
cells to be retarded against the magnetic walls. Each magnet was then inverted 
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in turn, with any unlabelled cells being decanted from the tube. This washing 
step was repeated a further two times for a total of three inversions of the 
magnet. 400 µl of complete media was added to the resultant positively labelled 
cells, and mixed to obtain an even suspension. These cells were smeared across 
the bottom of cell culture flasks, and left to attach for approximately 1 hour at 
37°C and 5% CO2. After confirming cell attachment by light microscopy, the cells 
were flooded with a larger volume of complete media. These positively-labelled 
cells are forthwith referred to as ‘CD271+ MSCs’ in this thesis.  
 
2.3.1.3 MACs selection of STRO-1+ MSCs  
 
Selection of MSCs positive for the STRO-1 antigen (provided by Professor Richard 
Oreffo, University of Southampton) was carried out by Ms Julia Wells, from bone 
marrow tissue that would normally be discarded following routine total hip 
replacement surgery.  Aspirate from trabecular bone marrow was centrifuged at 
250g for 4 minutes at 4°C to pellet the cells within. The pellet was resuspended 
in minimum essential medium Eagle with alpha modification containing L-
glutamine and nucleosides (alpha-MEM) and passed through a 70 µm pore mesh. 
Red blood cells were removed using lymphoprep gradient solution in combination 
with centrifugation. Cells in the buffy coat fraction were resuspended in 10 ml 
of HEPES saline containing 5% (v/v) FBS, 5% (v/v) human serum, and 1% (w/v) 
BSA. This was followed by incubation with STRO-1 antibody in hybridoma 
supernatant (Dr Beresford, University of Bath) and washing steps with MACs 
buffer. Human anti-IgM magnetic microbeads (Miltenyi Biotec) were added for a 
period of incubation, with bound cells positively labelled for STRO-1 being held 
in the magnetic column. These cells (STRO-1+ MSCs) were eluted and transferred 
to culture flasks for expansion and transported to the laboratory after reaching 
80% confluency.  Upon arrival, these cells were maintained as outlined for 
primary cell culture (section 1.3.1). 
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2.3.2 Substrate fabrication and preparation 
 
Substrates were kindly produced by members of the Gadegaard group 
(department of biomedical engineering, University of Glasgow). The following 
subsections briefly outline the main steps in substrate production. 
 
2.3.2.1  Electron Beam Lithography 
Master substrates for each nanopattern were fabricated using electron beam 
lithography (Gadegaard et al., 2003). The square-lattice arranged (SQ) 
nanopattern consisted of an ordered array of 120 nm diameter pits with 100 nm 
depth and 300 nm centre-centre spacing, and the disordered near-square (NSQ) 
nanopattern consisted of the same features as SQ, with an additional element of 
controlled disorder (± 50 nm), maintaining an average 300 nm centre-centre 
spacing. Interchangeable nickel inlays for the injection moulder were fabricated 
from patterned resists (silicon), and a thin layer of Ni-V (50 nm) was sputter-
coated onto the patterned structures, prior to electroplating. The resultant 
nickel shims were cleaned with chloroform in an ultrasound bath for 15 minutes. 
Any silicon residue was removed by wet etching in 25% KOH at 80°C for 1 hour, 
washed in ROH2O and subjected to a final air-drying step. This process was 
outsourced.  
 
2.3.2.2  Fabrication of polycarbonate substrates by injection moulding 
 
Nanopatterned substrates were produced in large numbers by injection moulding 
with an Engel Victory 28 hydraulic injection moulder and Makrolon® OD2015 
polycarbonate. Polycarbonate was added to the machine after inserting the 
required inlay. The first melt temperature was 280°C and applied through the 
nozzle which the beads of polycarbonate pass through. The polymer was then 
cooled to around 80°C. A clamping force of 250 kN assisted imprinting and 
transfer of the pattern from the inlay to one face of the substrate. The final 
surface area of each manufactured substrate measured 24 mm x 24 mm.  
 
2.3.2.3 Hot embossing/Replication of nanotopographies on 
polycaprolactone 
 
Imprints of the SQ and NSQ nanopatterns were transferred onto 
polycaprolactone (PCL) by hot-embossing using a fabricated nickel shim. Hot-
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embossing of flat regions of the shim were used to generate un-patterned 
control surfaces. The shim was placed onto a hot plate set at 80°C to melt the 
methanol-washed PCL beads (PCL has a melting temperature of 60°C). The 
beads were positioned onto the desired areas of the shim and pressure was 
applied to a glass slide placed carefully over the melted polymer to imprint the 
pattern onto the material. After cooling, the patterned PCL disk could be 
carefully lifted off, subjected to plasma cleaning and sterilisation and then 
transferred into cell culture plates ready for seeding.   
 
2.3.2.4  Plasma Cleaning 
 
A 30 second air plasma treatment at the highest setting (30W power and a total 
pressure of 0.27mbar) of the plasma cleaner (Harrick Plasma, USA) was applied 
to all PCL substrates and 20 second air plasma treatment at the highest setting 
was applied to all polycarbonate substrates for surface cleaning and to assist 
with cell attachment and overcome the slight hydrophobicity of these polymers. 
Substrates were covered in 70% ethanol solution overnight to sterilise prior to 
seeding.  
Oxygen plasma cleaning for X-ray photoelectron spectroscopy was performed by 
PhD student Daniel Morrison (University of Glasgow) using an oxygen barrel asher 
(Gala Instruments Plasmaprep 5 asher) with oxygen gas at 0.2 mbar total 
pressure, 32W power (the nearest equivalent setting to the air plasma 
treatment) in a clean room environment.  
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2.3.3 Material Characterisation  
 
2.3.3.1 Atomic Force Microscopy 
 
Images of plasma treated surfaces were acquired using atomic force microscopy 
(AFM) in AC mode on a NanoWizard 3 atomic force microscope using NCH Silicon 
cantilevers (NanoWorld) with assistance from Dr Alex Winkel (JPK). 
 
2.3.3.2  X-ray Photoelectron Spectroscopy 
 
X-ray photoelectron spectroscopy (XPS) is a technique that provides quantitative 
information about the surface of materials. Samples were plasma treated for the 
required times and cleaned by immersion in 70% ethanol overnight, and dried 
before proceeding with XPS. Processing and analysis was performed by Dr 
Rasmus Pedersen (University of Glasgow) using a SAGE 100 XPS system (Specs 
Surface Nano Analysis GmbH, Germany) with spatial resolution of approximately 
6 mm. The base pressure in the analysis chamber was approximately 2x10-7 
mbar, and the x-ray source was AlK#-operated at an anode voltage of 9.5 kV and 
140 W power. The pass energy for the hemispherical analyser was 50 eV for 
initial survey scans, and 15eV for final high resolution scans. Spectra were 
recorded at a 90° take-off angle and subsequently analysed using casaXPS 
processing software. Identification of atomic composition was determined by 
integration of peak areas using a standard Shirley background. 
 
2.3.3.3 Scanning electron microscopy  
 
Images of substrates and MSCs growing on the surfaces at high magnification was 
achieved using scanning electron microscopy (SEM). After the required culture 
periods, cells on the samples were fixed with 1.5% glutaraldehyde buffered in 
0.1M sodium cacodylate for 1 hr at 4°C. Cells were post-fixed in 1% osmium 
tetroxide in 0.1M sodium cacodylate buffer, and stained with uranyl acetate. 
Dehydration was achieved with the following alcohol series (30%, 50%, 70%, 90%, 
absolute ethanol, and dried absolute ethanol). Following this, 
hexamethyldisilazane was used in a final dehydration step. Upon removal of the 
solution, samples were placed inside a dessicator overnight to dry out. Following 
this, they were attached to aluminium stubs with double-sided conductive 
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carbon tape and sputter coated with gold-palladium to a thickness of 15-20 nm 
(Polaron SC515 SEM coater). Sputter coating and image acquisition were 
performed with kind assistance from Margaret Mullin and Peter Chung (University 
of Glasgow) using either a JEOL JSM 6400 scanning electron microscope with 
Olympus Scandium software or Sigma Variable Pressure analytical scanning 
electron microscope (Carl Zeiss) with Oxford Microanalysis software at an 
accelerating voltage of 10kV.  
 
2.3.3.4  Water Contact Angle Measurement 
 
Multiple water contact angle (WCA) measurements at three random regions of 
each substrate were taken at room temperature using a sessile drop technique 
and a KSC CAM 100 contact angle goniometer (KSV instruments, USA). A droplet 
of water was suspended from the point of a needle with attached syringe 
(clamped in position so that the droplet was in range of the camera). A trigger 
point was set so that when the droplet was transferred to the surface of the 
substrate, measurement of angles would take place 2 seconds afterwards, giving 
time for the droplet to settle. Measurements for the same surface type were 
subsequently averaged to obtain the final values.  
 
2.3.4 Cell seeding 
 
Substrates left sterilising overnight were washed to remove traces of ethanol 
and particulates prior to seeding: twice in sterile PBS, and once in media. These 
were transferred into wells of 6 well plates. All MSCs were seeded using 
polycarbonate cell seeding devices (designed by Dr Mathis Riehle, and fabricated 
by Dr Paul Reynolds, University of Glasgow). This device was patented 
(application number PCT/GB2013/052776, publication number WO2O14O64449 
A1; inventors: Paul Reynolds, Mathis Riehle, Nikolaj Gadegaard). 
 
Sterilised seeding devices were placed carefully onto the top of each 24 mm x 24 
mm square nanotopography (2 mm thickness), and 500 µl of cell suspension was 
carefully pipetted through a circular opening located in the corner of each 
seeder (!"#$%&'9)?). The entire setup was placed into the incubator for 1-2 hours 
to allow initial cell attachments to form, before addition of more media to each 
well and subsequent removal of the device. 
Chapter 2: Materials and Methods 
 
 55 
 
(a) 
 
(b) 
 
!"#$%&'9)?*'>&//'6&&;"1#';&-"7&8'^5_'=7,&450"7';"5#%54'.2'0,&';&-"7&8'+,&'6&&;"1#';&-"7&'7.16"606'
.2'5'9944'V'9944'6F$5%&'B"&7&'.2'B./A75%3.150&'S"0,'?'f2&&0g'.1'0,&'$1;&%6";&'^;&1.0&;'56'3/57G'
,5/2C2$//'7"%7/&6_'51;'51'"1/&0'2.%'B"B&00"1#'0,&'7&//'6$6B&16".1'/.750&;'"1'0,&'7.%1&%'^;&1.0&;'3A'51'
$12"//&;'7"%7/&_8'^3_'<,.0.#%5B,"7'"45#&68'+5G&1'S"0,'5'=546$1#':5/5VA'].0&'TT'754&%58''
 
2.3.5 MSC Characterisation 
 
2.3.5.1  Driving differentiation using chemical induction media  
 
Chemical induction of MSCs to undergo adipogenic or osteogenic differentiation 
was achieved using DMEM media supplemented with a number of inducing 
agents.  
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CD271+ MSCs were seeded at a density of 1000 cells/cm2 onto 13mm glass 
coverslips and cultured for a period of 6 weeks. Samples were cultured in either 
adipogenic induction media alternated with maintenance media to achieve 
adipogenesis or osteogenic induction media for osteogenesis.  
In the case of MSCs induced to undergo adipogenesis, the adipogenic induction 
media was added to the cells first, then replaced with maintenance media at the 
next media change, with repeated switching between the two media types 
maintained throughout the culture time.  
 
Adipogenic induction media consisted of DMEM basal media containing 10% 
(v/v) FBS, 1% antibiotic-antimycotic-glutamine mix, insulin (1.7 nM), 
indomethacin (200 µM), and isobutylmethylxanthine (500 µM). 
 
Adipogenic maintenance media consisted of DMEM basal media containing 10% 
(v/v) FBS, 1% antibiotic-antimycotic-glutamine mix, and insulin (1.7 nM) 
 
Osteogenic induction media consisted of DMEM basal media containing 10% 
(v/v) FBS, 1% antibiotic-antimycotic-glutamine mix, dexamethasone (1 mM) and 
ascorbate-2-phosphate (350 µM).  
Media was changed on cells twice weekly throughout the duration the 
experiment.  
 
2.3.5.2 Fixing cells for staining 
 
After removal of media, samples were washed with PBS and fixed (in 
duplicate/triplicate for each type of topography per experiment) in buffered 4% 
formaldehyde: 2% sucrose solution at 37°C for 15 minutes. Fixative was then 
removed and enough PBS was added to cover the cells. Samples were stored at 
4°C until ready to proceed with various staining protocols.  
 
2.3.5.3 Oil Red O staining  
 
Oil Red O solution (10 mg/ml) in 60% (v/v) triethyl phosphate (aqueous; aq) was 
used to confirm adipogenesis in MSC cultures supplemented with adipogenic 
media. Cells were fixed as outlined in 1.3.5.2, and then rinsed with 60% (v/v) 
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triethyl phosphate (aq). A volume of Oil Red O solution was added (sufficient to 
cover the cells) and left at room temperature for 10 minutes to allow staining of 
lipid deposits to occur. After this time, the solution was removed and cells were 
washed again in 60% (v/v) triethyl phosphate (aq) to remove excess staining 
solution. Filtered Mayer Haematoxylin solution was added to the cells for 2 
minutes at room temperature, and rinsed off with tepid tap water. Coverslips 
were mounted onto glass slides using ImmunoHistoMount mounting medium. 
 
2.3.5.4 Von Kossa staining  
  
Von Kossa stain demonstrates the presence of calcium phosphate and calcium 
carbonate, indicators of progress in osteogenesis. A 5% (v/v) silver nitrate was 
prepared (aq) and added in sufficient volumes to cover the samples. All samples 
were exposed to UV light for 30 minutes, and then the solution was replaced 
with 5% (v/v) sodium thiosulphate (aq) for a further 10 minutes incubation. 
Samples were washed using a slow stream of tepid tap water for 5 minutes, and 
then rinsed in distilled water. These were counterstained with nuclear fast red 
prior to mounting onto glass slides using ImmunoHistoMount mounting medium. 
 
2.3.5.5 Nuclear Fast Red Staining  
 
Nuclear counterstaining with Nuclear Fast Red was performed for the samples 
subjected to Von Kossa staining. A 0.1% (v/v) Nuclear Fast Red solution was 
prepared containing 1.5 mM aluminium sulphate (aq). The solution was boiled 
for 10 minutes with continuous stirring, cooled and filtered prior to use. Samples 
were incubated with the staining solution for 4 minutes, and then rinsed well 
with distilled water and briefly in 70% (v/v) ethanol.  
 
2.3.5.6  Coomassie Staining 
 
After removal of the culture media, MSCs were fixed in 4% (v/v) 
paraformaldehyde: 2% (w/v) sucrose fixative at 37°C for 15 minutes. These were 
then stained with filtered 0.5% (w/v) Coomassie blue stain (Coomassie blue 
G250, prepared in 50% (w/v) methanol and 10% (v/v) glacial acetic acid) for 10 
minutes at room temperature. Excess staining solution was then removed, and 
samples were washed three times successively with distilled water. Brightfield 
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images were acquired using a Zeiss Axiovert 25 inverted transmitted light 
microscope with a 5x A-plan objective (Zeiss). Full size scans of the substrates 
were also obtained using an Epson scanner at 800 dpi resolution in 24 bit colour.  
 
2.3.5.7  Immunostaining 
 
Cells were fixed as outlined in section 1.3.5.2. For immunostaining, cells were 
permeabilised with permeabilisation buffer (0.1% (w/v) sucrose, 50 mM NaCl, 3 
mM MgCl2.6H2O, 20 mM HEPES, 0.5% (v/v) Triton X-100 in H2O and adjusted to pH 
7.2) and blocked in 1% (w/v) BSA in PBS for 15 minutes at 37°C. Anti-ALCAM 
antibody (1:150) or anti-STRO-1/OCN/OPN antibodies (1:50 dilution) were added 
and incubated with the cells at 37°C for 1 hr. After washing three times with 
0.5% (v/v) Tween-20 in PBS (PBST), the samples were incubated with biotin-
conjugated anti-rabbit/mouse secondary antibody for 1 hr at 37°C. Samples 
were washed again three times with PBST, and further incubated with 
fluorescein isothiocyanate (FITC) conjugated streptavidin (diluted 1:50 in 1% 
BSA) for 30 minutes at 4°C. A final three washes were carried out before 
samples were mounted onto glass coverslips using mounting medium containing 
4’, 6-diamidino-2-phenylindole (DAPI).  
 
2.3.5.8  BrdU labelling 
 
1mM BrdU in complete DMEM media was added to cells for the final 6 hours of 
the required culture time, and incubated at 37°C and 5% CO2 as for normal cell 
culture. Following this, MSCs were washed with PBS, fixed, permeabilised and 
blocked as outlined in 1.3.5.7 for immunostaining. Anti-BrdU antibody was 
diluted 1:100 in DNase I solution and incubated with the cells for 2.5 hrs at 
37°C. After washing with PBST, samples were incubated for 1 hr at 37°C with 
anti-mouse secondary antibody conjugated to texas red diluted 1:50 in blocking 
solution. Following further washes with PBST, the samples were mounted using 
mounting medium containing DAPI.  
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2.4 Microscopy and imaging 
 
Images of the cells were acquired using brightfield, fluorescence or confocal 
microscopy. The specific details pertaining to each of these will be discussed in 
the following subsections. An indicator of scale was either obtained through the 
imaging software itself (confocal) or through acquiring an image of a 1mm 
graticule under the appropriate magnification lens (brightfield and 
fluorescence). This was then converted into pixels using Image J software 
(Abramoff et al., 2004, Schneider et al., 2012).  
 
2.4.1 Brightfield microscopy 
 
Stained or unstained cells were observed using a Zeiss Axiovert 25 light 
microscope. Images were acquired using QCapture software. Other specific 
details are outlined in figure legends and relevant sections as appropriate.  
 
2.4.2  Fluorescence Microscopy  
 
Immunostained specimens were imaged using either an inverted microscope 
(Axiovert 200M; Carl Zeiss, Germany) linked to a CCD camera (QImaging) or an 
upright microscope (Olympus BX51) with motorised stage capabilities (Prior) 
linked to a QCapture camera. Both of these microscopes operated using Image 
Pro software (the Olympus uses ImageProPlus) (Media Cybernetics, UK). The 
motorised stage was utilised for the samples subjected to BrdU staining. This 
involved setting a scan pattern so that the stage moved horizontally across the 
substrate, down one step, then horizontally in the reverse direction, repeated 
continually until a preset number of images had been obtained. Acquired 
greyscale images corresponding to the different filters were converted to RGB 
colour format using Adobe Photoshop imaging software. Composite images were 
generated by overlaying the coloured greyscale images (red, green or blue 
depending on the fluorescence emission of the fluorophores used in the staining 
process).  
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2.4.3 CellProfiler Image Analysis 
 
Grey-scale images corresponding to cell nuclei, cell cytoskeleton and a protein 
of interest were inspected using CellProfiler open source cell image analysis 
software (version 2.1.0). CellProfiler software allowed for the quantification of 
proteins of interest in cells following immunostaining and microscopy.  Pipelines 
were designed to define the location of cells by first identifying the nuclei from 
the images corresponding to DAPI-staining. Briefly, this was achieved through 
defining threshold strategies alongside filtering criteria such as size and intensity 
rules which would be applied to the relevant images. The area covered by each 
cell was then extrapolated from the locations of the nuclei to the edges, which 
were designated using images corresponding to cytoskeletal staining of F-actin. 
After correct segmentation parameters were implemented, measurements 
pertaining to the cell area and protein of interest were made for a number of 
cells detected across 20 images per substrate. Exposure times during image 
acquisition were maintained at a constant for the protein of interest, to allow 
valid comparisons to be made between samples.  
 
2.4.4 Synchronisation and release of MSCs for analysis of cell 
cycle 
 
STRO-1+ MSCs were seeded on substrates at a density of 1000 cells/cm2 and 
allowed to attach and establish for a period of 48 hours. The cells were washed 
in serum free media and then incubated for a further 48 hours in 0.1% FBS (low 
serum) media (Jaejin et al., 2012) to induce cell cycle arrest and thereby 
synchronise the cells.  
After this period in low serum media, MSCs were released back into the cycle by 
replacement of this media with serum containing maintenance media (10% FBS) 
for the required durations for each experiment. 
 
2.4.5 Preparation of samples for flow cytometry 
 
STRO-1+ MSCs were seeded on substrates at a density of 1000 cells/cm2 and 
synchronised as described in section 1.4.4. The media was changed to 
maintenance media containing 10% FBS for 24 hours following synchronisation. 
Cells were washed with sterile PBS, trypsinised, and pooled (according to 
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substrate type/culture condition). Cells were pelleted by centrifugation at 345g 
and the supernatant was removed. Cells were washed twice, each time 
resuspending the pellet in PBS and then centrifuging as described in the previous 
step. Fixing was achieved by adding 3 ml of cold ethanol (molecular grade; 
Sigma-Aldrich) drop-wise whilst vortexing to minimize clumping, and left at 4°C 
for 1 hour. Samples were then sent to the University of Southampton, where 
cells were washed and propidium iodide staining solution (3.8 mM sodium 
citrate, 40 µg/ml propidium iodide in PBS) was added to the pellets together 
with RNase A (10 µg/ml RNase A in PBS) for 3 hours at 4°C (protected from 
light). Flow cytometry was carried out on a Guava® easyCyte flow cytometer 
(Merck Millipore), with subsequent analysis performed using FlowJo data analysis 
software.     
 
2.4.6 Quantitative in-cell western and detection 
 
MSCs cultured on all surfaces were fixed in 4% paraformaldehyde and briefly 
permeabilised in the appropriate buffer as outlined previously for 
immunostaining. Surfaces were then transferred to new plates so that there 
would be no signal from cells that had not adhered to the samples during the 
culture period. Samples were then blocked in Odyssey blocking buffer for 1.5 
hours at room temperature. Primary antibodies (protein of interest and GAPDH 
as a normalisation protein) were diluted in the same blocking buffer and applied 
to the samples for 3 hours at room temperature. Washes were carried out using 
0.1% Tween in PBS washing solution. Liquid was added and aspirated carefully as 
not to dislodge any cells. A total of 3 washes were performed each time. IRDdye 
secondary antibodies (red and green; 680 and 800 respectively) were diluted to 
1:800 in blocking buffer and incubated with the samples for 1 hour at room 
temperature, protected from light. After further washing and removal of as 
much residual washing solution as possible, measurement of intensity from 
labelled proteins was achieved using the Odyssey Sa imaging system (LI-COR) 
which has a plate reading format. After performing dual scanning at both 
wavelengths, a grid was applied to the resulting scan in order to quantify the 
intensity solely from a square region corresponding to the seeded portion of the 
substrates (!"#$%&'9)D).  
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2.4.7 Filopodial inhibition  
 
Inhibition of filopodia was attempted using a chemical inhibitor of cdc42. 
Complete media containing the inhibitor was made fresh prior to beginning the 
experiment. Initial testing of inhibition was assessed with MSCs seeded onto 
glass coverslips, with different concentrations of inhibitor in media being added 
to the cells 1 hour post-seeding. Cells were then fixed and stained for F-actin 
using rhodamine phalloidin as outlined for immunostaining. Coverslips were 
transferred onto glass slides for ease of handling and visualisation. Fluorescence 
images were taken using a Zeiss Exciter confocal microscope.  
For the proceeding nanotopography filopodia studies, cdc42 inhibitor was added 
at the determined optimal concentration with the complete media after 
synchronisation of the cells. These were then fixed for visualisation by SEM. 
Images were acquired with kind assistance from Mrs Margaret Mullin (SEM 
facility, University of Glasgow).  
 
2.4.8 Next generation sequencing 
 
Synchronised and 24 hour released MSCs were trypsinised from the surfaces, 
pooled accordingly and washed with PBS. The cell pellets were subsequently 
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frozen on dry ice and transferred to -80°C storage until ready to proceed with 
RNA extraction. This was performed using the RNeasy extraction kit procured 
from QIAGEN following the manufacturer’s instructions.  
Briefly, the cell pellets were dislodged by flicking the tubes and disrupted in 
buffer RLT. Then 70% ethanol was added, and the lysate was transferred to a 
spin column. The remainder of the procedure was followed as per outlined in the 
instructions provided with the kit. The RNA was eluted from the columns after 
addition of 10 µl of RNase-free water. RNA quality and concentration of samples 
were then determined using a Nanodrop ND1000 spectrophotometer (Thermo 
Scientific) using water as a blank. Absorbance readings at 260 nm (A260) were 
used for quantification with the A260/A280 ratio being noted as an assessment of 
purity. Samples were stored at -80°C until ready to proceed with the next steps.  
 
Extracted RNA samples were processed and analysed by Mrs Jing Wang and Ms 
Julie Galbraith (Polyomics facility, University of Glasgow). 136 ng of total RNA 
per sample were processed using a TruSeq® stranded mRNA low throughput kit 
according to the manufacturer’s protocol (Illumina).  Conversion of the mRNA 
within the total RNA was required to generate a library of template molecules 
for sequencing. The steps carried out included poly A selection for purification 
of poly A-containing mRNA followed by fragmentation, first and second strand 
cDNA synthesis, sample cleanup, adenylation of 3’ ends, ligation and cleaning of 
adapters, PCR amplification (98°C for 30 seconds followed by 15 cycles of: 98°C 
for 10 seconds, 60°C for 30 seconds, 72°C for 30 seconds, then 72°C for 5 
minutes, hold at 4°C) and cleanup. All cleanup steps were performed using 
AMPure XP beads (Beckman Coulter). This was followed with sequencing by 
adding 3.2 pM libraries (Illumina NextSeq 500 sequencer). The raw data was pre-
processed by bioinformatician Manikhandan Mudaliar (Polyomics facility, 
University of Glasgow), using the BaseSpace® next-generation sequencing cloud 
computing environment (Illumina) (Anders and Huber, 2010, Dobin et al., 2013).  
 
Generated logfold change values and adjusted p values were then uploaded and 
analysed using the (QIAGEN) Ingenuity® Pathway Analysis (IPA) online software 
application (www.ingenuity.com) and the data assessed for up- or 
downregulation of canonical pathways and networks.  
Chapter 2: Materials and Methods 
 
 64 
2.4.9 Western blotting 
 
MSCs on the substrates were harvested by detaching the cells from each surface 
with 1x trypsin/versene working solution followed by use of a cell scraper. After 
5 minutes incubation at 37°C, the cells could be seen to begin detaching under a 
light microscope. After scraping, cells from several of the same type of 
substrates were pooled together in order to gather enough protein for 
subsequent analysis. Cells were lysed in RIPA buffer (150 mM NaCl, 50 mM Tris-
HCl, 1% Triton-X 100, 1% sodium deoxycholate, 1% sodium dodecyl sulphate, 
adjusted to pH 7.5) supplemented with protease and phosphatase inhibitor 
cocktails. The lysates were transferred into tubes and subjected to end-over-end 
mixing at 4°C before removal of any cell debris by centrifugation at 10,000g and 
transfer of the supernatant into new tubes. The amount of extracted protein 
obtained in each sample was measured by performance of a Bradford’s assay and 
comparison with a range of BSA standards (Bradford, 1976). Readings were 
measured using a spectrophotometer (Molecular Devices Spectra Max Plus) for 
absorbance at 595 nm or with an automated plate reader at 595 nm (Anthos 
Labtec 2010 with ADAP version 1.6 software).  
Samples were equalised for protein and 2x Laemlli loading buffer containing 
beta-mercaptoethanol (4% SDS, 10% 2-mercaptoethanol, 20% glycerol, 0.004% 
bromophenol blue, 0.125M Tris HCl, pH 6.8) was added to each (Laemmli, 1970). 
The lysates were resolved at 200V constant voltage using pre-cast 4-12% gradient 
NuPAGE bis-tris polyacrylamide gels and accompanying gel system (Novex) and 
subsequently transferred onto a PVDF membrane according to the 
manufacturer’s instructions. Antibodies were added to the membrane at the 
appropriate dilutions in 1% non-fat milk powder overnight at 4°C. Levels of 
GAPDH, alpha-tubulin or total protein when looking at phosphorylation, were 
used as loading controls. HRP-conjugated secondary antibodies were diluted at 
1:5000, and incubated on the membrane for 1hr with shaking. After washing the 
membrane with PBST, detection was achieved using enhanced 
chemiluminescence methods. Western blot bands were quantified by 
densitometry, with the use of image J (Abramoff et al., 2004, Schneider et al., 
2012).  
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2.5 Metabolomics 
 
2.5.1 Sample preparation 
 
MSCs cultured on surfaces had media removed, and were washed in cold PBS 
prior to carrying out the extraction procedure. Metabolites were extracted using 
a cold methanol-chloroform solution (1:3:1 ratio of chloroform: methanol: 
water). To achieve this, each substrate was inverted on top of the extraction 
solvent, and sealed with parafilm within culture plates to minimise evaporation. 
The same steps were performed for a series of ‘blanks’, which consisted of 
placing the solvent onto substrates that had not been seeded with cells 
throughout the culture period. All of the samples were vigorously agitated on a 
rotary shaker for 1 hour at 4°C.  
The resulting solutions were transferred to tubes, centrifuged for 3 minutes 
13000g to remove cell debris, then kept at -80°C until ready to proceed with 
liquid chromatography mass spectrometry. A pooled aliquot of all samples within 
the batch was made and used for quality control purposes as requested by the 
metabolomics facility at Glasgow Polyomics (University of Glasgow).  
 
2.5.2 Liquid chromatography mass spectrometry 
 
These steps were performed by staff at the metabolomics facility of Glasgow 
Polyomics (University of Glasgow), headed by Dr Karl Burgess, with assistance 
from Dr Lesley-Anne Turner. 
Liquid chromatography mass spectrometry was employed as a technique to 
isolate each metabolite from the mixture of metabolites within each sample, 
and for the detection of each separated metabolite according to their mass 
(UltiMate 3000 RSLC with a 20 mm x 2.1 mm ZIC-pHILIC guard column coupled to 
a 150 mm x 4.6 mm ZIC-pHILIC analytical column running at 300 µl/min, coupled 
to an Orbitrap Q-Exactive (Thermo Fisher). Each detected metabolite generates 
a spectrum of peak intensity against retention time.  
Known ‘standard’ samples were analysed together with each batch of samples, 
which consist of known metabolites. The retention times of these were used to 
assist identification of sample metabolites.  
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2.5.3 Data analysis 
 
Raw mass spectrometry data was first processed using XCMS for peak picking 
(Tautenhahn et al., 2012). An IDEOM/MzMatch Excel interface (Scheltema et al., 
2011, Creek et al., 2012) was used for the purposes of converting all the raw 
data files, chromatographic peak selection and subsequent measurement of peak 
intensities, in order to filter, post-process and finally investigate the putative 
identities of the separated metabolites. The KEGG database was referenced for 
inference of metabolomics pathways. 
 
2.6 Preliminary collagen gel study 
 
2.6.1 Collagen gel preparation 
 
All reagents used to make the gels were at 4°C prior to commencing the 
protocol.  
Reagent Volume (ml) for 1x mix 
Rat tail collagen solution 2.5 
0.1M sodium hydroxide 1.0 
10X MEM 0.5 
FBS 0.5 
Complete media  0.5 
.&"/0(BP?*'I&5#&10'-./$4&6'2.%'0,&'B%&B5%50".1'.2'7.//5#&1'#&/68'+,&'-5/$&6'7.$/;'3&'675/&;'$B'
577.%;"1#/A'0.'B%.;$7&'&1.$#,'#&/'4"V0$%&'2.%'6&-&%5/'B/50&68''
 
FBS, 10x MEM and complete media were added to a universal tube and kept on 
ice. In another tube, 0.1M sodium hydroxide was added directly to the collagen 
solution and inverted several times to mix. This solution was then poured into 
the first tube containing media and FBS. This resulted in a yellow solution. 
Additional 0.1M sodium hydroxide was added gradually until a colour change to 
pink was observed, indicating neutralisation of the collagen. The pH of the final 
solution was checked using a pH probe to ensure that the range was between 
7.0-7.5.  
The final mixture was divided between wells of 6 well plates as required (2ml 
per well), on top of seeded nanotopographies and incubated at 37°C for at least 
30 minutes to form a gel. The volumes outlined in table 1 were scaled up as 
necessary for additional samples.  
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2.6.2 Cell viability assay 
 
The viability of the cells was assessed by carrying out live/dead staining. 
Complete media containing calcein acetoxymethyl ester (calcein AM) and 
ethidium homodimer (1 µl of each into 1 ml of media, with volumes scaled up as 
required) were added to the cells and incubated for 1 hr at 37°C. After 
incubation, media was removed and three successive washes with media were 
carried out. Imaging was then performed using a Zeiss Axiovert 200M inverted 
fluorescence microscope. Non-fluorescent calcein AM permeates cells, whereby 
the acetoxymethyl group is hydrolysed by intracellular esterases, leaving 
calcein, which emits a green signal. In contrast, the ethidium homodimer binds 
to nucleic acids resulting in emission of red fluorescence. Thus, any red 
fluorescent signal must be due to damage to the cell membrane, and assigned as 
a dead cell. 
 
2.7 Statistical Analysis 
 
Suitable statistical tests were performed using Microsoft Excel (t-tests for 
comparisons between two groups) or Graphpad Prism 6 software (multiple 
comparison tests to analyse data from three groups or more). Statistical 
significance was noted when the p value was less than 5% confidence (0.05). 
Standard error was calculated using Microsoft Excel.  
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3 Chapter 3 
 
3.1 Introduction 
 
MSCs are subject to a plethora of instructional physical and biochemical cues 
within niche microenvironments in the body, which exert a level of control on 
the state of the stem cells and regulate their differentiation. As mentioned in 
chapter 1, in order to successfully promote these cells to undergo either self-
renewal or differentiation on biomaterials for regenerative medicine, we must 
successfully mimic an aspect of these cues and transfer these to the interacting 
surfaces.  
In this study, polycarbonate substrates with nanoscale pits were utilised with the 
distribution of the nanotopographical features being of importance in influencing 
antagonistic effects on stem cell fate. The fabrication method for these 
topographies was developed by Gadegaard et al. (Gadegaard et al., 2003), with 
the nanotopographies being named square (SQ) - describing a square lattice 
arrangement of ordered pits - and near square (NSQ), whereby an element of 
disorder was introduced (±50 nm) giving a degree of offset from an absolutely 
square arrangement of pits. Culture of MSCs on the NSQ nanotopography was 
conducive for MSC differentiation into bone (Dalby et al., 2007) whilst it was 
more recently shown that the SQ surface maintained MSC phenotype (McMurray 
et al., 2011). These established SQ and NSQ nanopatterns allow for investigation 
into the basis of self-renewal and differentiation at the molecular level, without 
the use of additional chemical factors.  
One important aspect of experimental design and setup that must be considered 
is the quantity of materials used. Researchers must continually devise strategies 
to minimise any wastage of biological and substrate materials, as the former can 
be difficult to acquire (particularly in the case of stem cells) and the latter can 
be costly. In addition, the seeding density of cells on a surface can have a 
considerable impact on the phenotype of cells, and thus should be controlled for 
reproducibility. Cell density can affect cell morphology and stem cell 
differentiation. For example, a previous study noted that lower seeding densities 
directed stem cells towards an osteogenic phenotype, whereas higher seeding 
densities drove adipogenic differentiation (McBeath et al., 2004). Increasing 
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efficiency of seeding, and maximising data yield from the substrates available 
can be addressed through the technique employed.  
Conventional cell seeding onto scaffolds and substrates typically adopt the static 
seeding method, one that is hampered by the disadvantages of low seeding 
efficiencies and non-uniform distribution of cells across surfaces. This involves 
adding a suspension of cells contained within a small volume directly to the 
substrate or scaffold held within a culture dish (Shahin and Doran, 2011). Other 
seeding methods include the semi-static cell suspension technique, whereby the 
added cell suspension is manually shaken at periodic intervals in the attempt to 
improve the distribution of cells (Dolder et al., 2003) and other more elaborate 
methods involve dynamic seeding in bioreactors and use of vacuum systems. It 
could be argued that the better methodology must be one that incorporates the 
simplicity and high reproducibility of static cell seeding, together with the 
increased seeding efficiency of micromass culture, with the uniform cell 
distribution that is associated with dynamic seeding. In this work, a cell seeding 
device (patented by Mathis Riehle, Paul Reynolds and Nikolaj Gadegaard, 
University of Glasgow) was utilised to counter the outlined limitations related to 
currently available seeding techniques. Each seeder can be easily placed on top 
of substrates and a suspension added through an inlet incorporated into the 
design.   
Continuous promotion of symmetrical MSC self-renewal is desirable due to the 
importance in amassing large numbers of cells for downstream applications as 
native numbers are low (Caplan, 2007). Expanded cells could later be induced to 
differentiate into the required cell type. As cells are the building blocks of 
tissues, which in turn are components of organs, these fundamental components 
are the greatest limiting step to regenerative medicine. It is important to 
remember that in addition to efficient cell propagation, stem cell phenotype 
must be retained in tandem. This has proved a particular difficulty with in vitro 
culture, with spontaneous differentiation increasing over time (Bosnakovski et 
al., 2004, Streckfuss-Bömeke et al., 2013). In order to indicate the state that a 
stem cell has reached in terms of differentiation, numerous studies make use of 
phenotypic marker proteins. Using osteogenic differentiation as an example, 
osteoprogenitor cells will exhibit an increase in alkaline phosphatase levels 
during the maturation stage and produce more osteocalcin and osteopontin 
(Marom et al., 2005) during the matrix mineralisation phase.  
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Characterisation of MSCs is subject to wide variation among research groups, due 
to the number of candidate markers ascribed to them in the literature. 
However, in recent years, moves have been made to standardise the criteria, 
and produce a set of minimum requirements to define a multipotent MSC 
population from human tissue (Dominici et al., 2006). These include adherence 
to tissue culture plastic when cultured, positive expression of several ‘cluster of 
differentiation’ (CD) antigens such as CD105 (endoglin), CD73 (ecto 5’ 
nucleotidase), CD90 (Thy-1), and lack expression of haematopoietic markers 
CD45, CD34, CD14/CD11b, CD79 alpha or CD19, HLA-DR, and successful in vitro 
differentiation into adipocytes, osteoblasts and chondroblasts. In addition to 
these, positivity for STRO-1 (Oreffo et al., 1998, Triffitt and Oreffo, 1998) and 
ALCAM markers have often been used to gauge levels of stemness in MSC 
populations (Dalby et al., 2007, McMurray et al., 2011). Here, we describe 
extraction of patient derived mononuclear cells, which include a population of 
MSCs. Following publishing of the minimum requirement guidelines, expression 
of CD271 has recently become an indicator for multipotent MSCs (Bühring et al., 
2007, Jones et al., 2010, Boxall and Jones, 2012), thus further selection of the 
adherent bone marrow population for cells containing markers allows for 
isolation of a cell fraction of increased purity and heterogeneity, which can be 
then characterised accordingly. Ultimately, MSCs must exhibit multipotency, 
which can easily be tested by artificial induction of differentiation through the 
use of different formulations of so-called induction media.  
Metabolomics is a fairly recent biological tool that provides a large-scale 
strategy for identification of small molecules that are within cells at any given 
time. This metabolomic ‘fingerprint’ gives an indication of the cellular processes 
that have taken place (McNamara et al., 2012) and can be thought of as a 
‘snapshot’ of cellular state when cultured under specific conditions, such as 
incorporation into a gel, following drug treatment, or from stimulation by 
nanotopographical cues. A metabolomics approach has been adopted in the 
study of ESCs (Yanes et al., 2010), iPSCs (Panopoulos et al., 2012) and MSCs 
(McNamara et al., 2011, Tsimbouri et al., 2012). The entire complement of 
metabolites within a cell at a particular point in time, known as the 
metabolome, is in a state of constant flux, with biochemical factors being 
continually produced and degraded, and interactions occurring between 
molecules. Adopting an untargeted global metabolomics approach lends itself 
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well to discovery of key metabolites that vary under different conditions, which 
will be exploited to identify important molecules for self-renewal. 
 
The main aims of this chapter were to successfully isolate and culture a 
subpopulation of CD271+ MSCs from human bone marrow aspirate by magnetic-
activated cell sorting selection (MACS), and to determine the optimal conditions 
for efficient use of the SQ surface, in order to promote self-renewal whilst 
maintaining maximal retention of stem cell marker expression. Use of the 
conditions eliciting the largest retention of stemness was then carried forward in 
assessing the metabolomic profile of these MSCs on the different 
nanotopographies. Characterisation of the cells and substrate were additionally 
performed, in order to provide a basic understanding of the key materials 
utilised in this project.  
 
 
 
3.2 Results 
 
3.2.1 Reproducibility of polycarbonate substrates 
 
The substrates used in this thesis were produced in high volume by injection 
moulding. However, these were manufactured in several batches depending on 
availability of equipment. Therefore, it was noted that there may be variation 
introduced between different production runs. In order to assess the extent of 
such variation, the diameter of pits was measured from SEM images of 
nanopatterned substrates taken from several batches (!"#$%&'?)().   
 
The results firstly show that injection moulding successfully confers the 
nanotopography onto the polycarbonate base material. Comparison of the initial 
shim and the final substrates show that the pit distributions match their 
respective patterns (!"#$%&'?)(). Secondly, there were no significant differences in 
pit diameter when comparing between five manufacturing batches of SQ and 
NSQ polycarbonate nanotopographies, and thus the slight variation in dimensions 
of the features is not an important factor between the two surfaces.  
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="#1"2"7517&'S56'0&60&;'$6"1#'5'60$;&10g6'0)0&60Y'S"0,'0,&'0,%&6,./;'2.%'6050"60"75/'6"#1"2"7517&'6&0'50'
BmO8OH8'+,&'75/7$/50&;'B)-5/$&'S56'BnO8HY'6$##&60"1#'0,50'0,&';"22&%&17&'3&0S&&1'B"0';"54&0&%6'
S56'1.0'6"#1"2"75108''
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3.2.2  Plasma cleaning of nanotopographical substrates 
 
The base material of the nanotopographical substrates used in this study was 
polycarbonate, a transparent and stable polymer with a melting point of 149°C, 
that has slight hydrophobic properties. Cell adhesion is regarded as a pivotal 
initial process in tissue engineering, as attachment precedes cell migration and 
spreading. In addition, as a cell attaches, the formation of focal adhesions can 
be observed, which can trigger downstream processes such as differentiation 
(Biggs et al., 2007b). The formation of these adhesions can be influenced by 
surface properties including surface wettability, which can be regarded in terms 
of hydrophobicity and hydrophilicity (Lim et al., 2005).  Plasma cleaning is a 
strategy frequently adopted to promote surface oxidation and hydroxylation to 
assist cell adhesion and overcome the hydrophobicity of tissue culture 
plasticware and polymers (Ikada, 1994, van Kooten et al., 2004).  
Flat, SQ and NSQ surfaces were subjected to a range of plasma treatments and 
water contact angles (WCAs) were measured and calculated using the Cassie-
Baxter equation (!"#$%&'?)9).   
 
 
!"#$%&'?)9*'@&56$%&;'51;'75/7$/50&;'0,&.%&0"75/'S50&%'7.10570'51#/&6'2.%'B./A75%3.150&'2/50'
51;'151.B500&%1&;'6$%257&68'+,&'0,&.%&0"75/'S50&%'7.10570'51#/&'S56'75/7$/50&;'$6"1#'0,&'>566"&)
[5V0&%'&F$50".1'566$4"1#'(Oo'7.-&%5#&8''
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The WCAs were observed to immediately decrease upon application of the air 
plasma treatment, which is expected as more oxygen becomes incorporated into 
the surface. This indicates a decrease in hydrophobicity. However, the measured 
WCA increased slightly over time, as it is likely that particles from the ambient 
air began to deposit on the material surface.  For efficient experimental setup, 
it is desirable to have a relatively short treatment time for preparation of 
substrates in vast quantities and to avoid this deposition on the surface. It was 
observed that after 20 seconds plasma treatment, there is a significant 
difference in WCA when comparing between flat and SQ and flat and NSQ. At 
this point, the theoretical angle correlates relatively well with the measured 
WCA values for SQ and NSQ.  
 
For more controlled measurements, X-ray photoelectron spectroscopy (XPS) 
analysis was carried out to investigate the elemental composition on each of the 
surfaces following timed oxygen plasma treatment. This confirmed the 
successful incorporation of oxygen into the material after 10 seconds (!"#$%&'?)?, 
!"#$%&'?)D, +53/&'?)(,+53/&'?)9). There appeared to be no significant benefits with 
prolonged treatment, therefore a short duration of plasma treatment is 
sufficient to gain an increase in oxygen functionalities.  
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(a) 
 
(b) 
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(a) 
 
(b) 
 
!"#$%&'?)D*'U<='515/A6"6'.2'.VA#&1'B/5645'0%&50&;'B./A75%3.150&8'+"4&'B."106'.2'0%&504&10'5%&'
"1;"750&;'53.-&'&57,'0%57&'^5_'U<='6$%-&A'6B&70%$4'S"0,'B&5G6'7.%%&6B.1;"1#'0.'.VA#&1'51;'
75%3.1'^3_'K"#,'%&6./$0".1'7.43"1&;'6B&70%5'6,.S"1#'.1/A'5'6"1#/&'B,.0.&4"66".1'B&5G'
7.%%&6B.1;"1#'0.'>(6'3&0S&&1'0,&';"22&%&10'B/5645'0%&50&;'654B/&68'+,&';505'2.%'&57,'6B&70%$4'
"1'0,"6'7.43"1&;'2"#$%&'5%&'5%0"2"7"5//A'.226&0'.1'0,&'A)5V"6'2.%'7/5%"0A8'
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Air plasma treatment time (s) Carbon (%) Oxygen (%) 
0 (No treatment) 87.0 13.0 
5 85.0 15.0 
10 85.7 14.3 
20 86.4 13.6 
40 86.7 13.3 
60 84.6 15.4 
300 85.1 14.9 
+53/&'?)(*'W$510"2"750".1'.2';&05"/&;'U<='6B&70%5'7.%%&6B.1;"1#'0.'5"%'B/5645'0%&50&;'
B./A75%3.150&8'+,&'053/&'6,.S6'0,&'B&%7&105#&'.2'75%3.1'51;'.VA#&1';&0&70&;'.1'0,&'6$%257&'.2'
&57,'654B/&8'U<='515/A6"6'S56'B&%2.%4&;'3A'R%'I564$6'<&;&%6&1'^\1"-&%6"0A'.2':/56#.S_8'
 
 
Oxygen plasma treatment time (s) Carbon (%) Oxygen (%) 
0 (No treatment) 87.0 13.0 
6 84.8 15.2 
12 85.0 15.0 
18 84.9 15.1 
42 84.6 15.4 
60 82.4 17.6 
300 85.5 14.5 
+53/&'?)9*'W$510"2"750".1'.2';&05"/&;'U<='6B&70%5'7.%%&6B.1;"1#'0.'.VA#&1'B/5645'0%&50&;'
B./A75%3.150&8'+,&'053/&',"#,/"#,06'B&%7&105#&6'56';&67%"3&;'2.%'053/&'(8'QVA#&1'B/5645'
0%&504&10'0"4&6'S&%&'G&B0'56'7/.6&'0.'0,&'5"%'B/5645'0%&504&10'0"4&6'56'B.66"3/&Y'S"0,"1'0,&'/"4"06'
.2'0,&'457,"1&%A8'QVA#&1'B/5645'0%&504&10'S56'75%%"&;'.$0'3A'R51"&/'@.%%"6.1Y'51;'U<='515/A6"6'
S56'B&%2.%4&;'3A'R%'I564$6'<&;&%6&1'^\1"-&%6"0A'.2':/56#.S_8''
 
 
 
In some cases plasma treatment can etch the surface of materials. This was 
tested for the plasma treatment times used in previous steps of this part of the 
work. SEM and AFM images (Figure 3-5 and Figure 3-6) did not reveal any distinctive 
differences as the duration of plasma treatment was increased. In addition there 
were not any significant changes in pit depth (Figure 3-7). 
 
Chapter 3: Characterisation of Mesenchymal Stem Cells and Nanotopography Optimisation 
 79 
'
!"#$%&'?)H*'=X@'"45#&6'.2'2/50'51;'151.B500&%1&;'6$%257&6'2.//.S"1#'5"%'B/5645'0%&504&108'
=75/&'35%*'9c48'I&#".1'3.V&;'"1'%&;'%&B%&6&106'51'&VB51;&;'B5%0'.2'0,&'.%"#"15/'"45#&8''
 
 
 
Chapter 3: Characterisation of Mesenchymal Stem Cells and Nanotopography Optimisation 
 80 
 
 
!"#$%&'?)J*'X22&70'.2'5"%'B/5645'0%&504&10'.1'151.0.B.#%5B,A'6$%257&6'566&66&;'3A'E!@'
"45#"1#8'=54B/&6'S&%&'6$3d&70&;'0.'5"%'B/5645'0%&504&10'2.%'0,&'"1;"750&;'0"4&6'51;'"45#&;'
$6"1#'E!@'"1'.%;&%'0.'0&60'S,&0,&%'0,"6'S.$/;',5-&'51A';&0%"4&105/'&22&706'.1'-5/";"0A'.2'0,&'
151.B500&%168'T45#"1#'S56'75%%"&;'.$0'3A'R%'E/&V'a"1G&/'^e<`'E!@'6&%-"7&6_8'=75/&'35%*'HOO'148'!
 
 
 
 
 
Chapter 3: Characterisation of Mesenchymal Stem Cells and Nanotopography Optimisation 
 81 
 
!"#$%&'?)L*'</5645'0%&50&;'151.0.B.#%5B,A'B"0';&B0,'4&56$%&4&106';&%"-&;'2%.4'E!@'"45#&68'
<"0';&B0,'4&56$%&4&106'S&%&'.305"1&;'$6"1#':SA;;".1'.B&1'577&66'6.20S5%&8'E-&%5#&';&B0,'
4&56$%&4&106'.2'B"06'57%.66'0,&'6$%257&'.2'=Z'51;']=Z'B/5645'0%&50&;'6$360%50&6'6,.S&;'
4"1"45/'-5%"50".1'"1';&B0,'S"0,'B%./.1#&;'B/5645'0%&504&108'W%%.%6'35%6';&1.0&'p'6051;5%;'
;&-"50".18''
 
Based on the results of the plasma cleaning assessment, 20 seconds of air plasma 
treatment was deemed to be sufficient to assist cell attachment. All 
polycarbonate surfaces were thus pre-treated in this fashion prior to cell 
seeding.  
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3.2.3 Effect of nanotopography on phenotype of MSCs cultured 
on PCL 
 
The nanoscale pit features described have previously been fabricated in 
different materials, such as poly(methyl methacrylate) (PMMA) and 
polycaprolactone (PCL), and were reported to promote either osteogenic 
differentiation or maintenance of self-renewal of STRO-1 selected MSCs (Dalby 
et al., 2007, McMurray et al., 2011). To ensure that these nanotopography 
induced osteogenesis and stem cell maintaining phenotypes were reproducible, 
SQ and NSQ pit nanotopographies were hot embossed onto PCL and seeded with 
STRO-1+ MSCs, and cultured for 28 days, in an experiment similar to that 
described by McMurray et al (McMurray et al., 2011). Immunostaining to detect 
STRO-1 and osteocalcin clearly showed that osteocalcin was indeed higher on 
NSQ in comparison to SQ and flat, and STRO-1 was higher on SQ in comparison to 
flat and NSQ (!"#$%&'?)M). These results increased confidence that the 
nanotopographies selected for study have reproducible effects on bone marrow 
derived MSCs.  
 
!"#$%&'?)M*'Q60&.#&1&6"6'B%.4.0"1#'51;'60&4'7&//'45"105"1"1#'B,&1.0AB&6'"1;$7&;'3A'151.B"0'
151.0.B.#%5B,A'.1'<>P8'=+IQ)(X'@=>6'S&%&'6&&;&;'.10.'2/50'.%',.0'&43.66&;'<>P'S"0,'=ZC]=Z'
151.B500&%16'50'(V(OD'7&//6C4/'56';&67%"3&;'3A'@7@$%%5A'&0'5/8'I&;'q'!)570"1Y'3/$&'q'1$7/&"Y'#%&&1'
q'=+IQ)('.%'.60&.75/7"1'56'"1;"750&;'0.'0,&'/&20'.2'&57,'%.S'.2'"45#&68'=75/&'35%*'(OO'c48'
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3.2.4 Characterisation of CD271+ MSCs 
 
3.2.4.1  Assessment of CD271 selection from bone marrow populations 
 
Following selection of the adherent bone marrow cell population, MACS selection 
of CD271+ cells was incorporated into the existing protocol following selection of 
the adherent bone marrow cell population, in order to increase the purity or 
homogeneity of the cells used in experimentation. As such, the selected cells 
were stained for CD271 to confirm that only positive cells were being selected. 
CD271 expression was confirmed after 7 days culture following selection  
(!"#$%&'?)N).   
 
!"#$%&'?)N*'=&/&70&;'@=>6'$6"1#'5'>R9L('45#1&0"7'6&B5%50".1'G"0'605"1'B.6"0"-&'2.%'>R9L(8':%&&1'
q'>R9L(Y'[/$&'q']$7/&"'^RE<T'605"1&;_8'=&/&70&;'7&//6'7$/0$%&;'2.%'L';5A6'605"1'B.6"0"-&'2.%'>R9L(8'
=75/&'35%*'HO'c48'
 
 
3.2.4.2  Characterisation of stem cell phenotypic markers in CD271+ MSCs 
 
Aside from adherence to tissue culture plastic, MSCs should stain positively for 
stem cell markers. Partial characterisation of the selected cells was carried out 
to determine what positive markers were expressed. The CD271+ cell fraction 
appeared to express several proteins described as being characteristic of stem 
cells, staining positively for the reported stem cell associated markers STRO-1, 
CD63 and bone marrow niche marker nestin (!"#$%&'?)(O). These results are 
consistent with the notion that the selected CD271 bone marrow subpopulations 
contained MSCs.  
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!"#$%&'?)(O*'+,&'>R9L(Y'@=>'B.B$/50".1'605"1'B.6"0"-&/A'2.%'60&4'7&//'45%G&%6'=+IQ)(Z'>RJ?Z'
51;'1"7,&'45%G&%'1&60"18'!/$.%&67&17&'4"7%.67.BA'"45#&6'.2'6&/&70&;'@=>6'"44$1.605"1&;'2.%'
0,&'.$0/"1&;'45%G&%6'520&%'(';5A'.2'7$/0$%&'2.//.S"1#'6&/&70".1'B%.7&;$%&68'=+IQ)(Y'>RJ?'51;'
1&60"1'5%&'5//'%&B.%0&;'@=>'45%G&%68'+S.'%&B%&6&1050"-&'"45#&6'^%.S6_'605"1&;'2.%'&57,'45%G&%'
5%&'6,.S18'=75/&'35%*'HO'c48'
 
3.2.4.3 Functional characterisation: differentiation into multiple lineages 
 
To prove that the isolated CD271+ cells indeed included an MSC population, they 
needed to possess the ability to differentiate into mesenchymal lineages. 
Chemical induction media was added to the cells to drive adipogenic and 
osteogenic differentiation (!"#$%&'?)(().  
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!"#$%&'?)((*'>,&4"75//A'"1;$7&;'.60&.#&1"7'51;'5;"B.#&1"7';"22&%&10"50".1'.2'>R9L(Y'@=>68'
>R9L(X'@=>6'S&%&'7$/0$%&;'2.%'J'S&&G6'"1'.60&.#&1"7'.%'5;"B.#&1"7'"1;$70".1'4&;"5'0.';%"-&'0,&"%'
;"22&%&10"50".1'0.'51'.60&.#&1"7'.%'5;"B.#&1"7'/"1&5#&8'^5_'>&//6'7$/0$%&;'"1'3565/'4&;"5'.%'
5;"B.#&1"7'4&;"5'51;'605"1&;'S"0,'Q"/'I&;'Q'0.';&0&70'/"B";';%.B/&068'^3_'>&//6'7$/0$%&;'"1'3565/'
4&;"5'.%'.60&.#&1"7'4&;"5'51;'605"1&;'S"0,'b.1'`.665'605"1'51;'1$7/&5%'2560'%&;'0.'"1;"750&'
B,.6B,50&'"1'75/7"$4';&B.6"06'51;'1$7/&"'%&6B&70"-&/A8'=75/&'35%*'(OOc4'
 
Positive staining for lipid droplets and phosphate (as an indicator of calcium 
phosphate) by histological staining showed that MSCs were present in the CD271+ 
population, confirming successful isolation of MSCs for study.  
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3.2.5  Optimising seeding density for nanotopography efficiency 
 
Previous seeding protocols involved addition of cells in a suspension to the 
substrate, which is not very efficient, as some of the cells fall outwith the area 
of the substrate. Use of a cell seeding device increases nanotopography seeding 
efficiency by ensuring that the majority of a small volume suspension of cells 
remains on top of the substrate, rather than falling onto areas of the well that 
were not covered by the topography (!"#$%&'?)(9).  
 
 
!"#$%&'?)(9*'>.4B5%"6.1'.2'7.1-&10".15/'6&&;"1#'51;'6&&;"1#'S"0,'5';&-"7&8'=7,&450"7';"5#%54'
"//$60%50"1#'0,&';"22&%&17&6'3&0S&&1'5;;"0".1'.2'5'7&//'6$6B&16".1'0.'5'S&//'7.105"1"1#'5'6$360%50&Y'
51;'$6&'.2'5'7&//'6&&;&%8'E%&56'7./.$%&;'%&;';&B"70'%&#".16'S,&%&'0,&'7&//6'S"0,"1'0,&'6$6B&16".1'
S.$/;'%&57,8'+,&'/.S&%'B51&/';&67%"3&6'0,&';"22&%&17&6'"1'7&//';"60%"3$0".1'S"0,'0,&'0S.';"22&%&10'
4&0,.;6'^7&//6'5%&'%&B%&6&10&;'56'3/$&'7"%7/&6_8'>.1-&10".15/'6&&;"1#'5//.S6'0,&'7&//6'0.'25//'.1'
%&#".16'.$0S"0,'0,&'6$360%50&Y'S,&%&56'$6&'.2'5'7&//'6&&;"1#';&-"7&'7.105"16'0,&4'.1'0.B'.2'0,&'
6$360%50&8'
 
 
However, this in turn increased the degree of cell coverage in comparison to 
addition of the same cell number held within a much larger volume, thus the 
number of cells to be added per substrate became a factor to be considered in 
subsequent experiments. Use of the cell seeder should be more efficient in 
terms of surface coverage, yet will result in an increased number of cells in 
direct contact, elevating the risk that they will stop responding to 
nanotopographical cues. It was hypothesized that the number of cells seeded 
onto the area of the substrate would be important to the eventual fate of the 
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MSCs, due to the small size of the patterned features and the strength of such 
physical cues in comparison to cell-cell contact signalling. That is, an 
accumulating number of cell-cell contact cues may predominate over the effects 
of nanotopography. To address this issue, cells were seeded at a number of 
seeding densities to firstly compare surface coverage. Previous seeding was at 
10,000 cells/ml (McMurray et al., 2011, Tsimbouri et al., 2014), which would be 
equivalent to adding approximately 6000 cells/cm2 using the current size of 
substrate. Initial assessment of cell distribution and coverage was assessed with 
Coomassie blue protein staining (!"#$%&'?)(?). After 7 days surface coverage was 
relatively high using seeding densities over 2000 cells/cm2, and therefore would 
have increased risk of leading to lots of overlapping cells at early timepoints as 
the topography influences cell fate.  
 
 
 
!"#$%&'?)(?*'T1"0"5/'566&664&10'.2'7&//'6B%&5;'51;'7.-&%5#&'S,&1'6&&;"1#'50';"22&%&10';&16"0"&6'
$6"1#'5'6&&;"1#';&-"7&8'[%"#,02"&/;'"45#&6'.2'>R9L(X'@=>6'6&&;&;'.10.'2/50'B./A75%3.150&'$6"1#'5'
7&//'6&&;"1#';&-"7&'50'0,&'"1;"750&;';&16"0"&6Y'7$/0$%&;'2.%'L';5A6'51;'605"1&;'S"0,'>..4566"&'3/$&8'
=75/&'35%*'9OO'c4'
 
 
Following these observations, the focus of our study was narrowed to three 
decreased densities: 500 cells/cm2, 1000 cells/cm2 and 2000 cells/cm2, 
representing low, medium and high density seeding. The growth patterns were 
assessed temporally, monitored after growth at 1, 7, 14, 21, and 28 days.  
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During the initial periods of culture, there were no visible differences between 
the flat, SQ or NSQ growth patterns. After 21 days, however, it was interesting 
to note that a number of cell clusters where cells were expanding in colonies 
(which we termed ‘colony growth’) was observed only at the low and mid 
densities, with the lowest density showing the most colony growth (Figure 3-14). 
In the case of the highest density, this appeared to favour uniform coverage of 
the entire substrate, exhibiting a ‘fibroblastic growth’ arrangement.  
After each successive timepoint, it became apparent that the cells grew closer 
together leaving less space between adjacent cells, and as expected, this was 
most pronounced with the highest cell density. Cells began to overlap and grow 
closely together in certain areas of the substrate (!"#$%&'?)(H).  
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(b) Day 7  
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!"#$%&'()*+,'-./0*1'23-4'5$67$%&8'97'8"::&%&;7'8&;4"7"&4'&<=">"7'$;"?$&'5&66'#%@A7='B977&%;4C'!"#$%&'()'*+,*%&'-,.'&#/&012'&-($*(+%3&/#+&4,5&6&4)5&7&4-5&68&435&96&,.3&4%5&
9:&3,;'<&'*,=.%3&>=*"&2##?,''=%&)$(%&,*&3%.'=*=%'&#/&@AA<&6AAA&,.3&9AAA&-%$$'B-?9C&D?,E%'&'"#>.&,+%&+%F+%'%.*,*=G%&#/&*+=F$=-,*%&?,*%+=,$&+%F$=-,*%'C&2%$$'&'%%3%3&,*&*"%&
*>#&$#>%+&3%.'=*=%'&%HF,.3%3&,'&-#$#.=%'<&>"=-"&)%E,.&*#&)%&.#*=-%3&,/*%+&68&3,;'<&>"%+%,'&*"#'%&-($*(+%3&,*&9AAA&-%$$'B-?9&E+%>&=.&,&(.=/#+?&?,..%+<&-#G%+=.E&*"%&
%.*=+%*;&#/&*"%&'(+/,-%C&I"%'%&E+#>*"&F,**%+.'&#--(++%3&=.3%F%.3%.*$;&#/&*"%&-($*(+%&'(+/,-%&('%3<&=?F$;=.E&*",*&*"%'%&#)'%+G,*=#.'&>%+%&3%.'=*;J3%F%.3%.*C&&
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!"#$%&'()*D,'E%@A7='9;8'4B%&98'@:'-./0*1'23-4'@;':697'9;8';9;@B977&%;&8'4$>47%97&4'9:7&%'/F'89G4'5$67$%&C'K+=E"*J/=%$3&?=-+#'-#F;&=?,E%'&#/&2##?,''=%J'*,=.%3&-%$$'&
,/*%+&9:&3,;'<&*,L%.&,*&@H&?,E.=/=-,*=#.C&2%$$'&)%E=.&*#&'%G%+%$;&#G%+$,F&,*&*"%&"=E"%'*&3%.'=*;&#/&9AAA&-%$$'B-?9C&1-,$%&),+M&@A&N?C&
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Marker expression was tested in MSCs seeded at these densities to investigate a 
possible relationship between seeding number and phenotype. Western blotting 
was used as an initial screening technique (!"#$%&'()*+), which revealed that stem 
cell marker expression was more effectively retained on SQ at the low and 
medium seeding densities, whereas the highest seeding density favoured 
osteogenic differentiation and expression of osteopontin on NSQ (!"#$%&'()*,).  
 
!"#$%&'()*+,'-..&/0'1.'2&&3"4#'3&42"05'14'6%10&"4'&76%&22"14'"4'89:2'2&&3&3'14'4;410161#%;6<5='
-&./&%0'123/'40425.".'60'7*8'39':;'<45'=$2/$%&<'>?:,*@'AB>'25.4/&.'C%31&<'93%'648'>?:,*'618'
DE>DA'40<'6=8'3./&3C30/"0'/3#&/F&%'G"/F'234<"0#'=30/%32.'HDI?J'3%'642CF48'/$1$2"0K'
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!"#$%&'()*>,'?$;40"."&3'6%10&"4'&76%&22"14'@&A&@2'B5'3&42"01C&0%5='L$40/"9"=4/"30'39'140<.'.F3G0'
"0'!"#$%&'()*+M'93%'648'>?:,*'618'DE>DA'40<'6=8'3./&3C30/"0M'40<'&NC%&..&<'%&24/"O&'/3'234<"0#'
=30/%32'C%3/&"0.'HDI?J'3%'642CF48'/$1$2"0K'P&24/"O&'140<'<&0."/"&.'4%&'&NC%&..&<'"0'4%1"/%4%5'$0"/.K'
B4QC2&'140<.'G&%&'03%Q42".&<'/3'/F&'924/'.$%94=&'"0'&4=F'=4.&'607*M'/F&%&93%&'03'&%%3%'14%.'=3$2<'
1&'"0=2$<&<8K''
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As western blotting is a bulk cell analysis, that involves producing a lysate from 
all of the cells, quantitative analysis of microscopy images was adopted as a 
method to determine the expression of protein in each cell in high numbers for 
statistical analysis (!"#$%&'()*;). Use of techniques like western blotting involve 
population analysis and can mask data regarding individual cells. The results 
paralleled the western blotting data, in that similar trends were observed for 
stem cell markers CD271 and ALCAM. The seeding density that resulted in 
highest levels of CD271 and ALCAM on SQ was 1000 cells/cm2. It was noted that 
500 cells/cm2 was also relatively good for stem cell marker levels, however this 
would pose problems in terms of requiring large numbers of substrates to seed. 
CD271+ MSCs appear to be poor for osteogenesis compared to STRO-1+ MSCs and 
unselected progenitors from bone marrow used in other studies (Rickard et al., 
1994, Jones et al., 2002, Dalby et al., 2006c, Biggs et al., 2009a).  
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(b)
 
!"#$%&'()*D,'-..&/0'1.'2&&3"4#'3&42"05'14'6%10&"4'&76%&22"14'"4':EF>*G'89:2H';22&22&3'B5'"C;#&'
;4;@52"2='>&22.'9%3Q'RS)+S'"Q4#&.'G&%&'40425.&<'C&%'=30<"/"30K'E&O&2.'39'>?:,*M'DE>DA'40<'
3./&3C30/"0'6TIU8'G&%&'Q&4.$%&<'$."0#'>&22I%39"2&%'"Q4#&'40425.".'.39/G4%&'93%'=&22.'.&&<&<'4/'648'
VSS'=&22.W=Q:'40<'*SSS'=&22.W=Q:'618':SSS'=&22.W=Q:'30'924/WBLWUBLK'DO&%4#&'23#'/%40.93%Q4/"30.'
39'3%"#"042'<4/4'4%&'.F3G0K'X%%3%'14%.'%&C%&.&0/'Y'./40<4%<'&%%3%'39'/F&'Q&40K'T0&)G45'DUTZD'
G"/F'[$\&5].'C3./)/&./M'3%'^%$.\42)-422".'/&./'G"/F'?$00].'C3./)/&./'G&%&'C&%93%Q&<'/3'4..&..'
."#0"9"=40=&K'_C`SKSVM'__C`SKS*M'___C`SKSS*'
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3.2.6 MSC proliferation on nanotopography  
 
CD271+ MSCs on nanotopographies were assessed for changes in proliferation by 
bromodeoxyuridine (BrdU) labelling (a structural analog of thymidine) over 
several timepoints. BrdU added to the media was incorporated into newly 
synthesised DNA during the synthesis or S phase of the cell cycle in place of 
thymidine. The results indicate that the number of cells passing through S phase 
was not significantly different on SQ and NSQ over the timepoints tested, 
suggesting that proliferation rate was unchanged in the MSCs during self-renewal 
and differentiation (!"#$%&'()*a).  
 
!"#$%&'()*I,'J%3K'"4/1%61%;0"14'"4':EF>*G'89:2='>&22.'G&%&'.&&<&<'4/'4'<&0."/5'39'*SSS'=&22.W=Q:'
40<'=$2/$%&<'93%'*M'(M','40<'*R'<45.K'P&.$2/.'.F3G'/F&'4O&%4#&'%4/"3'39'b%<c'C3."/"O&'=&22.'40<'
0$Q1&%'39'/3/42'0$=2&"'9%3Q'/F%&&'Q4/&%"42'%&C2"=4/&.K'B"#0"9"=40=&'G4.'4..&..&<'$."0#'4'^%$.\42'
-422".'/&./'G"/F'?$00].'C3./)/&./K'X%%3%'14%.'%&C%&.&0/'./40<4%<'&%%3%'39'/F&'Q&40K'
 
 
Growth (increase in cell number) over the same timepoints on each of the 
substrates was compared by counting the number of nuclei falling within a grid 
of pre-defined size. The number of cells on each surface did not show significant 
changes (!"#$%&'():S). 
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!"#$%&'()FL,'M22&22C&40'1.'89:'#%1N0<'14'4;410161#%;6<"&2'1A&%'0"C&='>&22.'.&&<&<'4/'4'
<&0."/5'39'*SSS'=&22.W=Q:'G&%&'=$2/$%&<'93%'*M'(M','40<'*R'<45.K'P&.$2/.'.F3G'/F&'Q&40'0$Q1&%'39'
0$=2&"'=3$0/.'9%3Q'R;'"Q4#&.'3O&%'/F%&&'Q4/&%"42'%&C2"=4/&.K'B"#0"9"=40=&'G4.'4..&..&<'$."0#'4'
^%$.\42'-422".'/&./'G"/F'?$00].'C3./)/&./K'X%%3%'14%.'%&C%&.&0/'./40<4%<'&%%3%'39'/F&'Q&40K''
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3.2.7 Metabolomic profile of CD271+ MSCs  
 
Analysis of the entire cell metabolome offers a strategy for observing the range 
of molecules that are present within cells at a specific point in time. The 
metabolite profiles of in-house selected MSCs were assessed following 7 day and 
14 day periods in culture. High performance liquid chromatography (HPLC) was 
used to separate the metabolites within the samples by retention time on the 
column followed by mass spectrometry to detect the mass/charge (Mz) ratio, 
from which the mass can be inferred (LC-MS). Data processing was achieved 
through analysis of derived chromatographic peak intensities using an IDEOM/Mz 
match Excel interface and various metabolomics data analysis tools. 
 
3.2.7.1 Assessment of cell metabolome after 7 day culture 
 
3.2.7.1.1 Overview of data output and activity within metabolic pathways 
 
Looking firstly at the results from cells cultured for one week, it can be observed 
that a number of significant alterations were detected on the SQ and NSQ 
samples in comparison to those on flat controls (!"#$%&'():* 648 40< 6=8). There 
appeared to be a balance of increased and decreased relative abundances of 
metabolites associated with both nanotopographies, with some larger 
differences detected on NSQ (!"#$%&'():* 618 40< 6<8).  
 
The dataset yielded a list of 670 metabolites that were assigned putative 
identifications within the IDEOM/Mz match Excel interface, which aided grouping 
of the metabolites into broad classifications, namely metabolites that could be 
considered as being nucleotides, amino acids, lipids, secondary metabolites, 
vitamins and cofactors, and a remaining subset, which were not associated with 
any known metabolic maps.  
 
Grouping by referencing the maps assigned by IDEOM indicated that the many of 
the detected metabolites had unknown associations, with the majority of the 
remaining metabolites being part of lipid and amino acid metabolism, with a 
smaller number of molecules being part of carbohydrate, nucleotide, and 
secondary metabolite and cofactor pathways. 
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(a) SQ/Flat: T-test 
 
(b) SQ/Flat (fold change) 
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(c) NSQ/Flat (t-test) 
 
(d) NSQ/Flat (fold change) 
 
 
!"#$%&'()F*,'OA&%A"&N'1.'3&0&/0&3';43'2"#4"."/;40'C&0;B1@"0&2'"4'89:2'14'9?'"4'/1C6;%"214'01'
.@;0';.0&%'>'3;52'1.'/$@0$%&='d<&0/"9"&<'Q&/4132"/&.'9%3Q'Q$2/"C2&'.4QC2&'%&C2"=4/&.'60'7+8'4%&'
"0<"=4/&<'15'#%&5'="%=2&.M'G"/F'."#0"9"=40/25'"0=%&4.&<'3%'<&=%&4.&<'Q&/4132"/&.'6%&24/"O&'/3'/F&'924/'
=30/%328'1&"0#'<&03/&<'15'/F&'C"0\'="%=2&.K'648'40<'6=8'/)/&./'C23/.'G"/F'4'."#0"9"=40=&'/F%&.F32<'.&/'
4/'C`SKSV'618'40<'6<8'!32<'=F40#&'C23/.'G"/F'=$/)399'/F%&.F32<'.&/'4/':'932<'=F40#&K'X4=F'39'/F&'
=3QC4%".30.'5"&2<&<'4'Q&/41323Q"='e9"0#&%C%"0/]'"0<"=4/"O&'39'/F&'=&22'./4/&'4/'/F4/'C4%/"=$24%'/"Q&'
C3"0/K''
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Assessment of the fold changes in total metabolite intensity level for each of 
these pathway groups did not show dramatic changes between SQ and NSQ, 
However, data appeared suggestive to potential beginnings of a shift in 
metabolomic activity between the surfaces (!"#$%&'()::). Other studies have 
mentioned that stem cells are metabolically ‘quiet’ whereas differentiating cells 
are much more metabolically active (Reyes et al., 2006, Yanes et al., 2010, 
Tsimbouri et al., 2012).  
 
!"#$%&'()FF,'P%1$6&3'010;@'C&0;B1@"0&'.1@3'/<;4#&2'.1%'89:2'/$@0$%&3'14'4;410161#%;6<"&2='[F&'
C&4\'"0/&0."/"&.'39'422'/F&'Q&/4132"/&.'=24..&<'"0/3'&4=F'#%3$C"0#'G&%&'/3/422&<M'4O&%4#&<'40<'/F&'
932<'=F40#&'<&/&%Q"0&<'15'=3QC4%".30'/3'924/'=30/%32.K'DQ30#./'/F&'<"99&%&0/'1%34<'C4/FG45'
#%3$C.M'4'#&0&%42'/%&0<'39'23G&%'Q&/4132"/&'41$0<40=&.'G&%&'.$##&./&<'30'BL'"0'=3QC4%".30'/3'
UBLM'G"/F'/F&'&N=&C/"30'39'/F&'2"C"<'#%3$CK'J3G&O&%M'/F&.&'=F40#&.'G&%&'03/'93$0<'/3'1&'
./4/"./"=4225'."#0"9"=40/'"0'/F".'<4/4.&/K'A4/&%"42'%&C2"=4/&.M'924/'607+8'BL'607'R8'40<'UBL'607'V8K'
X%%3%'14%.f'./40<4%<'&%%3%'39'/F&'Q&40K'
 
3.2.7.1.2 Visualisation of changes in metabolic groups with heatmap analyses 
 
Investigation into the metabolites within each of the broad groups was taken 
further by performing fold change calculations for metabolites classed into 
smaller data clusters. Heat maps were used to visualise the results, and allow 
fold increases and decreases to be observed more easily. Ranking the 
metabolites in each of the heat maps from ‘hot’(increased abundance, red) to 
‘cold’ (decreased abundance, blue) gives an indication of whether more fold 
increases or decreases are favoured on each substrate. In most of the groups, 
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increases in metabolite abundance were more common on NSQ than SQ (!"#$%&'
():(, !"#$%&'():R, !"#$%&'():+), though this trend is reversed with the lipid related 
metabolites (!"#$%&'():+). Secondary metabolite, vitamin and cofactor groups, and 
unmapped metabolites had similar numbers of increases and decreases (!"#$%&'
():, and !"#$%&'():;).  
 
 
!"#$%&'()F(,'Q$/@&10"3&'C&0;B1@"0&'6%1."@&2'14'9?';43'Q9?';.0&%'>'3;52'1.'/$@0$%&='A&/4132"/&.'
=24..&<'4.'1&"0#'"0O32O&<'"0'0$=2&3/"<&'Q&/4132".Q'G&%&'40425.&<'93%'13/F'BL'6Q4/&%"42'%&C2"=4/&.M'
07'R8'40<'UBL'607'V8K'J&4/'Q4C.'G&%&'#&0&%4/&<'9%3Q'4O&%4#&'932<'=F40#&'O42$&.'G"/F'%&9&%&0=&'
/3'924/'=30/%32.'607'+8M'4.."#0"0#'4'=323$%'.=42&'/3'/F&'.$1.&g$&0/'%&.$2/.K'b2$&'%&#"30.'."#0"95'932<'
"0=%&4.&.M'%&<'%&#"30.'%&C%&.&0/'932<'<&=%&4.&.'40<'5&223G'%&#"30.'<&03/&'03'=F40#&.K'Z42$&.'"0'
1&/G&&0'/F&.&'&N/%&Q&.'G&%&'.F4<&<'4==3%<"0#25K'[F&'&0/"%&'0$=2&3/"<&'<4/4.&/'.3%/&<'9%3Q'
F"#F&./'/3'23G&./'932<'=F40#&'41$0<40=&'".'.F3G0'/3'/F&'%"#F/'39'/F&'Q4"0'F&4/Q4CM'F"#F2"#F/"0#'
4'=30/%4./'1&/G&&0'BL'40<'UBL'"0'/&%Q.'39'/F&'0$Q1&%'39'Q&/4132"/&.'1&"0#'Q3%&'41$0<40/'40<'
2&..'.3M'"0'=3QC4%".30'/3'924/K''UBL'F4<'4'F"#F&%'2&O&2'39'"0=%&4.&.'"0'0$=2&3/"<&'Q&/4132"/&.K''
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!"#$%&'()FR,'MC"41';/"3'C&0;B1@"0&'6%1."@&'14'9?';43'Q9?';.0&%'>'3;52'1.'/$@0$%&='A&/4132"/&.'
"0O32O&<'"0'4Q"03'4="<'Q&/4132".Q'G&%&'40425.&<'93%'BL'6Q4/&%"42'%&C2"=4/&.M'07'R8'40<'UBL'607'
V8K'J&4/'Q4C.'G&%&'#&0&%4/&<'9%3Q'4O&%4#&'932<'=F40#&'O42$&.'G"/F'%&9&%&0=&'/3'924/'=30/%32.'607'
+8M'4.."#0"0#'4'=323$%'.=42&'/3'/F&'.$1.&g$&0/'%&.$2/.K'b2$&'%&#"30.'7'932<'"0=%&4.&.M'%&<'%&#"30.'7'
932<'<&=%&4.&.'40<'5&223G'%&#"30.'7'03'=F40#&K'D'/%$0=4/&<'2"./'".'.F3G0'F&%&M'4.'/F&'0$Q1&%'39'
Q&/4132"/&.'G&%&'g$"/&'&N/&0."O&K'[F&'&0/"%&'4Q"03'4="<'<4/4.&/'.3%/&<'9%3Q'F"#F&./'/3'23G&./'".'
.F3G0'/3'/F&'%"#F/'39'/F&'Q4"0'F&4/Q4CM'F"#F2"#F/"0#'4'=30/%4./'1&/G&&0'BL'40<'UBL'"0'/&%Q.'39'
/F&'0$Q1&%'39'41$0<40/'Q&/4132"/&.K'd0=%&4.&.'"0'Q&/4132"/&.'G&%&'Q3%&'C%&O42&0/'30'UBLK'
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4.."#0"0#'4'=323$%'.=42&'/3'/F&'.$1.&g$&0/'%&.$2/.K'b2$&'%&#"30.'7'932<'"0=%&4.&.M'%&<'%&#"30.'7'932<'
<&=%&4.&.'40<'5&223G'%&#"30.'7'03'=F40#&K'D'/%$0=4/&<'2"./'".'.F3G0'F&%&M'4.'/F&'0$Q1&%'39'
Q&/4132"/&.'"0'/F".'=24..'G&%&'g$"/&'&N/&0."O&K'[F&'&0/"%&'2"C"<'<4/4.&/'.3%/&<'9%3Q'F"#F&./'/3'
23G&./'".'.F3G0'/3'/F&'%"#F/'39'/F&'Q4"0'F&4/Q4CM'.F3G"0#'40'"0=%&4.&<'41$0<40=&'39'2"C"<'
Q&/4132"/&.'30'BL'/F40'UBLK''
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Z42$&.'"0'1&/G&&0'/F&.&'&N/%&Q&.'G&%&'.F4<&<'4==3%<"0#25K'[F&'&0/"%&'0$=2&3/"<&'<4/4.&/'.3%/&<'
9%3Q'F"#F&./'/3'23G&./'932<'=F40#&'41$0<40=&'".'.F3G0'/3'/F&'%"#F/'39'/F&'Q4"0'F&4/Q4CM'
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%&.$2/.K'b2$&'%&#"30.'."#0"95'932<'"0=%&4.&.M'%&<'%&#"30.'%&C%&.&0/'932<'<&=%&4.&.'40<'5&223G'%&#"30.'
<&03/&'03'=F40#&.K'Z42$&.'"0'1&/G&&0'/F&.&'&N/%&Q&.'G&%&'.F4<&<'4==3%<"0#25K'[F&'<4/4.&/M'
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!"#$%&'()FD,'W%1."@&'1.'$4/@;22"."&3'C&0;B1@"0&2'14'9?';43'Q9?';.0&%'>'3;52'/$@0$%&=!A&/4132"/&.'
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Z42$&.'"0'1&/G&&0'/F&.&'&N/%&Q&.'G&%&'.F4<&<'4==3%<"0#25K'[F&'<4/4.&/M'.3%/&<'9%3Q'F"#F&./'/3'
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!"#"$"%"! !"#$#%"&'$()*$*+',&*(#-(#./*)+*0(&1',%*/(",(2*3'.#$"&('&3"+"34(&
 
Following more detailed analysis of the average peak intensities across sample 
replicates, comparing SQ with the flat surface, 41 annotated peaks were 
significantly modulated in abundance (p<0.05). Fold changes in peak intensity of 
NSQ compared to the flat control revealed 42 annotated peaks as having 
significant changes.  
 
Using identifiers for the putative metabolites in the Kyoto Encyclopaedia for 
Genes and Genomes (KEGG) database, pathways that contained some of these 
metabolites were highlighted. Focusing only on the relatively small number of 
significantly changed metabolites enhances the difficulty in drawing many 
conclusions, however, an assessment of the identified metabolic pathways was 
attempted. Noteworthy observations in MSCs on SQ include significant reductions 
in the abundance of two metabolites involved in nicotinate and nicotinamide 
metabolism ((S)-6-Hydroxynicotine and nicotinamide-beta-riboside), which are 
components of oxidative energy pathways, and a significant decrease in O-
acetyl-L-homoserine, involved in the metabolism of amino acids cysteine and 
methionine. This suggests a decreased readiness of cells to participate in 
differentiation-related or growth-related processes, such as protein synthesis, 
and mitochondrial oxidative phosphorylation. It appeared that there was a 
general balance of increases and decreases in arginine and proline metabolism 
and biosynthesis of amino acids, with similar numbers highlighted in these 
pathways after input of significantly enhanced and reduced fold change data.  
With regards to NSQ, a number of elevated metabolites were detected in 
biosynthesis of amino acids (!"#$%&'():a) and aminoacyl-tRNA biosynthesis 
pathways.  
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!"#$%&'()FI,'J"12540<&2"2'1.';C"41';/"32'X-PP'C;6'N"0<'&@&A;0&3'Q9?'C&0;B1@"0&2='A&/4132"/&.'
9%3Q'UBL'"0=%&4.&<'932<'=F40#&'<4/4'"<&0/"9"&<'G"/F"0'/F&'C4/FG45'4%&'%&C%&.&0/&<'15'%&<'3C&0'
="%=2&.K'A4C'G4.'31/4"0&<'9%3Q'^XHH'<4/414.&K''
 
 
Use of Ingenuity Pathway Analysis (IPA) software allowed for investigation of the 
datasets in terms of functional processes and wider networks. Firstly, a general 
assessment was made into the number of up and downregulated gene networks 
on each nanotopography (!"#$%&'()(S 40< !"#$%&'()(*). Processes on SQ were mainly 
downregulations, whereas those on NSQ were predominantly upregulations, 
suggesting that MSCs on the latter surface were more metabolically active.  
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3;52='H%&&0'%&#"30.'39'14%.'%&C%&.&0/'<3G0)%&#$24/"30.M'40<'%&<'%&#"30.'%&C%&.&0/'$C)%&#$24/"30.K'
[F&'0$Q1&%'39'Q&/4132"/&.'"0'/F&'<4/4.&/'/F4/'4%&'"0=2$<&<'G"/F"0'&4=F'=4/&#3%5'4%&'.F3G0'/3'/F&'
%"#F/'39'/F&'14%.K'[F&'%4/"3.'39'<&/&=/&<'Q&/4132"/&.'/3'/3/42'=40<"<4/&.'4..3="4/&<'G"/F'&4=F'
#%3$C"0#'39'=&22$24%'C%3=&..&.'4%&'.F3G0'"0'3%40#&K'd/'=40'1&'.&&0'/F4/'4'24%#&'<&#%&&'39'
Q&/4132"/&.'30'BL'=30/%"1$/&'/3'<&=%&4.&.'"0'/F&'3$/2"0&<'Q&/4132"='C4/FG45.M'.$##&./"0#'/F4/'
AB>.'30'BL'4%&'Q3%&'Q&/4132"=4225'"04=/"O&'3%'eg$"&/]K'A4/&%"42'%&C2"=4/&.M'924/'607+8'BL'607'R8'40<'
UBL'607'V8K' ' ' ' ' ' '
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/$@0$%&='H%&&0'%&#"30.'39'14%.'%&C%&.&0/'<3G0)%&#$24/"30.M'40<'%&<'%&#"30.'%&C%&.&0/'$C)
%&#$24/"30.K'[F&'0$Q1&%'39'Q&/4132"/&.'"0'/F&'<4/4.&/'/F4/'4%&'"0=2$<&<'G"/F"0'&4=F'=4/&#3%5'4%&'
.F3G0'/3'/F&'%"#F/'39'/F&'14%.K'[F&'%4/"3.'39'<&/&=/&<'Q&/4132"/&.'/3'/3/42'=40<"<4/&.'4..3="4/&<'
G"/F'&4=F'#%3$C"0#'39'=&22$24%'C%3=&..&.'4%&'.F3G0'"0'3%40#&K'd/'=40'1&'.&&0'/F4/'4'24%#&'<&#%&&'39'
Q&/4132"/&.'30'UBL'4%&'"0O32O&<'"0'$C)%&#$24/"30.'39'Q&/4132"='C4/FG45.M'.$##&./"0#'/F4/'UBL'".'
Q3%&'Q&/4132"=4225'4=/"O&K'A4/&%"42'%&C2"=4/&.M'924/'607+8'BL'607'R8'40<'UBL'607'V8K''' '
 
Functional networks that contained a high number of candidates from the 
uploaded datasets on SQ included those involved in cell growth and 
proliferation, lipid and amino acid metabolism, and cell cycle. In the latter 
group of networks, of particular interest was that nine molecules including 
several amino acids were associated with arrest in cell cycle progression and 
identified on SQ, with their trends suggestive of a reduction in proliferation 
(p<0.0001). Deprivation of L-methionine, for example, is associated with an 
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increased arrest in the cell cycle. Similarly, some members of the dataset were 
part of a network related to cell cycle progression, and according to the 
increased/decreased abundance of these metabolites, it could be predicted that 
an overall impeded or slower progression may be taking place in MSCs on SQ. An 
example of one of the metabolites involved is ascorbic acid, which has anti-
proliferative effects, and this was found to be increased.   
The signalling network incorporating metabolism of amino acids was highlighted 
on SQ. It can be seen that the network has links to ERK1/2, which has been 
reported to have roles in cell cycle, proliferation, and differentiation  
(!"#$%&'()(:).  
 
!"#$%&'()(F,'Y4#&4$"05'6;0<N;5'<"#<@"#<0"4#'3"%&/0';43'"43"%&/0';221/";0"142'.1%';C"41';/"3'
C&0;B1@"0&2'"4'89:2'/$@0$%&3'14'9?'4;410161#%;6<"&2=!A&/4132"/&.'9%3Q'/F&'$C234<&<'<4/4.&/'
93%'BL'4%&'=323$%&<'#%&&0'/3'."#0"95'<3G0%&#$24/"30M'%&<'GF&0'$C%&#$24/&<'3%'#%&5'"9'$0=F40#&<K'
?4%\&%'.F4<&.'%&C%&.&0/'24%#&%'=F40#&.K'?"%&=/'"0/&%4=/"30.'4%&'<&C"=/&<'4.'$01%3\&0'4%%3G.'40<'
"0<"%&=/'"0/&%4=/"30.'6O"4'."#0422"0#'C4/FG45.8'4%&'<&C"=/&<'4.'1%3\&0'4%%3G.K'[F".'0&/G3%\'".'
"0O32O&<'"0'4Q"03'4="<'Q&/4132".QM'G"/F'.3Q&'39'/F&'4Q"03'4="<.'F4O"0#'C3/&0/"42'"0/&%4=/"30.'
G"/F'XP^*W:M'GF"=F'F4.'1&&0'%&C3%/&<'/3'F4O&'%32&.'"0'=&22'C%32"9&%4/"30'40<'<"99&%&0/"4/"30K''''
 
Yanes et al. proposed that stem cells and their differentiated counterparts 
utilise different energy pathways, with differentiated cells exploiting oxidative 
processes that generate large amounts of energy required for differentiation, in 
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comparison to self-renewing stem cells that make use of anaerobic pathways to 
avoid damage from reactive oxygen species (Yanes et al., 2010). Indeed, low 
oxygen conditions can prevent differentiation of human ESCs (Ezashi et al., 
2005). Looking more closely at the Krebs cycle (also known as the TCA cycle) on 
SQ (!"#$%&'()((), which is an oxidative pathway that occurs in mitochondria, it is 
interesting to note that the majority of detected Krebs cycle-associated 
metabolites were decreased in abundance on the SQ surface. It is tempting to 
speculate that there is reduced activity within this pathway on SQ, as most of 
the MSCs on this surface are not undergoing differentiation processes and 
therefore their energy requirements are met without a large shift to 
mitochondrial oxidative phosphorylation.  
 
!"#$%&'()((,'X%&B2'/5/@&Z0%"/;%B175@"/';/"3'U[:MV'/5/@&'"4'89:2'14'9?='[F&'^%&1.'3%'[>D'=5=2&'".'4'
=&0/%42'C4/FG45'"0'Q&/4132".QM'GF"=F'/4\&.'C24=&'"0'Q"/3=F30<%"4M'$0<&%'4&%31"='=30<"/"30.K'
>4%13F5<%4/&.M'C%3/&"0.'40<'94/.'4%&'3N"<".&<'"0'4'.&%"&.'39'%&4=/"30.M'40<'=30O&%#&'"0'/F&'[>D'
=5=2&'93%'D[I'.50/F&.".K'd/'F4.'1&&0'%&C3%/&<'/F4/'3N"<4/"O&'C4/FG45.'4%&'2"0\&<'G"/F'
<"99&%&0/"4/"30h'/F&%&93%&'"/'".'"0/&%&./"0#'/F4/'Q405'39'/F&'.$1./%4/&.'"0'/F&'=5=2&'4%&'.F3G"0#'
<&=%&4.&.'30'BLM'.$##&./"0#'4'<&=%&4.&<'Q"/3=F30<%"42'4=/"O"/5'"0'AB>.'30'/F".'.$%94=&K''
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Functional networks that were proposed likely to be occurring on NSQ included 
amino acid metabolism, proline, citrulline and arginine biosynthesis, nucleic acid 
metabolism, and those related to cell growth and proliferation. It can be seen 
that in the amino acid pathway map, there is a shift towards more upregulations 
(!"#$%&'()(R) in comparison to the same map on SQ. This elevation in amino acids 
may be an indicator of a degree of increase in protein synthesis on NSQ, as more 
basic components are produced in readiness for the process to occur.  
 
 
!"#$%&'()(R,'Y4#&4$"05'6;0<N;5!<"#<@"#<0"4#'3"%&/0';43'"43"%&/0';221/";0"142'.1%';C"41';/"3'
C&0;B1@"0&2'"4'89:2'/$@0$%&3'14'Q9?'4;410161#%;6<"&2=!A&/4132"/&.'9%3Q'/F&'$C234<&<'<4/4.&/'
93%'UBL'4%&'=323$%&<'#%&&0'/3'."#0"95'<3G0%&#$24/"30M'%&<'GF&0'$C%&#$24/&<'3%'#%&5'"9'$0=F40#&<K'
?4%\&%'.F4<&.'%&C%&.&0/'24%#&%'=F40#&.K'?"%&=/'"0/&%4=/"30.'4%&'<&C"=/&<'4.'$01%3\&0'4%%3G.'40<'
"0<"%&=/'"0/&%4=/"30.'6O"4'."#0422"0#'C4/FG45.8'4%&'<&C"=/&<'4.'1%3\&0'4%%3G.K'd0'=3QC4%".30'/3'/F&'
.4Q&'C4/FG45'30'BLM'/F&'Q&/4132"/&.'.F3G'4'/%&0<'/3G4%<.'1&"0#'$C%&#$24/&<K'!
 
It was additionally promising that IPA predicted an increase in production and 
activation of alkaline phosphatase in MSCs cultured on NSQ, with identification 
of L-arginine, L-lysine, ascorbic acid, beta-estradiol, chenodeoxycholic acid, and 
phosphate from the dataset, which are genes involved in these processes, and 
occur during osteogenic differentiation.  
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3.2.7.2 Assessment of cell metabolome after 14 days culture 
 
567686769 :+*)+"*;(#-(31*(2*3'.#$#2*('-3*)(<9(0'4/(&=$3=)*(
 
After 14 days of culture, the metabolic profiles of the MSCs on the surfaces were 
analysed once more. The portion of the dataset that were assigned putative 
metabolite identities was taken forward, consisting of a list of 819. General 
trends were firstly visualised by plotting all the data as a heatmap. A shortened 
list of some of these showing promising changes between nanotopographies are 
shown in !"#$%&'()(V in order to illustrate the initial reasons for proceeding with 
the data.  
 
!"#$%&'()(S,'O$0@"4&'1.'C&0;B1@"0&'6%1."@&'1.'89:2';.0&%'0N1'N&&\2'/$@0$%&='AB>'Q&/4132".Q'30'
BL'40<'UBL'.$%94=&.'%&24/"O&'/3'4'924/'=30/%32'G&%&'O".$42".&<'$."0#'4'F&4/Q4CK'[F&'<4/4'<".C245&<'
=30."./.'39'4'/%$0=4/&<'2"./'39'Q&/4132"/&.'/F4/'.F3G&<'4'<"99&%&0=&'"0'=323$%'%&#4%<2&..'39'
."#0"9"=40=&'GF&0'=3QC4%"0#'1&/G&&0'932<'=F40#&.'607'+8K'?&=%&4.&.'4%&'=323$%&<'"0'12$&M'5&223G'
"0<"=4/&.'03'=F40#&M'40<'"0=%&4.&.'4%&'<&."#04/&<'%&<K'D05'O42$&.'"0'1&/G&&0'/F&.&'&N/%&Q&.'
G&%&'.F4<&<'4==3%<"0#25K'''
 
Even though some of the heatmaps indicated a degree of change in relative 
abundance between MSCs cultured on the different nanotopographies, with some 
individual metabolites showing significant differences, the overall combined 
metabolomic activity within the pathway groups did not appear to show much 
change at this timepoint (!"#$%&'()(+), therefore detailed analysis of each broad 
grouping was not carried out as extensively as for week 1 and heatmaps 
generated are not shown here. Nevertheless, significant changes in activity of 
particular metabolites were looked at in more detail, and there was not much 
overlap between putative metabolites between the two timepoints. This 
suggests that stem cells are in a different state after 14 days culture in 
comparison to 7 days.  
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!"#$%&'()(+,'[10;@'C&0;B1@"/'"40&42"05'.1@3'/<;4#&2'"4'89:2'/$@0$%&3'14'4;410161#%;6<"&2'
N"0<"4'6;0<N;5'#%1$62';.0&%'0N1'N&&\2='E&O&2.'39'Q&/4132"='4=/"O"/5'4CC&4%'/3'%&Q4"0'%&24/"O&25'
."Q"24%'1&/G&&0'BL'40<'UBL'4/'/F".'/"Q&C3"0/M'4=%3..'/F&'0$=2&3/"<&M'4Q"03'4="<M'2"C"<.M'O"/4Q"0.'
40<'=394=/3%.M'.&=30<4%5'Q&/4132"/&'40<'3/F&%'2&..'41$0<40/'#%3$C"0#.'6"0=2$<"0#'1"3.50/F&.".'39'
.&=30<4%5'Q&/4132"/&.M'Q&/4132".Q'39'O"/4Q"0.'40<'=394=/3%.M'&0&%#5'Q&/4132".Q'40<'
Q&/4132"/&.'G"/F'03'Q4CC&<'C4/FG45.8K'A4/&%"42'%&C2"=4/&.M'924/'607+8'BL'607'R8'40<'UBL'607'V8K'
X%%3%'14%.f'./40<4%<'&%%3%'39'/F&'Q&40K'
 
56768676> ?#3*;#)314(0"--*)*,&*/(.*3;**,(@A(',0(?@A('-3*)(<9(0'4/(
 
The KEGG database was used to discern whether there was any biological 
relevance in the metabolites showing the largest differences on SQ and NSQ. 
Increases in iminoaspartate and maleamate were noticed on SQ, which are 
involved in nicotinate and nicotinamide metabolism. Several metabolites that 
could be categorised as being involved in the biosynthesis of secondary 
metabolites, or metabolism of vitamins and cofactors did not match to any 
maps, and some had no categories assigned despite having KEGG identifiers, 
which posed a setback in interpretation of this data.  
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3.2.7.3 Degree of unsaturation analyses 
 
Yanes et al. (2010) put forward the concept of a high degree of unsaturated 
metabolites being associated with pluripotency of ESCs. This was shown to 
contrast with differentiated cell types, which possessed more saturated 
metabolites (Yanes et al., 2010). Similarly, the degree of unsaturation within 
detected metabolites was tested with our MSC dataset, for only those 
metabolites exhibiting significant up-regulations in comparison to the flat 
control (fold change), at both of the culture timepoints.  
Calculation of a degree of unsaturation score for the significantly up-regulated 
lipids for SQ and NSQ, showed a higher value for SQ (0.08) compared to NSQ 
(0.04).  This indicates that the lipid profile on SQ is distinct from NSQ and that 
there is a probable decrease upon nanotopographical induction of 
differentiation. The calculated values corresponding to each of the individual 
significantly changed metabolites are shown in !"#$%&'()(,. From these, total 
degree of unsaturation values were determined for each nanotopography, and 
the results indicate that the MSCs do have higher levels of unsaturated 
metabolites on SQ (0.51) in comparison to NSQ (0.21) after one week of culture. 
After two weeks, the value for SQ remained relatively unchanged (0.49), 
whereas a slight increase was detected on NSQ (0.29).  
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 (a) Week 1: SQ 
 
 
(b) Week 1: NSQ 
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(c) Week 2: SQ 
 
 
(d) Week 2: NSQ 
 
!"#$%&'()(>,'8&0;B1@"0&2'"4'89:2'14'9?'2<1N';4'"4/%&;2&3'4$CB&%'1.'$6%&#$@;0&3'C&0;B1@"0&2'
N"0<'$42;0$%;0&3'20%$/0$%&2='[F&'<&#%&&'39'$0.4/$%4/"30'G4.'=42=$24/&<'93%'422'$C%&#$24/&<'
Q&/4132"/&.'30'648'40<'6<8'BL'40<'618'40<'6<8'UBL'40<'03%Q42".&<'/3'<&/&=/&<'Q4..&.K'
>3QC4%".30.'G&%&'Q4<&'1&/G&&0'30&'40<'/G3'G&&\.'39'=$2/$%&K'A4/&%"42'%&C2"=4/&.M'924/'607+8'BL'
607'R8'40<'UBL'607'V8K!
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3.3 Discussion 
 
3.3.1 Characterisation of substrates  
  
The work of this chapter indicated the successful translation of the SQ and NSQ 
nanotopographies from PCL onto polycarbonate. The necessary conditions and 
protocols are now in place to best use the surfaces to greatest effect. The initial 
characterisation of the nanotopography substrates determined that batch-to-
batch variation was not a risk when using injection-moulded surfaces in this 
instance. Ruling out the variation of nanopit diameter was of importance as the 
distribution of the features should be the sole characteristic that defines each of 
the nanotopographical substrates. In part, the coating of the substrates for SEM 
imaging occluded some of the edges of the pits, introducing some difficulties in 
making diameter measurements with high accuracy, though even this method for 
comparison did not highlight any large differences between the surface features. 
Thus, it can be concluded that nanopit features were preserved during different 
times of manufacture, which is important as experiments had to be setup using 
multiple batches at times.    
 
Plasma treatment of polymers is a well-established method of assisting cell 
attachment (Jin Ho et al., 1991, Chu et al., 2002); indeed standard tissue 
culture plastic (polystyrene) products are treated similarly with surface 
modification by either gas plasma (Biazar et al., 2011) or corona discharge 
(Curtis et al., 1983). Various polymers such as polypropylene, polyethylene 
terephthalate and polycarbonate have been shown to improve surface 
hydrophilicity following application of plasma (Lai et al., 2006). The technique 
was implemented in this study, as polycarbonate possesses slightly hydrophobic 
properties, a common trend of polymers in general (Chu et al., 2002). Plasma 
treatment was shown to result in an improvement of surface wettability 
(evidenced by a reduction in water contact angle) thereby rendering the surface 
more hydrophilic, which should be advantageous in enhancing cell adhesion. This 
is due to the generation of oxygen functionalities (Hegemann et al., 2003), with 
incorporation of these into the material surface shown by XPS analysis. Although 
air plasma treatment is the method that is available for use in this work, it was 
noted that oxygen plasma treatment applied in a clean room environment would 
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reduce the ‘noise’ from contaminants in the air and cause less interference in 
the XPS results, which is the reasoning for use of oxygen plasma in these tests. 
Based on the results from both the water contact angle measurements and XPS 
analysis, adopting plasma treatment of surfaces prior to seeding would be 
beneficial. Moreover, this type of treatment did not appear to cause any obvious 
damage to the nanofeatures themselves, even at the longest treatment time 
tested, though it was observed that some damage in the form of scratches or 
indentations might occur during transport from the location of manufacture. 
Subsequent experiments showed that cell attachment occurred after several 
hours on our treated substrates. Furthermore, use of a seeding device allowed 
cells to be added directly to the top of each substrate, thereby minimising 
wastage whilst preserving good seeding distribution. Therefore, this section of 
work establishes the baseline protocol for preparation and seeding of substrates 
for the remainder of the study.  
 
3.3.2 Initial seeding density affects response to nanotopography 
 
The level of some MSC surface markers decrease as they differentiate into other 
cell types, such as STRO-1, CD166/ALCAM, CD90 and CD105 (Lee et al., 2009). It 
has also been suggested that some markers are subject to influence from donor 
age, number of passages, and density of culture (Boxall and Jones, 2012). In this 
part of the study, MSCs positive for the CD271 marker were investigated with 
regards to seeding density. The advantages of this were two-fold, firstly CD271 
could be argued as the most translational marker between species (Boxall and 
Jones, 2012), thus accumulating evidence for CD271-selected MSCs may be of 
wide use to the scientific community, and secondly, determining the optimal 
seeding density will help to standardise use of the nanotopographies, minimising 
experimental variation, and reducing the number of cells needed without having 
to add more than necessary to cover the required area. There are reports that 
cell density may influence MSC phenotype due to constraints on cell morphology, 
which appear to drive MSC differentiation down specific pathways (McBeath et 
al., 2004, Lu et al., 2009, Xue et al., 2013). Furthermore, cell density can affect 
MSC proliferation (Neuhuber et al., 2008) and differentiation (Gobaa et al., 
2011). From the three densities tested, expression of phenotypic marker 
proteins appeared to vary depending on the initial seeding. It was hypothesized 
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that the optimal cell number to be seeded would be that which enabled a 
balance between fair coverage of the material surface, yet did not allow too 
many cell-cell contacts to be established. Cell-cell contact signalling could 
potentially compete against the nanotopographical instructional cues, which 
may diminish the effects of the nanotopographies. Certainly, it appeared that 
lowering cell density elicited enhanced retention of stem cell marker expression. 
Seeding at 500 cells/cm2 and 1000 cells/cm2 were effective for stem cell marker 
expression of CD271 and ALCAM in MSCs cultured on SQ, however using 500 
cells/cm2 is impractical for experimental purposes (requiring many substrates to 
be seeded), therefore a compromise between adequate clonal growth and 
desirable phenotypic marker expression could be achieved by using a density of 
1000 cells/cm2. This apparent optimal density was maintained for the 
proceeding experiments described in further chapters.       
 
It was noted that levels of ALCAM were high in MSCs cultured on NSQ after 28 
days, though this may be due to the NSQ surface successfully mimicking the 
endosteal niche in the bone marrow. This microenvironment contains both 
osteoblasts and MSCs in addition to HSCs that ‘home’ towards this region of bone 
marrow, with associative behaviour proving important to support the cell types 
(Nakamura et al., 2010). Thus it would not be unusual to find a population of 
MSCs being maintained on NSQ. The CD271 marker was also maintained to a 
degree on flat, however MSCs on both flat and NSQ were unable to retain 
expression of both markers as successfully as MSCs on SQ. Thus we conclude that 
transfer of the SQ nanopattern onto polycarbonate enables MSCs to retain their 
potential for multipotency.  
 
In light of observing that changes in seeding density affect eventual cell 
phenotype with regards to marker expression, it is tempting to additionally 
speculate that the distinct colony growth patterns observed at the lower 
densities are important in the maintenance of ‘stemness’, and that a fibroblastic 
growth pattern favours differentiation into osteoblasts. The appearance of these 
growth patterns correlates with the aforementioned data regarding marker 
expression. Initial analysis of the differences between MSCs cultured on flat, SQ 
and NSQ in terms of proliferation, did not highlight any obvious changes in the 
number of cells progressing through S phase or in total cell number.  
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3.3.3 Metabolism of CD271+ MSCs on nanotopography 
 
Metabolomic examination of CD271+ MSCs yielded a large amount of data. The 
putative metabolites with assigned KEGG identifiers were taken forward to 
narrow down the focus of the analysis. Grouping the metabolites into broad 
pathways suggested that there were more changes at the 7 day timepoint than 
after 14 days. This suggests that many of the larger changes in the cells 
undergoing self-renewal and differentiation were occurring early, though the 
significantly altered metabolites at each timepoint were found to be different, 
suggesting changes in cell state had occurred as time progressed. There was a 
trend towards lower total metabolic activity on SQ in comparison to NSQ after 7 
days of culture, with the exception of lipids. Neuronal stem cells have shown to 
be dependent on production of fatty acids and lipids to divide and generate 
neurons (Knobloch et al., 2013). This signals that the regulation of lipid 
biosynthesis and metabolism is important in self-renewal and differentiation. 
Furthermore, fatty acid oxidation has been shown to promote symmetric division 
in haematopoetic stem cells (Yusuf and Scadden, 2012). Lipid metabolism 
appears to be linked to stem cell plasticity, thus it may be worthwhile to 
investigate fatty acids in more detail in future work.  
 
Further investigation showed that many metabolites were downregulated on SQ 
and upregulated on NSQ after 7 days, suggesting a reduced metabolic activity of 
MSCs on SQ. This agrees with some of the existing literature and previous work, 
describing undifferentiated MSCs as being metabolically quiet whereas 
differentiating cells are generally more metabolically active (McMurray et al., 
2011, Tsimbouri et al., 2012).  
 
The metabolites on SQ linked to pathways associated with growth, proliferation 
and the cell cycle. IPA predicted that arrest in cell cycle progression would be 
heightened on SQ due to identification of 9 molecules from the dataset known to 
have roles in this network and based on the peak metabolite intensities of these 
metabolites when compared to flat controls. However, this is at odds with the 
results from the BrdU assay and cell counts, as there were no significant 
differences between surfaces detected. This may be due to some aspect of cell 
cycle regulation being affected, which prompted further investigations described 
in the proceeding results chapter. A decrease in L-methionine was noted, which 
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is of interest as methionine metabolism has a role in regulating maintenance of 
human pluripotent stem cells (Shiraki et al., 2014). ESCs require methionine to 
maintain pluripotency, and therefore levels must be regulated (Shiraki et al., 
2014). The methionine concept has not been investigated in MSCs as yet, 
therefore it is possible that MSCs do not require as much methionine to remain 
multipotent, or that its presence in this stem cell type is subject to some 
temporal changes, which are not extreme enough to induce differentiation.  
 
Stem cells require an increase in energy requirements as they differentiate, and 
these energy needs can be provided by oxidative energy pathways such as those 
that take place in mitochondria (Chung et al., 2007). The data suggested a low 
likelihood that MSCs on SQ were obtaining their energy from these oxidative 
processes, suggesting that the cells were not undergoing differentiation, and not 
requiring the large energy demands associated with maturation into a specified 
cell type. In addition, utilising anaerobic energy pathways would decrease risk of 
damage from reactive oxygen species and oxidative stress, which would be 
detrimental to the maintenance of a stem cell population. MSCs on NSQ showed 
an increase in amino acids, which may be indicative of an increase in protein 
synthesis, an important step in stem cell differentiation (Sampath et al., 2008).  
 
Comparison of the upregulated metabolites that were significantly changed on 
SQ and NSQ, revealed a greater abundance of unsaturated metabolites in MSCs 
on SQ and a decreased level on NSQ, which is in agreement with the findings of 
Yanes et al. and draws parallels with the group’s observations in ESCs. Yanes and 
colleagues had observed that ESCs contained many unsaturated metabolites and 
this number would decrease upon differentiation (Yanes et al., 2010). It is 
promising to observe that after 14 days of culture, the level of unsaturation on 
SQ is similar to that after 7 days, suggesting a level of maintenance on SQ. In 
contrast, the degree of unsaturation on NSQ was found to increase slightly after 
14 days. This may be due to the MSCs reaching a pre-osteoblast stage, and 
switching their bioenergetics towards oxidative pathways important for 
differentiation. Oxidation reactions will increase the number of molecules 
containing multiple carbon-carbon bonds. There could also be an increase in 
unsaturated molecules to provide energy to initiate this second wave in 
differentiation towards an osteoblast phenotype. Unsaturations are known to be 
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highly reactive under oxidative conditions (Yanes et al., 2010); therefore an 
accumulation of unsaturated metabolites may be a ‘priming’ event for MSCs to 
move past their pre-osteoblastic status. The number of timepoints investigated 
in this case was restricted to two. However, it may be interesting to investigate 
earlier and later timepoints to those included in this study to determine when 
the largest changes on both nanotopographies occur and to see how long SQ can 
maintain the same level of unsaturated metabolites over time. 
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4 Chapter 4 
4.1 Introduction 
 
Cell cycle changes have been associated with the differentiation status of 
several types of stem cell, including ESCs and HSCs. Mounting evidence indicates 
that differentiation and self-renewal are coupled to cell cycle regulation. The 
property of self-renewal can be described as an ability to retain stem cell status 
in order to undergo either symmetrical or asymmetrical division and generate 
new daughter cells with similar identities and differentiation capabilities. The 
inherent link between maintaining self-renewal and cell cycle appears to lie with 
overlapping signalling pathways and common genes pertaining to both activities 
(Orford and Scadden, 2008, Viatour, 2012).  
 
Developments into the study of ESC cell cycle have demonstrated that the 
duration of G1 phase can affect the maintenance of self-renewal and 
pluripotency. A prolonged G1 phase has been linked with human and mouse ESC 
differentiation (Li et al., 2012, Calder et al., 2013) whilst a shorter and more 
limited G1 phase has been proposed to retain pluripotency in ESCs. This was 
elegantly demonstrated in a study of murine neural stem cells, which normally 
possess a short G1 phase that becomes longer during differentiation (Lange et 
al., 2009). These effects were experimentally recapitulated by decreasing CDK4-
cyclin D1 expression to lengthen G1, which promoted neurogenic differentiation, 
or by overexpressing CDK4-cyclin D1 to shorten G1 and achieve the opposite 
effect (Lange et al., 2009). A restricted G1 phase reduces the time at which a 
cell remains responsive to differentiation signals, and conversely a lengthened 
G1 phase provides a sufficient period for activation and deactivation of genes 
and initiation of various processes allowing differentiation to occur. Despite 
several reports agreeing with these observations, a study of mouse ESCs with 
elongated G1 phases reported contradictory findings, reporting that lengthening 
G1 was not by itself sufficient to drive differentiation (Li et al., 2012).                   
 
Interestingly, through use of an adapted real time cell cycle reporter system, 
whereby human ESCs at different stages of the cell cycle expressed proteins in 
different colours, Pauklin et al. reported that their ESCs could only respond to 
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differentiation cues at particular stages of G1; those at early G1 expressed 
markers corresponding to endoderm and mesoderm differentiation, and late G1 
ESCs were restricted to neuroectoderm marker expression (Pauklin and Vallier, 
2013). In addition, they described a pivotal role for cyclin D in the localisation 
and subsequent action of Smad2/3; during early G1, low levels of cyclin D would 
lead to Smad2/3 mediated activation of genes associated with 
endoderm/mesoderm differentiation, making those cells more susceptible to 
undergoing differentiation to those lineages (Pauklin and Vallier, 2013). This 
shows that changes during G1 phase in particular, trigger signalling pathways 
that impact on the eventual fate of pluripotent stem cells.   
The bulk of the literature relating to adult stem cells is based on the study of 
HSC cell cycle, where it has been postulated that they utilise cell cycle 
regulation to preserve pools of non-dividing cells in addition to maintaining 
adequate numbers of actively proliferating cells that will be able to 
differentiate into tissue-specific cell types (Wilson et al., 2008). Some studies 
have suggested that HSCs are largely quiescent, and remain dormant until 
directed to self-renew or differentiate when replacement of mature cell types 
are needed (Wilson et al., 2008, Zou et al., 2011). The difficulty in discerning 
the details of HSC regulation is further compounded due to complexities in 
considering interactions between different cell types found in the in vivo niche. 
Close association between osteoblasts and HSCs, for example, allows 
thrombopoietin (THPO) expressed by osteoblasts to bind to the THPO surface 
receptor (MPL) found on the surface of HSCs (Yoshihara et al., 2007) causing 
dimerisation, and subsequent phosphorylation and activation of JAK2 and 
downstream effectors (Tortolani et al., 1995). Moreover, application of 
exogenous THPO resulted in an increase in the number of quiescent HSCs 
(Yoshihara et al., 2007).   
 
Other factors that may have important roles in the cell cycle of stem cells are 
retinoblastoma tumour suppressor (RB) and negative regulators. The latter 
includes members of the cyclin dependent kinase-inhibitory protein/kinase 
inhibitory protein (CIP/KIP) family. One of these, p27kip1, has been observed to 
increase during progression of differentiation (Egozi et al., 2007), and its 
overexpression can cause cell cycle arrest (Menchón et al., 2011). RB is of 
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interest as it may act to prevent premature senescence of MSCs by promotion of 
mitotic quiescence (Lin et al., 2014).  
 
In contrast to studies on ESCs and HSCs, research into the cell cycle of MSCs has 
been rather limited and is poorly understood. This gap in knowledge in the field 
of stem cell research should be regarded as an important consideration if MSCs 
are to be viewed seriously as a viable therapeutic option. Beneficial exploitation 
of regulatory genes and pathways could be utilised to encourage self-renewal 
over longer periods of time to increase the potential of MSCs for therapy and 
lessen wastage of MSCs that may have spontaneously differentiated or become 
senescent during expansion.  
 
From previous research with MSCs cultured on the SQ nanotopography, it can be 
argued that MSCs on this surface are more efficient at self-renewal whilst 
maintaining expression of stem cell surface markers, and are thereby primed to 
favour retention of an MSC-like phenotype. However, the nanotopography-
induced mechanisms and processes by which this beneficial self-renewal occurs 
remain unclear. Filopodia have been described as cellular sensors, allowing cells 
to probe the physical features of their surroundings, and thus could be involved 
in an important stage of biomaterial-cell interaction, well-placed to initiate 
downstream intracellular reactions in response to nanotopography (Dalby et al., 
2004a, Dalby et al., 2004b). There may exist an association between the initial 
recognition of instructional cues and the trigger of events involved in cell cycle. 
In this chapter, inhibition experiments were used to investigate this association 
at the level of filopodia and cell cycle protein expression. 
 
Furthering our understanding of SQ induced self-renewal would provide 
knowledge about the key factors that are important in giving rise to this 
property, and how the nanotopographical features or distribution may be further 
improved to exploit this technology to its full capacity in the provision of 
patient-specific MSCs. To this end, this chapter focuses on investigating 
potential changes in cell cycle on the nanotopographical surfaces, to determine 
whether cell cycle regulation could be a causative determinant of eventual MSC 
fate.  
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The aims of this chapter are: to begin to elucidate and define the cellular 
mechanisms at work on SQ that may contribute self-renewal, to investigate the 
potential changes in cell cycle regulation in MSCs cultured on nanotopography, 
and to assess the potential link between filopodial interactions with 
nanotopography and effects on the cell cycle.  
4.2 Results 
4.2.1 Assessing seeding density for STRO-1+ MSCs 
 
To briefly assess the continued use of the optimised seeding density for MSCs, 
for STRO-1 selected MSCs (herein referred to as STRO-1+ MSCs), western blotting 
was carried out after 28 days of culture on SQ and NSQ nanotopographies in 
addition to a flat control, and levels of STRO-1 and OPN were quantified for the 
initial seeding density of 1000 cells/cm2 (Figure 4-1). Comparison of the relative 
intensities of the bands indicated that continued use of 1000 cells/cm2 resulted 
in an elevated level of STRO-1 (a marker of stemness) on SQ in comparison to 
the flat control, and an elevated level of OPN (an indicator of osteogenic 
differentiation) on NSQ in comparison to the flat control.  
 
!"#$%&'R)*,']&20&%4'B@100"4#';0';'2&&3"4#'3&42"05'1.'*LLL'/&@@2Z/CF'N;2';3&^$;0&'.1%'$2&'1.'
4;410161#%;6<"&2'N"0<'9[_O)*G'89:2=!AB>.'G&%&'.&&<&<'30/3'924/WBLWUBL'93%':;'<45.'607*8K'648!
-&./&%0'123/.'C%31&<'93%'B[PT)*WTIUM'G"/F'HDI?JWi)/$1$2"0'$.&<'4.'234<"0#'=30/%32.'618'H%4CF.'
.F3G"0#'g$40/"9"=4/"30'39'140<.'4/'*SSS'=&22.W=Q:'$."0#'dQ4#&'jK'?4/4'G4.'03%Q42".&<'/3'234<"0#'
=30/%32.K'B[PT)*'G4.'F"#F'30'BL'40<'UBL'"0'=3QC4%".30'/3'/F&'924/'=30/%32'4/'/F".'<&0."/5M'
=30."./&0/'G"/F'>?:,*@'AB>.K'TIU'G4.'F"#F&./'30'/F&'3./&3#&0&.".)C%3Q3/"0#'UBL'.$%94=&'4.'
G3$2<'1&'&NC&=/&<K'[4\&0'/3#&/F&%M'40'"0"/"42'.&&<"0#'<&0."/5'39'*SSS'=&22.W=Q:'4CC&4%.'4<&g$4/&'
93%'$.&'39'B[PT)*@'AB>.'30'0403C"/'0403/3C3#%4CF"&.K'
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These observations give confidence to further use of this previously optimised 
seeding density for these MSCs. It is noted that STRO-1 is also increased on NSQ 
compared to the control and this potentially illustrates a heterogeneous 
population, which would merit further investigation if time had allowed. 
 
4.2.2 Synchronisation and release of MSCs for analysis of cell 
cycle 
 
 
STRO-1+ MSCs were seeded on substrates at a density of 1000 cells/cm2 and 
allowed to attach and establish for a period of 48 hours. The cells were washed 
in serum free media and then incubated for a further 48 hours in 0.1% FBS (low 
serum) media to induce cell cycle arrest and thereby synchronise the cells. 
Periods longer than 48 hours appeared to reduce the overall viability of the 
cells, and many cells were observed to detach. 
 
After this period in low serum media, MSCs were released back into the cycle by 
replacement of this media with serum containing maintenance media for the 
required durations for each experiment. A comparison of synchronised and 
asynchronous cells was carried out with propidium iodide staining and flow 
cytometry. The results showed that the number of cells in G0/G1 was far greater 
in the synchronised cells in comparison to those kept in maintenance media 
(Figure 4-2). Thus it can be said with confidence that the majority of the cells 
were in the G0/G1 stage when cultured in low serum media, and that this was a 
suitable treatment for synchronisation of MSCs. 
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.$1k&=/&<'/3'4'.50=F%30".4/"30'C%3=&<$%&'15'=$2/$%&'"0'23G'.&%$Q'Q&<"4K'>&22.'G&%&'<&/4=F&<'9%3Q'
/F&'.$1./%4/&.'40<'C332&<'93223G"0#'=3QC2&/"30'39'/F&'/%&4/Q&0/M'/3#&/F&%'G"/F'/F&'$0/%&4/&<'
=30/%32.M'./4"0&<'G"/F'C%3C"<"$Q'"3<"<&'40<'40425.&<'15'?%'A4%"4'>K'<&'D0<%l.'H30mn2&m'
6c0"O&%."/5'39'B3$/F4QC/308'$."0#'923G'=5/3Q&/%5K'[F&'/3C'%3G'39'C23/.'.F3G'/F&'#4/"0#'4CC2"&<K'
[F&'#4/&<'%&#"30'"0<"=4/&.'/F&'C3C$24/"30'/4\&0'93%G4%<'93%'40425.".M'.F3G0'"0'/F&'13//3Q'%3G'39'
C23/.K'd/'=40'1&'.&&0'/F4/'/F&'.50=F%30".4/"30'C%3/3=32'&99&=/"O&25'=4$.&.'422'39'/F&'AB>.'/3'4%%&./'
<$%"0#'HSWH*'CF4.&M'=309"%Q"0#'/F4/'=$2/$%&'"0'23G'.&%$Q'Q&<"4'=40'1&'$.&<'93%'.50=F%30".4/"30'
39'AB>.K''
 
4.2.3 Cell cycle screening on nanotopographies 
 
 
As it appeared that proliferation was not significantly affected by 
nanotopography (results of BrdU assay, chapter 3), we hypothesized that the 
differences in eventual cellular phenotype conferred by culture on SQ and NSQ 
might be at the level of cell cycle regulation. Firstly, quantification of the 
Chapter 4: Investigating MSC Cell Cycle using Nanotopography 
     137 
C
hapter 3-C
haracterisation of M
esenchym
al Stem
 C
ells and N
naotopography O
ptim
isation 
protein to be used for normalisation was carried out, to ensure that there were 
no fluctuations after culture on the different substrates, which would affect the 
final quantification of the in-cell western (ICW) experiments. The results showed 
that GAPDH levels were not significantly affected by seeding on different 
substrates (Figure 4-3).  
 
!"#$%&'R)(,'[&20"4#'PMWEa'@&A&@2'"4'89:2'/$@0$%&3'14'3"..&%&40'2$%.;/&2='HDI?J'2&O&2.'G&%&'
4..&..&<'"0'%&24/"30'/3'=&22'0$Q1&%'$."0#'>&22[4#'./4"0'15'd>-K'U3'."#0"9"=40/'<"99&%&0=&.'"0'HDI?J'
C%3/&"0'41$0<40=&'1&/G&&0'.$%94=&.'G&%&'<&/&=/&<'"0'AB>.M'Q4\"0#'"/'.$"/412&'93%'$.&'4.'4'
03%Q42".4/"30'C%3/&"0'93%'"0'=&22'G&./&%0'&NC&%"Q&0/.K'P&.$2/.'.F3G0'4%&'4O&%4#&'"0/&#%4/&<'
"0/&0."/5'39'HDI?J'03%Q42".&<'/3'>&22[4#'93%'R'Q4/&%"42'%&C2"=4/&.K'X%%3%'14%.'<&03/&'Y'./40<4%<'
&%%3%'39'/F&'Q&40K''
 
A panel of several cell cycle regulatory proteins were examined, with their 
levels assessed in MSCs cultured on the range of surfaces, to investigate any 
potential differences that may be occurring as a result of culture on a particular 
substrate. Phosphorylated proteins were normalised to their total protein 
equivalents, and testing of one of these, cdc2, also known as CDK1 (Dorée and 
Hunt, 2002) through comparison to GAPDH, showed that this protein remained at 
a similar level throughout the experiment for all of the substrates (Figure 4-4).  
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4O&%4#&'"0/&#%4/&<'"0/&0."/"&.'39'4/'2&4./'R'Q4/&%"42'%&C2"=4/&.M'03%Q42".&<'/3'&"/F&%'HDI?J'3%'/F&'
/3/42'2&O&2.'39'&g$"O42&0/'C%3/&"0'"9'/F&'CF3.CF3%524/&<'93%Q'G4.'./4"0&<M'40<'&%%3%'14%.'%&C%&.&0/'
Y'./40<4%<'&%%3%'39'/F&'Q&40K'Z42$&.'4%&'&NC%&..&<'"0'4%1"/%4%5'92$3%&.=&0=&'$0"/.'64K$K8K'b2$&'7'
924/M'%&<'7'BL'40<'#%&&0'7'UBLK'>3QC4%".30'39'C%3/&"0'2&O&2.'30'&4=F'/5C&'39'.$%94=&'%&O&42&<'
.3Q&'."#0"9"=40/'<"99&%&0=&.'4/'.C&="9"='/"Q&C3"0/.K'B/4/"./"=42'."#0"9"=40=&'G4.'/&./&<'15'^%$.\42)
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The CDK6 family of proteins appeared to be potentially interesting, as total 
CDK6 levels were elevated in MSCs cultured on SQ in comparison to flat and NSQ, 
and levels remain elevated throughout the 24 hours post-release after 
synchronisation (Figure 4-5).  
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93$0<'/3'1&'F"#F&./'30'BL'49/&%'*'F3$%'39'=$2/$%&'6C3./)%&2&4.&'"0/3'/F&'=&22'=5=2&'93223G"0#'
.50=F%30".4/"308K'B/4/"./"=42'."#0"9"=40=&'G4.'/&./&<'15'^%$.\42)-422".'/&./'G"/F'?$00].'Q$2/"C2&'
=3QC4%".30.'C3./)/&./'93%'&4=F'/"Q&C3"0/K'_C`SKSV''
 
4.2.4 Analysis of cell cycle stages on SQ using flow cytometry 
 
 
Flow cytometry allows depiction of the percentage of cells in the phases of the 
cell cycle. This was carried out for MSCs cultured on SQ and flat substrates 
following synchronisation (Figure 4-6). Comparison between MSCs on the two 
surfaces revealed a higher number of cells in G0/G1 phase and a subsequent 
decrease in S phase. These patterns were found to be reproducible with MSCs 
isolated from another patient, though patient 2 showed a higher percentage of 
cells in G2/M phase in comparison to the flat control (Figure 4-7). 
The observed trend in G1/G0 and S phases are suggestive of a slower progression 
through the cell cycle. The effect of SQ nanotopography does not appear to be 
to induce a complete block as there are still cells found in the latter G2/M 
stages, and thus these MSCs do not exhibit a pattern indicative of quiescence. 
This ties in with our hypothesis: that MSCs continue to divide and self-renew on 
SQ whilst maintaining multipotency, and shows that the time they spend in cell 
cycle phases is slightly different even though this does not necessarily 
dramatically affect their overall growth and proliferation.    
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4.2.5 Observing filopodial spread on nanotopography 
 
There are numerous reports of the role of filopodia in feature sensing on 
material surfaces in the literature (Biggs et al., 2007a, Hart et al., 2007, 
Albuschies and Vogel, 2013). We hypothesize that filopodia may undergo 
changes, perhaps in directionality, or spread as they move across surfaces with 
differing features on them. Thus, filopodia are ideally placed as initiators of 
downstream events. In order to investigate this possibility, the spread and 
directionality of filopodia were observed using SEM (Figure 4-8 to Figure 4-11).  
 
Synchronised MSCs did not show much difference in filopodia between surfaces 
(Figure 4-8). Filopodia were observed on flat, SQ and NSQ and were not restricted 
in their spreading. Interestingly, filopodia on SQ were able to elongate in the 
spaces between ‘rows’ of pits, and were perhaps restricted by the pits on either 
side. This behaviour is reminiscent of the effect of grooves, and can be 
described as a type of ‘contact guidance’ (Figure 4-9, Figure 4-10, Figure 4-11, central 
panels corresponding to SQ). In contrast, filopodia on the flat and NSQ surfaces were 
more randomly arranged (Figure 4-9, Figure 4-10, Figure 4-11, lower panels corresponding 
to NSQ). Filopodia on flat had no restrictive cues and it would be expected that 
filopodia would be able to spread in all directions (Figure 4-9, Figure 4-10, Figure 4-
11, uppermost panels corresponding to flat). On NSQ, the filopodia were also able to 
grow across the pits (Figure 4-9, Figure 4-10, Figure 4-11, lower panels corresponding to 
NSQ), which could be partially due to the reduced spacing between some of 
them, as a result of the small offset of the pattern.  
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4.2.6 Chemical inhibition of filopodia development  
 
Filopodial formation and development is under the control of several genes, one 
of which is cdc42. In order to disrupt filopodial mechanics, a chemical inhibitor 
of cdc42 was incorporated into the maintenance media added to the MSCs, to 
assess the importance/influence of filopodia on intracellular signalling events 
related to cell cycle regulation.  
 
The inhibitor was initially tested at a range of concentrations after allowing a 
short period of attachment and time for the establishment of filopodia. 
Concentrations of 40 µM and above caused cells to detach and die and were not 
imaged. Qualitative observation of cells (Figure 4-12) exposed to inhibitor 
concentrations of 10-20 µM indicated that the number of filopodia decreased and 
generally became shorter as the concentration of inhibitor increased, with the 
optimal concentration being 20 µM. Further observations at this proposed 
optimal inhibitor concentration were achieved with SEM (Figure 4-13), showing 
that filopodial formation was not impeded entirely in MSCs. However, drawing 
parallels with the observations of images taken at lower magnifications, the 
number and length of filopodial protrusions were somewhat inhibited.  
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The inhibitor concentration of 20 µM was taken forward and further tested in 
experimental conditions, adding the inhibitor to media for the 24 hour 
incubation period following synchronisation.  
 
 
4.2.7 Assessment of filopodia inhibition on CDK6 protein 
expression 
 
 
Upon successful filopodial inhibition, the next step was to assess the importance 
of the different filopodial spreading patterns observed on SQ and NSQ, in the 
eventual expression of cell cycle regulating proteins. Initial work focused on 
levels of CDK6, as it was a protein that was found to be elevated on our self-
renewing surface by ICW. Together with the observation that filopodia on SQ 
responded to contact guidance cues from the topography itself, there was the 
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potential that these physical constraints on the cell cytoskeleton might be an 
initiating event for changes in signalling downstream. Addition of the inhibitor 
for 24 hours did not have an impact on CDK6 protein levels on SQ; indeed, 
abundance of CDK6 was relatively similar for flat and SQ even without the 
addition of the inhibitor (Figure 4-14). This is in contrast with initial observations 
that there was a trend for CDK6 to be elevated on SQ. It is possible that in 
waiting to allow sufficient filopodia inhibition, we have missed the early changes 
occurring within a few hours after release into the cell cycle. Alternatively, this 
inhibition strategy is not sufficient to prevent formation of filopodia, and thus 
may mask some of the changes in protein expression so that they were not 
observed here. 
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."#0"9"=40/'<"99&%&0=&.'64..&..&<'15'$0C4"%&<'/)/&./8'"0'>?^+'C%3/&"0'2&O&2.'1&/G&&0'=30/%32'=&22.'
40<'"0F"1"/&<'=&22.'30'&4=F'.$%94=&K'X4=F'14%'%&C%&.&0/.'/F&'4O&%4#&'"0/&#%4/&<'"0/&0."/5'%4/"3'39'4/'
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4.2.8 Identifying signalling networks using Next-Generation 
Sequencing 
 
To add to the information gathered about changes occurring on specific 
nanotopographies, RNA was extracted from cells that had been synchronised and 
released into the cycle for 24 hours, and submitted for Next-Generation 
Sequencing (NGS). Ingenuity Pathway Analysis was utilised to investigate changes 
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in expression of detected genes for each sample, making use of existing 
databases to link changes in transcript abundance to known gene regulatory 
networks.  
 
4.2.8.1  Gene expression in synchronised cells on nanotopographies 
 
 
Pairwise comparisons of the flat control to each of the nanotopographies directly 
after synchronisation yielded small numbers of changes, as would be expected in 
low serum conditions. There were 90 transcript identifiers and abundances 
accepted for analysis in the SQ comparison and 279 transcript identifiers and 
abundances accepted for analysis in the NSQ comparison. Pathway analysis of 
differentially expressed genes showed that trends in functional pathway 
categories (Figure 4-15) were generally similar, with the top pathway on both SQ 
and NSQ falling into the cell cycle category, presumably due to the highly 
regulated checks on cell cycle progression preventing cells from progressing past 
G1 phase in unfavourable conditions. Since it has been shown that stem cell 
marker expression can be high on NSQ, this indicates the presence of a self-
renewing population on this surface too. Therefore it would be expected that 
cell cycle regulation would be highlighted on NSQ in addition to SQ. The number 
of indicated pathways and upregulated transcripts were greater on NSQ in 
comparison to SQ (Figure 4-16 and Figure 4-17). Many of these biological processes 
were indeed related to cell cycle. Although some cell cycle activity was 
apparent here, evidenced by upregulation of genes related to transcripts in the 
outlined groupings, the percentage of genes inferred from the dataset that were 
found in the networks were relatively low.  
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4.2.8.2  Gene expression changes post-release into cell cycle 
 
The next timepoint investigated was following release of MSCs into the cycle for 
a period of 24 hours. Several of the same functional signalling groups appeared 
for both SQ and NSQ, such as cellular growth and proliferation, gene expression, 
cell cycle, cellular assembly and organisation (Figure 4-18). 
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However, there were suggestions of differences in the number of genes in each 
dataset and their expression levels, and thus, further analyses were performed 
on both datasets. Breakdown of these broad canonical signalling groups into 
upregulations and downregulations showed that upon progression of MSCs 
through the cell cycle after synchronisation, a large majority of MSC genes were 
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downregulated on SQ (Figure 4-19). A similar trend was observed on NSQ in terms 
of most pathways exhibiting downregulations, however, there were more 
canonical signalling pathways containing up-regulated gene expression in 
comparison to SQ (Figure 4-20 and Figure 4-21). This could be due to a 
heterogeneous population, containing renewing and differentiating MSCs on NSQ. 
 
It was interesting to note that oxidative phosphorylation appeared to be 
downregulated to a greater extent on SQ (first bar of Figure 4-19) than NSQ 
(second bar of Figure 4-20) at this timepoint, supporting metabolomic data from 
chapter 3 and existing literature that proposes a decrease in oxidative 
bioenergetic processes favouring self-renewal (Yanes et al., 2010). Although 
reduced transcript abundance levels corresponding to a number of genes 
involved in oxidative phosphorylation were observed in MSCs on NSQ, a lesser 
percentage of genes were detected in this pathway grouping in comparison to 
SQ, suggesting that some of these cells are beginning to undergo a switch to 
differentiation.  
 
Additional support for the initiation of differentiation on NSQ is the indication of 
increased differential expression of inositol trisphosphate precursors (Figure 4-21) 
that increase entry of calcium across the plasma membrane (Putney et al., 
1989), and thereby intracellular calcium levels. This influx of Ca2+ may act to 
enhance calcium signalling with effects on Runx2 that is important for 
osteogenic differentiation (Zayzafoon, 2006).  
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Use of IPA to extrapolate potential phenotypic outcomes (from the transcript 
data), indicated that a low number of cell cycle-related processes were 
apparent on SQ after MSCs had been released back into cycle and allowed to 
progress through each phase. Looking more closely at this data, increases and 
decreases in differential expression were apparent, with an overall trend 
towards a decrease in transcript abundance in each case. Adhesion-related 
signalling processes including RhoA, integrin, Rac, and actin cytoskeleton 
signalling followed this pattern in a similar way, and were low on SQ.  
As more pathway information was available for MSCs released back into the cell 
cycle, this data was subjected to further analysis, focusing on gene interactions 
and signalling networks in MSCs on the SQ nanotopography, with some references 
to those on NSQ. Interpretations of networks deemed to be of particular interest 
are detailed in the following section.  
 
 
4.2.8.3  Analysis of interaction networks and pathways  
 
Distinct changes in gene expression in MSCs cultured on SQ and NSQ (in 
comparison to flat controls) at the later timepoint of 24 hours were classified 
into networks, and those related to cell cycle and growth were investigated in 
greater detail. It was noted that ERK1/2 was found to be downregulated on SQ, 
which may be important for stem cell renewal (Figure 4-22).  
With regards to cyclins and cell cycle regulation (Figure 4-23), key cyclins (cyclin 
D1 and cyclin B) and cyclin dependent kinase, (CDK1) that are involved in G1 and 
G2/M phases, were shown to be downregulated on SQ (green).  The observation 
that many negative regulators of the cell cycle were downregulated was not 
predicted. These included p21Cip1, p19INK4D and p18INK4C.  The INK4 family of 
proteins function to inhibit CDK4 and CDK6 to prevent G1 to S phase transition 
(Neganova and Lako, 2008). 
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There is a possibility that other negative regulators that did not pass the 
threshold criteria are acting to downregulate cyclin D1 and CDK4/6. Cyclin B was 
found to be downregulated on NSQ, together with CDK7 and p21Cip1. This 
downregulation of the latter two genes could be suggestive of cell cycle 
progression on NSQ, as CDK7 has been discussed as being a negative regulator of 
proliferation (Ganuza et al., 2012). This is at odds with the downregulation of 
cyclin B activity, which is associated with decreased proliferation. This 
discrepancy can be explained by considering different subpopulations, with some 
proliferating (displaying a degree of stem cell retention) and some beginning to 
transition into differentiation upon reaction to the instructional cues from the 
NSQ nanotopography. 
 
The E2F group of genes encoding transcription factors were shown to be 
upregulated on both SQ and NSQ, however, IPA did not show any clear 
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distinction (pictorially, as stronger or lighter shades of red) between these at 
the gene level. The caveat to this type of analysis is that some genes are 
displayed as signalling groups or nodes instead of individual entities, and thus it 
is difficult to deduce whether phosphorylation events are occurring downstream. 
Some of the other genes tested using ICW did not show in the networks (for 
example p27Kip1, RB), most likely due to stringent thresholds applied to reduce 
the number of genes taken forward for analysis.   
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Despite this, some of the larger gene changes could be investigated in more 
detail. In the stress-activated protein kinases/Jun amino-terminal kinases 
(SAPK/JNK) pathway, JNK was highlighted as being upregulated on NSQ  
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(Figure 4-24), which has downstream effects associated with triggering cell 
differentiation events in the nucleus (Jaiswal et al., 2000).  
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4.3 Discussion 
 
Current research into the cell cycle of MSCs is very limited, particularly in terms 
of the contribution of cell cycle regulation to the promotion of symmetrical self-
renewal. In this chapter, nanotopography was used as a tool to induce the 
divergent processes of self-renewal and osteogenic differentiation, and levels of 
cell cycle related proteins were assessed after synchronising and releasing MSCs 
into the cell cycle.  
 
4.3.1  Interpretation of cell cycle protein levels analysed by ICW  
 
A trend towards elevated pRB protein levels was consistently observed on NSQ at 
all the time points tested (Figure 4-4), which suggests that G1 to S transition has 
been repressed at an early stage. This effect appears to be unique to NSQ, as 
relative pRB levels remained low on both flat and SQ. RB is regulated by 
phosphorylation; hypophosphorylation of RB during G1 prevents cell entry into S 
phase, whereas an accumulation of hyperphosphorylation occurs as cell cycle 
progression unfolds (Ezhevsky et al., 1997). A switch from proliferation to 
differentiation has been discussed in the literature, reasoning this trend on the 
NSQ nanotopography in comparison to the other surfaces. The phosphorylation 
site serine 807/serine 811 has actions on nuclear tyrosine kinase c-Abl (Knudsen 
and Wang, 1996). In addition, pRb can directly interact with transcription factors 
such as Runx2 and PPAR! (Docheva et al., 2008), specific to osteoblasts and 
adipocytes respectively, therefore an accumulation of pRB may be beneficial 
during the early stages of differentiation.  
 
Levels of the CDK inhibitor p27Kip1 (Figure 4-4) were low in MSCs grown on both SQ 
and NSQ in comparison to the flat controls.  A lower level of p27Kip1 on NSQ may 
indicate that some MSCs are proliferating and progressing through the cell cycle. 
However, this CDK inhibitor being low on SQ would be unexpected if the cells 
were in a quiescent state during culture. It is possible that inhibitory proteins 
other than p27Kip1 have larger roles than in maintaining a degree of quiescence 
or slowing progression through the cycle on the self-renewing surface. 
Alternatively, there is evidence that p27Kip1 is important in regulating stem cell 
progenitor populations (Menchón et al., 2011), therefore it may stand to reason 
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that levels would be relatively similar on both SQ and NSQ at such an early stage 
of growth when progenitor cell numbers will be relatively comparable.  
Elevation of D type cyclins are generally associated with proliferation, though 
changes in cyclin D1 levels between surfaces were minimal for the majority of 
the experimental timepoints (Figure 4-4), until the 24 hours timepoint had been 
reached, whereby the change between flat and SQ began to reach significance. 
This lowered level of cyclin D1 on SQ is a promising indicator of decreased 
proliferation. Admittedly, the time constraints of the project restricted the 
number of cell cycle proteins tested, in addition to those with links to 
osteogenic differentiation. Runx2, for example, would be expected to show 
upregulation on NSQ as the onset of osteogenesis commenced, and should 
correlate with an increase in cyclin D1, whereas the reverse should be true on 
SQ. It would be of merit to test this in future work, and determine whether 
some of these proposed concepts and initial hypotheses are robust following 
further experiments.  
 
A decrease in E2F-1 transcription factor levels was also observed on NSQ at 
several timepoints (Figure 4-4). A link between E2F-1 and Rb exists, with a role for 
the protein complex in acting as a molecular ‘switch’ between differentiation 
and proliferation (Chong et al., 2009). The decrease in E2F-1 correlates with the 
concomitant increase in pRb, whereby the formation of pRb-E2F-1 complexes 
results in the sequestration and reduction in E2F-1 transcriptional activity, which 
has effects on the G1 to S transition (Johnson et al., 1993).  
 
CDK6 protein expression has recently been studied in HSCs, with high CDK6 in a 
subset of HSCs being correlated to the rapid exit of quiescence and entry into 
the cycle upon mitogenic stimulation (Laurenti et al., 2015). Intriguingly, two 
studies by Ogasawara et al. have shown that overexpression of CDK6 blocks BMP-
2 induced osteoblast differentiation (Ogasawara et al., 2004b), and that there 
was a requirement for CDK6 levels to fall in order for RANKL-stimulated 
osteoclast differentiation to occur (Ogasawara et al., 2004a). However, these 
investigations were carried out on murine cells (RAW264.7 macrophage cell line 
and MC3T3-E1 osteoblast precursors) and not MSCs.  
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Nevertheless, in the case of MSCs on SQ, CDK6 levels were elevated on SQ in 
comparison to flat and NSQ surfaces (Figure 4-5), with some significance (p<0.05) 
in protein level at the 1h timepoint with reference to the flat controls. This 
increase in CDK6 may have a potential role in repressing differentiation, perhaps 
even retaining cells in a primed state ready for differentiation. If an abundance 
of CDK6 is associated with tumour growth, and high levels of CDK6 progress cells 
through the cell cycle, it stands to reason that the regulation of CDK6 should be 
important in stem cells. As the observed increase in CDK6 in the experiments 
carried out in the present study were modest, perhaps this intermediate level of 
CDK6 is suggestive of a degree of proliferation on SQ, supporting the concept of 
dynamic stasis on this surface.  
 
4.3.2 Changes in cell signalling networks and cell cycle 
regulation  
 
Detailed study into the different stages of G1 is outwith the scope of this thesis 
but it would be interesting to determine which stage is affected with 
nanotopography, or whether the length of G1 is modulated by the surface. ESCs 
and HSCs display different mechanisms to preserve self-renewing populations, 
therefore it may be that MSCs utilise elements of these or even an entirely 
different process for the purposes of self-renewal. Therefore a wider picture of 
the effects of SQ and NSQ nanotopographies on gene expression was attempted 
from analysis of NGS data.  
 
It was interesting to observe that indications of an aerobic bioenergetic profile 
were present in MSCs on SQ, with oxidative phosphorylation and fatty acid 
oxidation pathways consisting of downregulations in genes related to the 
transcripts in the dataset (Figure 4-19). Although the differential expression of 
genes involved in oxidative phosphorylation were shown to be downregulated on 
NSQ (Figure 4-20 and Figure 4-21), this was to a lesser extent, and could perhaps be 
attributed to the early stages of differentiation where a bioenergetic switch 
towards oxidative energy processes had not yet taken place, or could indicate a 
plausible heterogeneous population.  
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NGS revealed that in networks involving some key cell cycle genes, the majority 
of genes related to the identified transcripts on SQ were inferred as being 
downregulated. One example is CDK1 (Figure 4-23). CDK1 is known to have roles in 
mitotic progression (Van Horn et al., 2010), yet in addition to this was shown to 
have effects on maintenance of pluripotency in human pluripotent stem cells 
(Neganova et al., 2014). Moreover, the aforementioned p27kip1, is thought to 
play a pivotal role in self-renewal and pluripotency of human ESCs (Menchón et 
al., 2011), in addition to having a role in the transition stages between 
proliferation and osteoblast differentiation (Drissi et al., 1999). This indicates 
that the complexities of cell cycle regulators may extend further than their 
direct action on cycle progression. Neganova et al. studied the effects of CDK1 
by using RNA interference to down-regulate CDK1 (Neganova et al., 2014). A 
similar strategy could be utilised to look at the importance of other important 
cell cycle regulators.   
 
Information about ERK1/2 and JNK on SQ and NSQ was gathered, with ERK1/2 
indicated as being downregulated on SQ (Figure 4-22) and JNK being upregulated 
on NSQ (Figure 4-24). There is evidence consistent with ERK1/2 and its associated 
signalling cascade being activated during the differentiation of MSCs towards an 
osteogenic lineage (Bai et al., 2013), therefore downregulation of ERK1/2 on SQ 
may indicate a lack of differentiation on SQ. JNK activation has been 
demonstrated to increase in response to culture in osteogenic media (Jaiswal et 
al., 2000), and MSCs subjected to geometric cues for enhancement of 
osteogenesis also point towards elevated JNK signalling in addition to elevated 
ERK signalling having roles in promotion of differentiation (Kilian et al., 2010).   
 
4.3.3 Link between filopodia and cell cycle regulation was not 
established 
 
 
Following observation that morphology at the level of filopodia was altered, with 
contact guidance of filopodia being demonstrated on SQ and not on NSQ, it was 
hypothesized that the directionality of filopodia, and subsequent effect on focal 
adhesion formation and clustering, may be an important initiating event that 
triggers signalling processes to progress onset of particular MSC phenotypes. 
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Other studies have shown that filopodia have roles in topographical sensing 
(Dalby et al., 2004a), and influence cell adhesion (Albuschies and Vogel, 2013). 
However, testing of CDK6 levels in MSCs subjected to cdc42 inhibition did not 
show an appreciative reduction of CDK6 on SQ (Figure 4-14). This may be due to 
the inhibition method utilised, as the chemical inhibitor that was applied only 
targeted one protein involved in formation of filopodia, and with less specificity 
than molecular targeting. An improved strategy would be to use a combination 
of inhibitors targeting different filopodial targets, to knock out the genes 
involved in filopodia development or to introduce non-functional versions of 
proteins (such as a dominant negative), to create a larger cumulative and 
thereby inhibitory effect. CDK6 was of particular interest as it was elevated on 
SQ as the cell cycle progressed. Thus, further study into this protein can reveal 
whether phosphorylation of CDK6 at different sites (both inhibitory or activating 
sites) is affected by filopodial inhibition, in addition to answering the question of 
whether associations between any cell cycle proteins and filopodia exist.  
 
4.3.4 Proposed models of self-renewal on SQ in relation to cell 
cycle 
 
 
If it is indeed the case that cell cycle regulators act to maintain multipotency or 
pluripotency, this is in keeping with our hypothesis that MSCs on SQ would be 
subject to differences in cell cycle regulation. As bone marrow derived MSCs do 
not appear to show significant changes in proliferation during culture on 
different nanotopographies, this suggests that MSCs on SQ nanotopography 
maintain a degree of self-renewal by a mechanism other than keeping reserve 
populations dormant, as has been proposed for HSCs (Wilson et al., 2008) which 
are largely used as a model for the study of adult stem cell self-renewal. Li et 
al. suggested that undifferentiated ESCs might progress through G1 at a slower 
rate (Li et al., 2012), which could be plausible for MSCs, due to a shift in 
populations in the earlier stages of the cell cycle on SQ (Figure 4-6 and 4-7). It 
would be interesting to compare SQ with NSQ in the same way; to assess cell 
cycle related changes in self-renewal against osteogenic differentiation.    
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It was not possible to reach a definitive conclusion about the mechanism of self-
renewal from the current data. However, a potential model for the self-renewal 
of MSCs on the SQ nanotopography could be that a proportion of cells are 
undergoing a degree of slow proliferation, yet do not lose their capacity for self-
renewal until a substantial amount of time has passed, as demonstrated by 
previous work using SQ nanotopography carried out at long timepoints of 8 weeks 
(McMurray et al., 2011). It seems plausible that the increasingly mature 
subpopulations could be acting to regulate self-renewal of early stage MSCs, akin 
to a more recent observation for HSCs, though this effect would be lost with the 
use of synchronised cells (Christopher et al., 2011).  Having some heterogeneity 
within stem cell pools would be more likely than an entirely homogeneous one, 
as biological systems are rarely found to consist of cells in the same state. If 
applying the concept of heterogeneity, populations of MSCs may be ‘primed’ on 
SQ, in terms of amassing energy to carry out differentiation into a particular 
lineage, and could be described as being in a mode of dynamic stasis, poised for 
activation. With regards to cell cycle regulation, some differences are apparent 
between SQ and NSQ nanotopographies. It appears that MSCs cultured on SQ are 
subject to regulation to a greater extent. This may be explained by the fact that 
differentiating cells tend to divert their energies towards greatly energy-
consuming differentiation processes to the detriment of those related to 
proliferation. Thus, regulation pertaining to prevention of cell cycle progression 
can be relaxed in MSCs cultured on the differentiation-inducing NSQ surface.  
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5 Chapter 5 
5.1 Introduction 
 
A large disadvantage to the widespread use of stem cells is their tendency to 
exhibit uncontrolled and spontaneous differentiation and their limited numbers. 
In order to generate a source of undifferentiated stem cells, a strategy was 
formulated to take partially or even terminally differentiated cell types and 
attempt to revert them back to a stem-like state. This method is now commonly 
referred to as ‘reprogramming’. John Gurdon was an early pioneer in the 
foundations of this type of research, successfully using nuclear transplantation 
to transfer an adult frog intestine cell nucleus into an egg cell, resulting in a 
cloned frog (Gurdon, 1962, Gurdon and Uehlinger, 1966). In doing so, he 
demonstrated that adult cells retained the information required to form other 
cells, despite having become specialised, and that differentiation was not 
irreversible. This caveat was further addressed by Takahashi and Yamanaka in 
2006, and became one of the biggest and most publicised success stories of stem 
cell research. The group were able to take mouse and human fibroblasts and 
induce pluripotency solely through retroviral introduction of expression of four 
genes, namely, Oct3/4, Sox2, Klf4 and c-Myc (Takahashi and Yamanaka, 2006, 
Takahashi et al., 2007). The resultant iPSCs were shown to possess familiar 
characteristics of embryonic stem cells (ESCs) in terms of morphology, 
expression of typical ESC markers, and in vitro differentiation capability, proving 
that some reversion from a differentiated phenotype was achieved (Takahashi 
and Yamanaka, 2006, Takahashi et al., 2007).  
 
More recent work by Huangfu et al. showed that addition of DNA 
methytransferase and histone deacetylase (HDAC) inhibitors enhanced 
reprogramming efficiency of somatic cells into iPSCs (Huangfu et al., 2008a, 
Huangfu et al., 2008b), which originally takes a long time and has a low success 
rate (Yamanaka, 2009), likely due to mature cells requiring additional gene 
activation for reprogramming to take place (Bar-Nur et al., 2014). They 
described a dramatic increase in reprogramming efficiency with the use of 
histone deacetylation (HDAC) inhibitor valproic acid (VPA) (Huangfu et al., 
2008a). This is thought to be due to the resultant increase in histone acetylation 
that allows DNA to form an open structure for the binding of transcription 
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factors. A further study investigating benefits of grooved microtopography on 
reprogramming efficiency incorporated an experiment with the topography and 
VPA in tandem, although showing little difference between the presence and 
absence of VPA with a grooved surface (Downing et al., 2013).   
Song et al. carried out analyses of MSCs that had differentiated and de-
differentiated by addition and subsequent removal of induction media (Song et 
al., 2006). We proposed that the use of nanotopography instead of reliance 
solely on chemically-defined media, would be far more advantageous. This posed 
the question ‘would nanotopographical cues from SQ be strong enough to de-
differentiate MSCs that had been partially differentiated?’ This would present a 
novel application of nanotopography that has not previously been investigated.  
 
Further addressing the issue of reproducing conditions reminiscent of bone 
marrow, it has been noted that the nanotopographical substrate in isolation 
would not closely mimic the all aspects of the niche, but rather the 
topographical features mimic an aspect of a niche component, namely the 
sinusoidal capillaries that permeate the bone marrow. Intriguingly, the pores of 
these capillaries (fenestrae) are of similar scale to the size of the nanopits, 
which supports the use of this type of feature at nanometre dimensions, and is 
possibly indicative of why these substrates influence MSC phenotype. It has been 
recently reported that MSCs reside within two microenvironments in the bone 
marrow, termed the endosteal (bone) niche and the sinusoidal niche, the latter 
of which comprises the aforementioned sinusoidal capillaries (Ehninger and 
Trumpp, 2011).  
 
This chapter describes the initial assessment of the SQ nanotopography for “de-
differentiation” or specifically to attempt to revert MSCs that have been induced 
to undergo osteogenesis into an earlier ‘stem-like’ state. Nanotopography was 
utilised to both induce and reverse phenotype, with the NSQ substrate employed 
to induce osteogenesis and culture on the SQ substrate used to re-establish stem 
cell maintenance cues.  
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5.2 Results  
 
5.2.1 Investigating nanotopography for reprogramming  
 
5.2.1.1 Assessment of de-differentiation with stem cell marker expression 
 
Preliminary experiments assessed the use of nanotopography as a tool for 
reprogramming of MSCs. MSCs were induced to undergo osteogenic 
differentiation on the NSQ surface for 14 days, then reseeded onto SQ substrates 
for a further period of culture (7 or 14 days). Stem cell marker protein levels 
were used as an indicator of reversion to an earlier stem cell state prior to 
differentiation. The results unexpectedly showed that levels of CD63 protein 
decreased on SQ in comparison to CD63 in MSCs on NSQ prior to reseeding  
(Figure 5-2).  
 
!"#$%&'S)*,':E+('6%10&"4'@&A&@2'B&.1%&';43';.0&%'%&6%1#%;CC"4#'14'9?'4;410161#%;6<5='
L$40/"9"=4/"30'39'>?+('C%3/&"0'15'd>-K'!3223G"0#'%&.&&<"0#'39'AB>.'/F4/'G&%&'C%&)=$2/$%&<'93%'*R'
<45.'30'UBL'30/3'BL'0403/3C3#%4CF5M'>?+('2&O&2.'G&%&'4..&..&<'4#4"0'49/&%','3%'*R'<45.'39'
9$%/F&%'=$2/$%&K'P&.$2/.'<&03/&'40'4O&%4#&'"0/&#%4/&<'"0/&0."/5'03%Q42".&<'/3'HDI?J'&NC%&..&<'"0'
4%1"/%4%5'92$3%&.=&0=&'$0"/.M'39'R'Q4/&%"42'%&C2"=4/&.'93%'/F&'"0"/"42'=$2/$%&'C&%"3<'40<'V'Q4/&%"42'
%&C2"=4/&.'93%'/F&'%&.&&<&<'=$2/$%&.K'X%%3%'14%.'%&C%&.&0/'Y'./40<4%<'&%%3%'39'/F&'Q&40K''>?+('G4.'
31.&%O&<'/3'<&=%&4.&'."#0"9"=40/25'49/&%'%&.&&<"0#'4/'13/F'/"Q&C3"0/.K'B/4/"./"=42'."#0"9"=40=&'G4.'
/&./&<'15'30&)G45'DUTZD'G"/F'[$\&5].'Q$2/"C2&'=3QC4%".30.'/&./K''____C`SKSSS*''
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Results for ALCAM appeared to hold some promise, with a small elevation in 
ALCAM indicated for the further 7 day culture on SQ following reseeding, which 
was not observed for the 14 day timepoint (Figure 5-2). However, despite the 
encouraging increase in ALCAM for the 7 day culture, this change was not found 
to be statistically significant from ALCAM levels measured from the initial NSQ 
culture.  
 
!"#$%&'S)F,'MT:M8'@&A&@2'B&.1%&';43';.0&%'%&6%1#%;CC"4#'14'9?'4;410161#%;6<5=!
L$40/"9"=4/"30'39'DE>DA'C%3/&"0'15'd>-K'!3223G"0#'%&.&&<"0#'39'AB>.'/F4/'G&%&'C%&)=$2/$%&<'93%'
*R'<45.'30'UBL'30/3'BL'0403/3C3#%4CF5M'DE>DA'2&O&2.'G&%&'4..&..&<'4#4"0'49/&%','3%'*R'<45.'39'
9$%/F&%'=$2/$%&K'P&.$2/.'<&03/&'40'4O&%4#&'"0/&#%4/&<'"0/&0."/5'03%Q42".&<'/3'HDI?JM'&NC%&..&<'"0'
4%1"/%4%5'92$3%&.=&0=&'$0"/.'39'R'Q4/&%"42'%&C2"=4/&.'93%'/F&'"0"/"42'=$2/$%&'C&%"3<'40<'V'Q4/&%"42'
%&C2"=4/&.'93%'/F&'%&.&&<&<'=$2/$%&.K'X%%3%'14%.'%&C%&.&0/'Y'./40<4%<'&%%3%'39'/F&'Q&40K'DE>DA'
2&O&2.'&NF"1"/&<'4'Q3<&./'"0=%&4.&'49/&%'%&.&&<"0#'40<'=$2/$%&'93%','<45.'30'BLM'GF&%&4.'/F&'
230#&%'C&%"3<'39'9$%/F&%'=$2/$%&'<"<'03/'4CC&4%'/3'F4O&'405'#%&4/'&99&=/'30'DE>DA'C%3/&"0'
&NC%&.."30K'?&.C"/&'/F&'&0=3$%4#"0#'/%&0<'31.&%O&<'93%'/F&','<45'%&C%3#%4QQ"0#'=$2/$%&'30'BLM'
/F".'G4.'03/'=42=$24/&<'/3'1&'./4/"./"=4225'."#0"9"=40/'630&)G45'DUTZD'G"/F'[$\&5].'Q$2/"C2&'
=3QC4%".30.'/&./8K''
 
Following from these preliminary results, it was thought that performing 
additional experiments using a culture time of 7 days after reseeding would 
potentially yield some interesting observations about SQ for this application.  
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5.2.1.2 Re-evaluation of nanotopography for de-differentiation: 
incorporation of VPA 
 
As the cues from SQ in isolation did not appear to maximise numbers of MSCs 
expressing high levels of stem cells markers and override the differentiation 
signals, VPA, a HDAC inhibitor, was added to enhance the cues from 
nanotopography. VPA promotes histone acetylation, consequently opening up 
chromatin into a relaxed structure allowing transcription factors to more readily 
bind to the DNA (Göttlicher et al., 2001, Kernochan et al., 2005). Intriguingly, 
cells from another patient responded positively, with results suggesting that 
reseeding differentiating cells onto SQ nanotopography may be effective in 
reprogramming cells back into a stem cell-like state, with an increase of STRO-1 
protein levels, the marker with which they were isolated, on SQ in comparison to 
the flat control (Figure 5-3; statistical significance shown in table 5-1). Upon 
addition of VPA, protein expression of STRO-1 was heightened on both flat and 
SQ, indicating that use of VPA improves STRO-1 expression on all surfaces 
regardless of the presence of nanotopographical cues.   
!"#$%&'S)(,'9[_O)*'6%10&"4'@&A&@2'"4'3"..&%&40";0"4#'89:2'%&2&&3&3'14'9?'01';22&22'
%&6%1#%;CC"4#'610&40";@=!B[PT)*@'AB>.'G&%&'.&&<&<'30'UBL'40<'=$2/$%&<'93%':*'<45.M'/F&0'
<&/4=F&<'40<'%&.&&<&<'30/3'924/WBL'Y'ZID'93%'%&C%3#%4QQ"0#'6,'<45.8K'P&.$2/.'<&C"=/'4O&%4#&'
"0/&#%4/&<'"0/&0."/5'39'=&22.'9%3Q'C4/"&0/'*'<&/&=/&<'9%3Q'r+S'"Q4#&.'4=g$"%&<'4=%3..'('Q4/&%"42'
%&C2"=4/&.'C&%'=30<"/"30M'g$40/"9"&<'$."0#'>&22I%39"2&%'"Q4#"0#'.39/G4%&K'X%%3%'14%.'%&C%&.&0/'Y'
./40<4%<'&%%3%'39'/F&'Q&40K!X2&O4/&<'B[PT)*'G4.'<&/&=/&<'30'BL'4/'4'."#0"9"=40/25'F"#F&%'2&O&2'
/F40'/F&'924/'=30/%32K'D<<"/"30'39'ZID'4CC&4%&<'/3'F&"#F/&0'B[PT)*'C%3/&"0'30'13/F'924/'40<'BL'
.$1./%4/&.'/3'/F&'.4Q&'<&#%&&K'B/4/"./"=42'."#0"9"=40=&'G4.'/&./&<'15'^%$.\42)-422".'/&./'G"/F'4'
?$00].'Q$2/"C2&'=3QC4%".30.'C3./)/&./K''____C`SKSSS*M'___C`SKSS*K'B/4%.'/3'/F&'2&9/'39'14%.'
<&03/&'."#0"9"=40=&'GF&0'=3QC4%&<'/3'UBLK'T/F&%'=3QC4%".30.'4%&'Q4%\&<'G"/F'4'2"0&K  
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Comparison Statistical significance: STRO-1  
(Patient 1) 
NSQ initial culture vs Reseeded Flat *** 
NSQ initial culture vs Reseeded SQ **** 
NSQ initial culture vs Reseeded Flat + 
VPA 
**** 
NSQ initial culture vs Reseeded SQ + 
VPA 
**** 
Reseeded Flat vs Reseeded SQ **** 
Reseeded Flat vs Reseeded Flat + VPA **** 
Reseeded SQ vs Reseeded SQ + VPA No significance 
Reseeded Flat + VPA vs Reseeded SQ + 
VPA 
No significance 
[;B@&'S)*,'9$CC;%5'1.'20;0"20"/;@'2"#4"."/;4/&'/;@/$@;0&3'.1%'"4"0";@';22&22C&40'1.'9[_O)*=''
?&/4"2.'39'./4/"./"=42'."#0"9"=40=&'=42=$24/&<'9%3Q'<4/4'4=g$"%&<'15'"Q4#&'40425.".'93%'AB>.'9%3Q'
30&'<303%'6I4/"&0/'*8'"0'/F&'&NC&%"Q&0/42'%&.$2/.'<&C"=/&<'"0'!"#$%&'V)(K''
 
 
As there were indications that cues from SQ were acting to increase STRO-1 in 
this instance, further investigation into the consistency of the effect was carried 
out with MSCs from two additional patients. Some parallels were observed with 
MSCs from a second donor (Figure 5-4 upper graph; statistical significance shown in 
table 5-2) in that an increase of STRO-1 was demonstrated on SQ, with reseeding 
on flat leading to a significant drop in STRO-1. Once again, supplementing media 
with VPA resulted in higher STRO-1 expression to similar levels on flat and SQ. 
The third assessment of STRO-1 expression (patient 3) showed a detrimental 
effect with SQ, where the lowest level of STRO-1 was detected (Figure 5-4 lower 
graph; statistical significance shown in table 5-3). STRO-1 was found to be higher on 
flat with and without VPA. It was observed that VPA increased STRO-1 on SQ, 
however, this was significantly lower than that measured from the equivalent 
flat surfaces.  
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!"#$%&'S)R,'!$%0<&%';22&22C&40'1.'9[_O)*'6%10&"4'@&A&@2'"4'3"..&%&40";0"4#'89:2'%&2&&3&3'14'9?=         
B[PT)*@'AB>.'G&%&'.&&<&<'30'UBL'40<'=$2/$%&<'93%':*'<45.M'/F&0'<&/4=F&<'40<'%&.&&<&<'30/3'
924/WBL'Y'ZID'93%'%&C%3#%4QQ"0#'6,'<45.8'93%':'<"99&%&0/'C4/"&0/.'6C4/"&0/':'40<'(h'.&C4%4/&'
#%4CF.'<".C245&<'C&%'C4/"&0/8K'P&.$2/.'<&C"=/'4O&%4#&'"0/&#%4/&<'"0/&0."/5'39'=&22.'<&/&=/&<'9%3Q'
r+S'"Q4#&.'4=g$"%&<'4=%3..'('Q4/&%"42'%&C2"=4/&.'C&%'=30<"/"30M'g$40/"9"&<'$."0#'>&22I%39"2&%'
"Q4#"0#'.39/G4%&K'X%%3%'14%.'%&C%&.&0/'Y'./40<4%<'&%%3%'39'/F&'Q&40K!X2&O4/&<'B[PT)*'G4.'
<&/&=/&<'30'BL'4/'4'."#0"9"=40/25'F"#F&%'2&O&2'/F40'/F&'924/'=30/%32K'D<<"/"30'39'ZID'4CC&4%&<'/3'
F&"#F/&0'B[PT)*'C%3/&"0'30'13/F'924/'40<'BL'.$1./%4/&.'/3'/F&'.4Q&'<&#%&&K'B/4/"./"=42'."#0"9"=40=&'
G4.'/&./&<'15'^%$.\42)-422".'/&./'G"/F'4'?$00].'Q$2/"C2&'=3QC4%".30.'C3./)/&./K''____C`SKSSS*K''
B/4%.'/3'/F&'2&9/'39'14%.'<&03/&'."#0"9"=40=&'GF&0'=3QC4%&<'/3'UBLK'T/F&%'=3QC4%".30.'4%&'
Q4%\&<'G"/F'4'2"0&K'b%&4\.'"0'/F&'5)4N".'4%&'"0<"=4/&<'G"/F'4'<3$12&'2"0&K' 
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Comparison Statistical significance: STRO-1 
(Patient 2) 
NSQ initial culture vs Reseeded Flat *** 
NSQ initial culture vs Reseeded SQ **** 
NSQ initial culture vs Reseeded Flat + 
VPA 
**** 
NSQ initial culture vs Reseeded SQ + 
VPA 
**** 
Reseeded Flat vs Reseeded SQ **** 
Reseeded Flat vs Reseeded Flat + VPA **** 
Reseeded SQ vs Reseeded SQ + VPA No significance 
Reseeded Flat + VPA vs Reseeded SQ + 
VPA 
No significance 
[;B@&'S)F,!9$CC;%5'1.'20;0"20"/;@'2"#4"."/;4/&'/;@/$@;0&3'.1%'.$%0<&%';22&22C&402'1.'9[_O)*'
UW;0"&40'FV=''?&/4"2.'39'./4/"./"=42'."#0"9"=40=&'=42=$24/&<'9%3Q'<4/4'4=g$"%&<'15'"Q4#&'40425.".'93%'
AB>.'9%3Q'4'.&=30<'<303%'"0'/F&'&NC&%"Q&0/42'%&.$2/.'<&C"=/&<'"0'$CC&%'#%4CF'!"#$%&'V)RK'
 
Comparison Statistical significance: STRO-1 
(Patient 3) 
NSQ initial culture vs Reseeded Flat *** 
NSQ initial culture vs Reseeded SQ **** 
NSQ initial culture vs Reseeded Flat + 
VPA 
**** 
NSQ initial culture vs Reseeded SQ + 
VPA 
**** 
Reseeded Flat vs Reseeded SQ **** 
Reseeded Flat vs Reseeded Flat + VPA **** 
Reseeded SQ vs Reseeded SQ + VPA No significance 
Reseeded Flat + VPA vs Reseeded SQ + 
VPA 
No significance 
[;B@&'S)(,'9$CC;%5'1.'20;0"20"/;@'2"#4"."/;4/&'/;@/$@;0&3'.1%'.$%0<&%';22&22C&402'1.'9[_O)*'
UW;0"&40'(V=''?&/4"2.'39'./4/"./"=42'."#0"9"=40=&'=42=$24/&<'9%3Q'<4/4'4=g$"%&<'15'"Q4#&'40425.".'93%'
AB>.'9%3Q'4'/F"%<'<303%'"0'/F&'&NC&%"Q&0/42'%&.$2/.'<&C"=/&<'"0'/F&'23G&%'#%4CF'39'!"#$%&'V)RK'
 
It was noted that the observed STRO-1 increases on SQ for two of the 
experimental results following reseeding could have been due to expansion of 
the remaining STRO-1 cell population found on NSQ, rather than a result of 
reprogramming of partially osteo-committed MSCs back to early state MSCs.  
Therefore, an increased number of substrates were incorporated in the study of 
MSCs from two other patients (hereby referred to as patient 2 and patient 3), to 
allow for quantification of ALCAM and osteocalcin (OCN, an osteoblast marker) in 
addition to STRO-1. Levels of OCN were compared on NSQ following 21 days of 
culture and on SQ after 7 days post-reseeding. The reasoning was that if OCN 
levels on SQ subsequently fall, in parallel with a concomitant increase in    
STRO-1, this would suggest that SQ is presenting lineage reversal cues.  
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!"#$%&'S)S,'MT:M8'6%10&"4'@&A&@2'.1@@1N"4#'%&2&&3"4#'1.'Q9?)"43$/&3'89:2'14'9?';43'.@;0'
2$B20%;0&2='B[PT)*@'AB>.'G&%&'.&&<&<'30'UBL'93%':*'<45.M'<&/4=F&<'40<'%&.&&<&<'30/3'924/WBL'Y'
ZID'93%'%&C%3#%4QQ"0#'6,'<45.8'93%':'<"99&%&0/'C4/"&0/.'6I4/"&0/':'40<'(h'"0<"O"<$42'#%4CF.'
<".C245&<'C&%'C4/"&0/8K'P&.$2/.'<&C"=/'4O&%4#&'"0/&#%4/&<'"0/&0."/5'39'=&22.'<&/&=/&<'9%3Q'r+S'
"Q4#&.'4=g$"%&<'4=%3..'('Q4/&%"42'%&C2"=4/&.'C&%'=30<"/"30M'g$40/"9"&<'$."0#'>&22I%39"2&%K'X%%3%'14%.'
%&C%&.&0/'Y'./40<4%<'&%%3%'39'/F&'Q&40K!DE>DA'G4.'."#0"9"=40/25'F"#F&%'30'BL'/F40'924/'93%'C4/"&0/'
:'1$/'/F&'3CC3."/&'G4.'31.&%O&<'93%'C4/"&0/'(K'ZID'"0=%&4.&<'DE>DA'30'13/F'924/'40<'BLK'
B/4/"./"=42'."#0"9"=40=&'G4.'/&./&<'15'^%$.\42)-422".'/&./'G"/F'4'?$00].'Q$2/"C2&'=3QC4%".30.'C3./)
/&./K''____C`SKSSS*M'_C`SKSVK''B/4%.'/3'/F&'2&9/'39'14%.'<&03/&'."#0"9"=40=&'=3QC4%&<'/3'UBLK'
T/F&%'=3QC4%".30.'4%&'Q4%\&<'G"/F'4'2"0&K'b%&4\.'"0'/F&'5)4N".'4%&'"0<"=4/&<'G"/F'4'<3$12&'2"0&K 
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Conversely, if STRO-1 levels were elevated on SQ following reseeding, this would 
indicate an expansion of a STRO-1+ MSC population. 
 
Comparison Statistical significance: ALCAM 
(Patient 2) 
NSQ initial culture vs Reseeded Flat * 
NSQ initial culture vs Reseeded SQ **** 
NSQ initial culture vs Reseeded Flat + 
VPA 
**** 
NSQ initial culture vs Reseeded SQ + 
VPA 
**** 
Reseeded Flat vs Reseeded SQ **** 
Reseeded Flat vs Reseeded Flat + VPA **** 
Reseeded SQ vs Reseeded SQ + VPA No significance 
Reseeded Flat + VPA vs Reseeded SQ + 
VPA 
No significance 
[;B@&'S)R,!9$CC;%5'1.'20;0"20"/;@'2"#4"."/;4/&'/;@/$@;0&3'.1%'MT:M8'UW;0"&40'FV=''?&/4"2.'39'
./4/"./"=42'."#0"9"=40=&'=42=$24/&<'9%3Q'<4/4'4=g$"%&<'15'"Q4#&'40425.".'93%'AB>.'9%3Q'/F&'.&=30<'
<303%'"0'/F&'&NC&%"Q&0/42'%&.$2/.'<&C"=/&<'"0'/F&'$CC&%'#%4CF'6I4/"&0/':8'39'!"#$%&'V)VK!
 
Comparison Statistical significance: ALCAM 
(Patient 3) 
NSQ initial culture vs Reseeded Flat **** 
NSQ initial culture vs Reseeded SQ **** 
NSQ initial culture vs Reseeded Flat + 
VPA 
**** 
NSQ initial culture vs Reseeded SQ + 
VPA 
**** 
Reseeded Flat vs Reseeded SQ **** 
Reseeded Flat vs Reseeded Flat + VPA **** 
Reseeded SQ vs Reseeded SQ + VPA **** 
Reseeded Flat + VPA vs Reseeded SQ + 
VPA 
No significance 
[;B@&'S)S,!9$CC;%5'1.'20;0"20"/;@'2"#4"."/;4/&'/;@/$@;0&3'.1%'MT:M8'UW;0"&40'(V=''?&/4"2.'39'
./4/"./"=42'."#0"9"=40=&'=42=$24/&<'9%3Q'<4/4'4=g$"%&<'15'"Q4#&'40425.".'93%'AB>.'9%3Q'/F&'/F"%<'
<303%'"0'/F&'&NC&%"Q&0/42'%&.$2/.'<&C"=/&<'"0'/F&'23G&%'#%4CF'6I4/"&0/'(8'39'!"#$%&'V)VK!
 
An increase in ALCAM was detected on SQ at a significantly higher level than the 
flat control for patient 2 but the opposite trend was observed for patient 3 
(Figure 5-5, significance shown in tables 5-4 and 5-5). Addition of VPA increased 
ALCAM on both flat and SQ substrates for each donor in comparison to the initial 
level on NSQ. In each case, ALCAM marker expression fell when reseeded onto 
flat substrates without the addition of VPA. MSCs from patient 2 showed a 
particularly good response to the SQ nanotopography as ALCAM on SQ cultured in 
the presence or absence of VPA were both significantly elevated in comparison 
to the corresponding flat controls.   
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Some variation in results between MSCs derived from different patients was 
similarly observed for OCN. MSCs from patient 2 appeared to increase after 
reseeding across all of the substrates in both culture conditions (Figure 5-6, 
significance shown in table 5-6). In contrast, MSCs from patient 3 exhibited a 
decrease in OCN on SQ that was significantly lower than the comparative flat 
control (Figure 5-6, significance shown in table 5-7). In parallel with STRO-1 and 
ALCAM, VPA promoted increases in OCN, with similarity between flat and SQ 
cultured in VPA media.  
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!"#$%&'S)+,'O:Q'6%10&"4'@&A&@2'.1@@1N"4#'%&2&&3"4#'1.'Q9?)"43$/&3'89:2'14'9?';43'.@;0'
2$B20%;0&2= B[PT)*@'AB>.'G&%&'.&&<&<'30'UBL'93%':*'<45.M'<&/4=F&<'40<'%&.&&<&<'30/3'924/WBL'Y'
ZID'93%'%&C%3#%4QQ"0#'6,'<45.8'93%':'<"99&%&0/'C4/"&0/.'6<&."#04/&<'4.'I4/"&0/':'40<'(h'"0<"O"<$42'
#%4CF.'.F3G0'C&%'C4/"&0/8K'P&.$2/.'<&C"=/'4O&%4#&'"0/&#%4/&<'"0/&0."/5'39'=&22.'<&/&=/&<'9%3Q'r+S'
"Q4#&.'4=g$"%&<'4=%3..'('Q4/&%"42'%&C2"=4/&.'C&%'=30<"/"30M'g$40/"9"&<'$."0#'>&22I%39"2&%'"Q4#"0#'
.39/G4%&K'X%%3%'14%.'%&C%&.&0/'Y'./40<4%<'&%%3%'39'/F&'Q&40K!D'.2"#F/'&2&O4/"30'39'T>U'G4.'
31.&%O&<'4=%3..'422'.$1./%4/&.'G"/F'AB>.'9%3Q'C4/"&0/':'GF&%&4.'4'<&=%&4.&'G4.'<&/&=/&<'30'BL'
93%'C4/"&0/'(K'T>U'2&O&2.'G&%&'F"#F'30'422'.$%94=&.'=$2/$%&<'G"/F'ZIDK'B/4/"./"=42'."#0"9"=40=&'G4.'
/&./&<'15'^%$.\42)-422".'/&./'G"/F'4'?$00].'Q$2/"C2&'=3QC4%".30.'C3./)/&./K''____C`SKSSS*M'
___C`SKSS*M'__C`SKS*K''B/4%.'/3'/F&'2&9/'39'14%.'<&03/&'."#0"9"=40=&'GF&0'=3QC4%&<'/3'UBLK'T/F&%'
=3QC4%".30.'4%&'Q4%\&<'G"/F'4'2"0&K'b%&4\.'"0'/F&'5)4N".'4%&'"0<"=4/&<'G"/F'4'<3$12&'2"0&K  
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Comparison Statistical significance: OCN  
(Patient 2) 
NSQ initial culture vs Reseeded Flat **** 
NSQ initial culture vs Reseeded SQ **** 
NSQ initial culture vs Reseeded Flat + 
VPA 
**** 
NSQ initial culture vs Reseeded SQ + 
VPA 
**** 
Reseeded Flat vs Reseeded SQ *** 
Reseeded Flat vs Reseeded Flat + VPA **** 
Reseeded SQ vs Reseeded SQ + VPA **** 
Reseeded Flat + VPA vs Reseeded SQ + 
VPA 
**** 
[;B@&'S)+,!9$CC;%5'1.'20;0"20"/;@'2"#4"."/;4/&'/;@/$@;0&3'.1%'O:Q'UW;0"&40'FV=''?&/4"2.'39'
./4/"./"=42'."#0"9"=40=&'=42=$24/&<'9%3Q'<4/4'4=g$"%&<'15'"Q4#&'40425.".'93%'AB>.'9%3Q'/F&'/F"%<'
<303%'"0'/F&'&NC&%"Q&0/42'%&.$2/.'<&C"=/&<'"0'/F&'$CC&%'#%4CF'6I4/"&0/':8'39'!"#$%&'V)+K'
 
Comparison Statistical significance: OCN  
(Patient 3) 
NSQ initial culture vs Reseeded Flat ** 
NSQ initial culture vs Reseeded SQ **** 
NSQ initial culture vs Reseeded Flat + 
VPA 
**** 
NSQ initial culture vs Reseeded SQ + 
VPA 
**** 
Reseeded Flat vs Reseeded SQ **** 
Reseeded Flat vs Reseeded Flat + VPA **** 
Reseeded SQ vs Reseeded SQ + VPA **** 
Reseeded Flat + VPA vs Reseeded SQ + 
VPA 
No significance 
[;B@&'S)>,'9$CC;%5'1.'20;0"20"/;@'2"#4"."/;4/&'/;@/$@;0&3'.1%'O:Q'UW;0"&40'(V=''?&/4"2.'39'
./4/"./"=42'."#0"9"=40=&'=42=$24/&<'9%3Q'<4/4'4=g$"%&<'15'"Q4#&'40425.".'93%'AB>.'9%3Q'/F&'/F"%<'
<303%'"0'/F&'&NC&%"Q&0/42'%&.$2/.'<&C"=/&<'"0'/F&'$CC&%'#%4CF'6I4/"&0/'(8'39'!"#$%&'V)+K!
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5.3 Discussion 
 
In this chapter, a novel application of the SQ nanotopography for the 
reprogramming of differentiating MSCs was investigated. The nanotopography 
system was used to induce osteogenic differentiation through initial culture of 
MSCs on the NSQ surface, with subsequent reseeding onto SQ substrates, 
subjecting the partially differentiated cells to maintenance cues for potential 
reversion of phenotype to an earlier stem cell state. A desirable outcome would 
be to obtain a large number of MSCs with a strong degree of stem cell marker 
expression. It was also deemed pertinent to answer the question of whether the 
resultant effect was truly in the reprogramming of the differentiating cells, or if 
the multipotent population was merely expanding.  
 
Early indications suggested that reseeding on SQ might have enhanced the ability 
of the differentiating MSCs to express ALCAM. However, levels of another stem 
cell marker, CD63 were not elevated after reseeding, indicating that 
nanotopographical cues in isolation may not be strong enough to achieve a 
rescue of stem cell marker expression. In light of these observations, the 
inclusion of small molecule VPA was tested to determine whether an ‘in 
conjunction’ nanotopography-chemical approach would be more effective.  With 
the addition of VPA, the expression of the widely recognised STRO-1 marker, 
which was used to isolate the cells, was found to be amplified on MSCs reseeded 
on SQ for the preliminary experiment, though this trend was not exclusive to the 
nanotopographical substrates as cells on the flat control supplemented with VPA 
exhibited STRO-1 at similar levels. Unexpectedly, in this particular experiment, 
reseeding differentiated cells onto nanotopography alone was found to elevate 
levels of STRO-1 in comparison to reseeding onto a flat substrate, suggesting 
that the STRO-1 selected population of MSCs is more responsive to substrate 
cues. Thus, it was deemed interesting to determine whether cells from other 
patients also displayed an increase in STRO-1, and whether additional stem cell 
markers followed a consistent trend upon reseeding onto SQ substrates.  
Furthermore, it was decided to investigate the basis of the observed effect: if it 
was a result of re-direction in expression of markers associated with 
differentiation to those related to ‘stem-ness’ (de-differentiation) or due to 
expansion of a multipotent subpopulation amongst the ostoegenic cells on the 
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NSQ surface. Further experimental testing and analyses indicated that cells from 
different patients displayed variable responses, with cells from one patient 
showing no response at all. 
 
OCN results proved inconsistent. VPA tended to cause an increase in the 
expression of this osteo-specific differentiation marker and whilst some patients 
showed reduction of the marker after reseeding from NSQ, others increased OCN 
expression. This suggests that the osteogenic populations are either static or are 
even expanding on SQ and that they continue to expand with VPA. This leads us 
to hypothesize that reprogramming was not achieved, rather switching between 
substrates focuses expansion of different subpopulations and that VPA is 
generally inductive of marker expression as a whole, through the provision of an 
accessible DNA structure for the binding of transcription factors.  
 
Fluctuations in response are likely dependent on the initial profile of MSCs, 
reflected in the variable data between patients. Other studies have reported 
donor-to-donor variability in MSCs (Friedl et al., 2007, Siddappa et al., 2007), 
reflecting the heterogeneity within stem cell populations. At any given time, 
there will be populations of multipotent stem cells as well as primitive 
progenitor cells and those that have progressed further in differentiating to 
particular lineages, all which will differ in number between donors (Pevsner-
Fischer et al., 2011). This issue is reflected in the increased emphasis on 
development of ‘personalised medicine’, in which treatments are tailored to 
individual patients and their biological characteristics rather than attempting to 
provide a ‘blanket’ treatment to all (Schork, 2015).  
 
It may be of merit to assess a wider range of markers, such as Runx2, which is an 
early osteogenic marker (Ducy et al., 1997) in addition to mid or late stage 
differentiation markers, and to investigate longer periods of culture to assess 
whether the cues from nanotopography require more time to take effect. An 
interesting study by Lee et al. used a gel strategy for a similar purpose. This 
involved pre-culturing MSCs on either soft or stiff hydrogels to induce 
neurogenesis or osteogenesis with subsequent transfer of these cells to hydrogels 
of opposing stiffnesses to study the reversal of lineage specification defined by 
the preconditioning period (Lee et al., 2014b). They found that nuclear Runx2 
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remained elevated after transfer of MSCs to softer gels which suggests that some 
osteogenic signals become established and become irreversible (Lee et al., 
2014b). With this in mind, perhaps it is inevitable to observe an increase in some 
osteogenic markers to some extent. Moreover, it may stand to reason that 
greater changes in early markers could be possible with nanotopography. 
 
Taken together, the preliminary results indicate that the use of highly ordered 
nanopit nanotopography cannot reprogram osteo-committed MSCs. We propose 
that the SQ substrates are assisting expansion of any remaining STRO-1+ MSCs 
remaining from the initial culture period, and that expression of markers at any 
given time is likely to vary between patients, which supports the argument for 
tailoring of stem cell-based therapies. The addition of VPA in conjunction with 
nanotopography generally increased expression of all markers, and thus did not 
offer any advantage in targeted elevation of stem cell markers. Nevertheless, 
the observation that SQ retains the ability to expand small numbers of MSCs 
even after a relatively long period of time in culture is a promising one, and 
once more highlights SQ as a useful tool in expansion of MSCs. 
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6  Chapter 6 
6.1 General discussion 
 
Stem cells present vast potential in the regeneration of diseased or damaged 
tissue. In order to best exploit them, knowledge of self-renewal is of particular 
interest over differentiation, as the former will allow larger-scale investigations 
to take place in a laboratory setting in addition to generation of increased 
numbers for implantations for clinical purposes. Success in this regard would 
overcome the problems associated with limited availability of MSCs from bone 
marrow aspirate (estimated as being 0.001-0.01%) (Pittenger et al., 1999). 
Moreover, maintaining multipotency of the MSCs will be important during the 
expansion period, to ensure that the majority of cells differentiate to the 
required cell type. Control of these processes will be pivotal, in ensuring that 
the desired processes are promoted at the correct times, avoiding uncontrolled 
growth or spontaneous differentiation.  
 
To this end, nanotopography, which attempts to mimic the biophysical 
component of the cells’ extracellular environment or niche, offered a method in 
which to influence MSC response. Exploration of the mechanisms affected by 
nanotopography was carried out in this study. Following optimisation to obtain 
the most efficient response from the substrate of focus, SQ, self-renewal was 
compared to osteogenesis induced by culture on NSQ. Metabolomic profile, gene 
expression and cell cycle proteins were assessed and differences between 
surfaces were analysed. Recognising the complexities of the stem cell niche in 
bone marrow, a model incorporating nanotopography and other components was 
trialled in small-scale study, attempting to improve on the existing 2D system. 
The potential for the SQ nanotopography in reversion of lineage commitment 
was subjected to preliminary investigation; this was in keeping with the view to 
exploit nanotopography further for biomedical purposes. This chapter will 
discuss the main conclusions of each section of work and expand on some of the 
aforementioned findings and the wider implications of the results demonstrated 
in this thesis.  
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6.1.1  Utilising nanotopographies as a tool for study of MSCs 
 
It was demonstrated that nanotopographies could be utilised to induce 
osteogenesis in addition to maintaining multipotency, thereby are suitable for 
use as tool to further study these processes in MSCs. These particular 
nanopatterns chosen were previously tested for induction of these processes 
(Dalby et al., 2007, McMurray et al., 2011, Tsimbouri et al., 2012), and thus 
provided important foundations to this work. Although each of these studies 
were performed on different materials, PMMA, PCL and now polycarbonate, the 
effects of the pitted nanotopographies on MSC phenotype were shown to be 
reproducible, possibly indicating that these smaller scale stimuli are 
combinatorially stronger than the properties of the material itself. However, it 
stands to reason that the best approach would be to find a material that would 
markedly enhance the effect of nanotopography.  
 
It was found that cell seeding density was an important factor for the MSC 
response to nanotopography, which became a concern following implementation 
of a seeding device for the addition of cells. Although use of the cell seeder 
minimised the cell number required for each experiment due the ability to seed 
directly onto the surface of each substrate, using the same number of cells as 
previous work meant an over-confluence over longer periods of culture. A small 
number of studies have assessed MSC seeding density (Both et al., 2007), but 
none have addressed this issue on nanotopography. Seeding number has been 
indicated to have an effect on proliferation and differentiation, with lower 
densities being more conducive towards differentiation and higher densities 
exhibiting a greater degree of proliferation (Pittenger et al., 1999, McBeath et 
al., 2004, Gobaa et al., 2011), though there are some conflicting reports that 
lower densities promote faster proliferation (Colter et al., 2000, Sekiya et al., 
2002, Both et al., 2007) and retain a higher proportion of multipotent cells 
(Colter et al., 2000, Sekiya et al., 2002). Some of these findings contrast with 
the results obtained with nanotopography, whereby the MSCs seeded at higher 
concentrations were more likely to accumulate OPN, which together with OCN, 
show increased expression with osteogenic differentiation (Rickard et al., 1994).  
One of the benefits in determining and defining the number of MSCs seeded in a 
given area, is that the reproducibility of experiments will be improved, and this 
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value can be adapted depending on the size of the substrate if this changes in 
future work.   
 
6.1.2 Metabolomic changes in self-renewing and differentiating 
MSCs 
 
It was found that some of the metabolomic differences in self-renewing and 
differentiating MSCs drew parallels with ESCs, specifically studies by Yanes et al. 
which showed that the number of saturated metabolites increased when ESCs 
were undergoing differentiation (Yanes et al., 2010). Here, more unsaturated 
metabolites were detected in MSCs cultured on the SQ, which should contain 
more multipotent MSCs in comparison to NSQ, where the majority of cells should 
be undergoing differentiation. Global changes in metabolite profile were more 
evident at the shorter culture time of 7 days, suggesting that differences 
become established in the earlier stages of cell development. An observed 
abundance of amino acid metabolites on NSQ were attributed to preparatory 
stages of an increase in protein production, as many will be required for 
differentiation processes. Another interesting aspect of this part of the work was 
a trend towards downregulation of metabolites on SQ, whereas a greater number 
of upregulations were present on NSQ, contrasting the differences in activity 
between self-renewing and differentiation states. It has been shown that MSCs 
undergoing osteogenic differentiation induced by culture in osteogenic medium 
display increased metabolism (Reyes et al., 2006). Conversely, it is thus 
plausible that self-renewing MSCs will exhibit low metabolic activity, indications 
of which have been observed in this metabolic study in agreement with previous 
work (Reyes et al., 2006, McMurray et al., 2011). This further indicates that 
metabolic fingerprints are useful in describing the phenotype of MSCs and is in 
line with other MSC studies. 
 
Lipid metabolism has been investigated largely in HSCs, and has been 
demonstrated to have links with division and self-renewal (Ito et al., 2012, Yusuf 
and Scadden, 2012). In this work, it was shown that a high level of metabolic 
activity in the lipid data grouping was present on SQ, which implies that lipids 
have an important role in MSC maintenance. However, it is probable that lipids 
also contribute towards osteogenesis, particularly in terms of levels of 
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unsaturated fatty acids. A theory that tethers adipogenesis to osteogenesis 
suggests an inverse relationship between these two pathways of lineage 
commitment, with one occurring at the expense of the other (James, 2013). This 
is highlighted by the observation that ablation of OPN encourages adipogenesis 
to occur (Chen et al., 2014b). It is possible that a point of convergence exists 
within a stage of both adipogenic and osteogenic differentiation. The level of 
unsaturated fatty acids should decrease as osteogenesis progresses (showing 
decreased activation of peroxisome proliferator-activated receptors). 
Concomitantly, energy demands will steadily increase, leading to bioenergetic 
switching from anaerobic to oxidative processes (Yanes et al., 2010). It is 
interesting to note that a level of exposure to unsaturated fatty acids (linoleic 
and oleic acid) decreased proliferation of MSCs (Smith et al., 2012), a 
characteristic indicative of the onset of differentiation (Boland et al., 2004) 
which shows that fatty acids could be used to control the onset of osteogenesis.  
Further analysis of unsaturated fatty acids is therefore an avenue warranting 
exploration for continuation of this work.  
 
The metabolomics analyses carried out here did result in a number of 
metabolites that did not have known identities to linked databases, and 
conversely, some of those identified may not have active roles in MSCs, 
therefore validation of putative targets with other techniques and additional 
assessments would be logical next steps. Nevertheless, metabolomics offers 
interesting information that may lead to the identification of potentially 
important metabolites involved in establishment of osteogenesis or maintaining 
self-renewal. The untargeted metabolomics approach adopted is particularly 
useful in terms of hypothesis generation. It is recommended that proposed 
mechanisms and findings warrant further testing for reproducibility and 
confirmation of hypotheses put forward here. 
 
6.1.3 Influence of nanotopography on cell cycle and gene 
expression of MSCs 
 
Research pertaining to the cell cycle of MSCs limited and greatly lacking in the 
context of nanotopography. A recent study carried out by Kulangara et al. 
demonstrated decreased retinoblastoma protein levels and inferred decrease in 
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proliferation following culture on 350 nm grooves (Kulangara et al., 2014b), 
indicating that cell cycle is affected upon culture on nanotopographical 
features.  
 
Investigation into the cell cycle of MSCs on nanotopography yielded some 
interesting findings. There was evidence to indicate that populations of MSCs 
were being held in G0/G1 phase on SQ in comparison to those cultured on the 
flat control. In order to expand MSCs on the SQ substrates, cycle progression is 
still required through the cell cycle; therefore, it is reassuring to observe a 
similar proportion of cells in G2/M phase on both surface types. Quantification 
of cell cycle related proteins appeared to underline these observations, with 
levels of proteins such as cyclin D1, E2F-1 and pRb showing trends towards a 
degree of reduced proliferation and progression through the cell cycle on SQ.  
These observations conflict with results of BrdU assays performed at several 
time points, which did not reveal any significant differences in the number of 
cells progressing through S phase. This rules out quiescence on SQ, and large 
changes in proliferation between substrates. Thus, other possibilities include 
subpopulations of MSCs undergoing slower progression whilst others cycle 
normally, with SQ maintaining several pools of cells at the same time in a 
dynamic system.  
 
In addition, CDK6 was found to be elevated on SQ, however, an association 
between filopodial spreading and levels of this protein was not proven with 
inhibition experiments. However, it is possible that inhibition was not wholly 
efficient, in that filopodia formation was not prevented altogether, therefore 
other strategies could be employed to better target the genes involved. 
Assessment of phosphorylated forms of CDK6 would provide more information 
pertaining to the role of CDK6 on SQ, as some are activatory or inhibitory 
depending on the phosphorylation site (Kaldis, 1999, Pavletich, 1999). 
Indirect evidence strongly suggests that nanotopography is highly likely to induce 
changes in cell cycle. These are related to cellular spreading, integrins, 
intracellular tension and activation of signalling pathways. Inhibition of 
spreading has been shown to lead to arrest in G1 phase in growth factor treated 
cells (Folkman and Moscona, 1978). This is interesting with reference to 
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nanotopography due to contact guidance being observed on SQ, demonstrating 
partial inhibition of spreading of filopodia at the cell edges.  
 
Larger integrin-containing focal adhesions are associated with an osteogenic 
phenotype (Biggs et al., 2009a) and was shown to be the case on NSQ in previous 
work (Tsimbouri et al., 2014). Furthermore, this increase in focal adhesion size 
was significantly higher than SQ, showing that MSCs on the self-renewing 
substrates form smaller adhesions (Tsimbouri et al., 2014). These adhesion 
structures transmit force through the cytoskeleton, with larger adhesions 
creating larger forces (Choquet et al., 1997). Focal adhesions also respond to 
external forces from the surrounding environment (Wang and Ingber, 1995). It 
therefore follows that changing physical aspects of the MSCs culture 
environment will lead to adjustments in focal adhesions, altering intracellular 
tension and having actions on signalling molecules that associate with the 
cytoskeleton (Miyamoto et al., 1995). Evidence for this putative mechanism 
includes a study where an increase in ERK-mediated induction of cyclin D1 was 
demonstrated after increasing intracellular tension using cytochalasin D to 
disrupt the cytoskeleton (Böhmer et al., 1996). Walker et al. proposed a tension-
cell cycle model for growth factor stimulated cell signalling, which could be 
applicable to those cultured on nanotopography. The model illustrates that cells 
below a certain tension threshold will be unable to progress through the cell 
cycle due to failure to elicit ERK-dependent activation of cyclin D1 (Walker et 
al., 2005). Conversely, high levels of tension conferred by actin polymerisation 
or formation of actin stress fibres would result in Rho-mediated induction of 
cyclin D1 or prolonged ERK activation leading to recruitment of cyclin D1 
respectively (Walker et al., 2005). Synchronised MSCs released into cycle on SQ, 
showed elevated pERK and lowered cyclin D1 after 24 hours, which suggests 
transient activation of ERK, which would be insufficient to promote widespread 
cell cycle progression. This indicates that MSCs on SQ largely display a lower 
tension phenotype, one that does not exceed the tension threshold required to 
activate cell cycle related pathways associated with cytoskeletal integrity.       
 
Integrin signalling can trigger activation of focal adhesion kinase, which in turn 
can activate the MAPK cascade, resulting in activation of ERK (Moreno-Layseca 
and Streuli, 2014). ERK activity, (ERK 5 and ERK1/2) can affect cell cycle 
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progression, through regulation of cyclin D1 (Roovers and Assoian, 2000, Mulloy 
et al., 2003, Legate et al., 2009). It is important to note that ERK requires 
shuttling to the nucleus through association with anchoring proteins (Moreno-
Layseca and Streuli, 2014), therefore, the organisation of the cytoskeleton may 
become more important in this regard, in allowing or preventing the occurrence 
of such interactions.  
 
Indeed, links to pivotal signalling effectors ERK and JNK were identified as being 
up-regulated on NSQ (chapter 4), in agreement with previous work, in which 
inhibition of ERK and JNK decreased expression of lineage commitment markers 
(Tsimbouri et al., 2012). Initial indications point towards an increased 
proportion of cells being held in the early stages of the cell cycle, which is 
worthy of further investigation. Based on these observations, it is thus tempting 
to speculate that focus on the G1 phase will be of particular importance, as is 
the case with well-studied stem cell types, ESCs and HSCs. The duration of ERK 
activation was not investigated here, however it has been shown that transient 
and sustained ERK activity results in different actions, namely that sustained ERK 
signalling is pro-proliferative (Yamamoto et al., 2006), whereas transient ERK 
signalling prevents entry into the cell cycle (Sharrocks, 2006). The findings in 
this study show that there is much scope for continuing investigation into the 
cell cycle of MSCs cultured on nanotopography.  
 
6.1.4 Topography for MSC reprogramming 
 
The potential for nanotopography to redirect the onset of osteogenic 
differentiation was investigated in this thesis. This idea originated from the basis 
that stem cells respond to extracellular physical cues in their niche that are 
likely to assist in the maintenance of pools of self-renewing stem cells. As we 
postulate that the SQ nanotopography is successfully mimicking an aspect of 
these cues, there was a possibility that culture on SQ would partially negate the 
differentiation process. It was hoped that incorporation of nanotopography could 
be used in the optimisation of reprogramming, which is in itself an inefficient 
process due to epigenetic barriers including inaccessible chromatin structures 
(Hanna et al., 2010). However, it was found that marker levels in MSCs cultured 
on the nanotopographies tended to exhibit variable results from patient to 
Chapter 6: Discussion and Future Work 
 
     195 
C
hapter 3-C
haracterisation of M
esenchym
al Stem
 C
ells and N
naotopography O
ptim
isation 
patient. Nevertheless, some positive indications were observed for the STRO-1 
marker, with protein levels increasing following reseeding on SQ for two of the 
patients, though quantification of bone marker OPN did not provide evidence 
that reprogramming of differentiating cells was taking place. Inclusion of 
valproic acid generally led to increases in marker expression regardless of 
substrate type. Taken together, the SQ nanotopography may not provide 
sufficiently strong cues for the purposes of reprogramming, yet is able to expand 
the pool of MSCs that were originally selected for. This is a promising indication 
that the SQ substrates remain effective on populations of MSCs even after they 
have been subjected to differentiation cues.  
 
Reprogramming of cells remains a fairly recent concept, with the inclusion of 
topography being even more so. Polystyrene substrates patterned with micro-
gratings or micro-pillars of two diameters and spacing were assessed in terms of 
efficiency of reprogramming fibroblasts into induced neurons (Kulangara et al., 
2014a). Here, the authors indicated that morphological changes, with 
observations of increased neurite branching and outgrowth on some of these 
micropatterns, together with expression of neuronal genes demonstrated the 
potential of topography in reprogramming (Kulangara et al., 2014a). Downing et 
al. compared reprogramming of mouse primary fibroblasts on microtopography 
to assisted reprogramming using epigenetic modifiers, showing that micron scale 
grooves increased levels of histone H3 acetylation promoting reprogramming, 
and could replicate the effect of adding valproic acid and tranylcypromine 
hydrochloride in the generation of Nanog+ colonies (Downing et al., 2013). Use of 
nanotopography in reprogramming appears to be a growing area of research in 
recent years, and it would be useful to explore which types of nanopatterns are 
best for induction of pivotal epigenetic modifications to allow reprogramming to 
take place most efficiently.  
 
6.2 Thesis conclusion 
 
The research described in this thesis has contributed towards increasing 
understanding of MSC self-renewal. The results demonstrated that 
nanotopography could be used in the promotion of either maintenance of 
multipotency or osteogenic differentiation. MSCs were successfully isolated from 
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bone marrow (in-house), allowing testing of clinically relevant MSCs (chapter 3) 
in addition to those from an established source for more detailed aspects of this 
study (chapters 4 and 5). Colony growth patterns were observed upon seeding at 
lower initial densities, which may be important in maintaining a self-renewal 
state. Broad-scale analysis was achieved with metabolomics and next generation 
sequencing, highlighting that MSCs cultured on the SQ nanotopography may be 
exhibiting attributes associated with cells that are not undergoing 
differentiation. Furthermore, these MSCs were not demonstrated to maintain 
quiescence or a dormant state, but appeared, in some aspects, to be undergoing 
slowed progression through the cell cycle.  
 
6.3 Recommendations for future work 
 
As a result of the findings in this thesis, there is scope for additional research to 
take place in exploring the wider implications of culturing cells on nanopit 
nanotopography and to progress MSC studies still further. It has been shown here 
that nanotopography can be employed as a tool for study of maintenance of MSC 
phenotype as well as osteogenic differentiation, which means that mechanistic 
studies can be carried out in order to determine the importance of particular 
metabolites, genes or adhesion-related factors for self-renewal. Some 
suggestions for future work are detailed in the proceeding subsections. 
 
6.3.1 Nanotopography for the culture of MSCs in vitro 
 
From a practical view, nanotopography can be easily implemented for 
widespread use through the application of nanopatterns directly onto tissue 
culture plastic (polystyrene). The SQ nanopatterning would be of particular 
interest. If successful, this would potentially open up the possibility of 
preservation of stemness during expansion in vitro, and dampen the loss of 
markers associated with multipotency. As seeding density has now been 
optimised for human MSCs extracted from bone marrow, effective seeding 
conditions in combination with SQ nanotopography should present an attractive 
application of this work for the scientific community. Furthermore, as alluded to 
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in section 6.1.1, testing of other materials may enhance the strength of the 
nanocues further still.  
 
6.3.2 Three-dimensional MSC environments 
 
Much existing work in tissue engineering and regenerative medicine has been 
carried out on 2D surfaces, though it is increasingly evident that disparities exist 
between the mechanisms underlying biological processes in these different 
environments. It is now appreciated that 3D microenvironments offer more 
complexity than those in 2D, including interactions with multiple cell types, 
soluble factors, and elements of the ECM, including topographical cues and 
spatial/structural constraints. An attempt was made to address some of these 
factors and incorporate them into more physiologically relevant model, in the 
assessment of a multi-component system to achieve expansion of MSCs that 
retain a good degree of MSC marker expression. Using MSCs cultured on nanopit 
nanotopography as a foundation, we propose the addition of collagen and HSCs 
to increase the degree of MSC marker expression that could be achieved using 
nanotopography in isolation. This would provide further complexity to better 
mimic the in vivo bone marrow microenvironment.    
 
Initial work, to which lack of time did not allow further progress to be made, 
demonstrated that nestin expression increased after 7 days of culture with the 
addition of a collagen gel component, independent of whether nanopatterning, 
suggesting that this is a stiffness-mediated effect (Figure 6-1).  
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Engler et al. showed that nestin expression is stiffness induced, proposing that 
the soft gels used in their studies promoted commitment towards a neuronal 
lineage (Engler et al., 2006). Here, we alternatively suggest nestin as a niche 
marker rather than a neuron-specific marker, as nestin+ MSCs located in the 
bone marrow niche are closely associated with catecholaminergic nerve fibres 
and HSCs are responsive to the rhythmic oscillations delivered by the 
sympathetic nervous system (Mendez-Ferrer et al., 2010).  
 
Hypoxia could be a prerequisite factor for the expression of nestin, consistent 
with low oxygen conditions characteristic of bone marrow (Tsai et al., 2012). 
Moreover, this would explain the drop in nestin expression when cultured on the 
nanotopography and control surfaces without the gel. Existing literature 
supports incorporation of hypoxic conditions in MSC studies, as low oxygen 
tension has been shown to suppress adipogenic and osteogenic differentiation 
(Fehrer et al., 2007, Potier et al., 2007) as well as increasing proliferation in 
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terms of cell number (Grayson et al., 2007) or in the number of population 
doublings prior to eventual growth arrest (Fehrer et al., 2007).  
 
In addition, stem cell niches contain other cell types, such as osteoblasts and 
haematopoietic stem cells (HSCs) (Yin and Li, 2006). Cross-talk between the 
different cell types in the bone marrow appears to be important; an example 
being that signalling from MSCs are key to maintaining the survival and 
proliferation of HSC progenitor cells (Walenda et al., 2010). Therefore, the 
addition of other cell types might bring improvement to the current 
nanotopography system in terms of efficiently propagating MSCs. Preliminary 
work incorporated HSCs within the collagen gels that were placed over MSCs 
seeded on nanotopography, and demonstrated that both cell types remained 
viable (Figure 6-2).   
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Other studies have utilised aggregates of MSCs, known as ‘spheroids’ or 
‘mesenspheres’(Baraniak and McDevitt, 2012, Alimperti et al., 2014), which can 
be produced by the hanging drop method, low-binding plates, or forced 
aggregation by centrifugation, arguing that this is more reminiscent of the in 
vivo environment. Spheroids of adipose-derived stem cells display enhanced 
survival in nutrient-deprived conditions and proliferation to a lesser extent 
(Cheng et al., 2012). It is unknown whether MSCs migrating from the 
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nanotopography into a collagen gel would naturally cluster together if allowed 
sufficient time. If proven to be the case, this migratory behaviour would be 
intriguing, as it would indicate that patterns of movement are inherently 
programmed into MSCs when conditions mimic the bone marrow environment 
more closely. Therefore, there are avenues to explore in progressing 
nanotopography into a 3D platform for expansion of multipotent MSCs.  
 
6.3.3 MSCs as supporting cells for regenerative medicine 
 
MSCs themselves are immune privileged, meaning that they do not elicit immune 
responses when transplanted. This may be due to the fact that they can be 
found in many different tissues (Meirelles et al., 2006), including brain, dental 
pulp and even fat, which is now becoming an increasingly common source of 
MSCs (Zuk et al., 2001, Bunnell et al., 2008, Sun et al., 2009). Furthermore, 
MSCs have reported immunomodulatory functions on other cells, and it has been 
shown that they are immunosuppressive (Caplan, 2007, Ankrum and Karp, 2010), 
which may potentiate the engraftment of other cell types. Immuno-rejection is 
large limitation with proposed clinical therapies. The premise is that 
nanotopography-expanded MSCs could be delivered together with the desired 
cell type for tissue repair for example.  
 
Alternatively, there has been increasing interest in using MSCs to support cells of 
the haematopoietic system. HSCs are a rare population in bone marrow, and 
differentiate into mature blood cell types (Orkin and Zon, 2008). The ability to 
supply blood cells derived from progenitor cells would potentially relieve current 
pressure on blood donations. It has been demonstrated that co-culture of MSCs 
with haematopoietic progenitor cells over a period of 5 weeks supported 
haematopoietic proliferation and differentiation (Majumdar et al., 1998). Co-
culture of the two cell types is a logical strategy, as expansion and maintenance 
of HSCs is dependent on the presence of CXCL12 (Greenbaum et al., 2013), a 
chemokine produced by bone marrow MSCs (Mishima et al., 2010). Although the 
concept of MSCs supporting haematopoiesis is not new, MSCs cultured on SQ 
nanotopography could plausibly support haematopoietic cells over longer periods 
of culture, as it has been shown that MSCs on SQ expressed stem cell markers 
after 8 weeks (McMurray et al., 2011). Comparison to the NSQ substrates should 
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be tested in parallel, as there is evidence to suggest that co-culture with 
osteogenic differentiated MSCs has a stronger effect on HSC expansion compared 
to undifferentiated MSCs (Mishima et al., 2010). 
 
6.3.4 Nanotopography as a platform to investigate adhesion and 
tension  
 
As alluded to previously, it is likely that the nanotopographies affect focal 
adhesions, influencing their size and distribution, and could affect their stability 
and downstream effects on signalling pathways. Although focal adhesions were 
not studied in this project, nanotopography has been shown previously as being 
implicated in eliciting changes to these anchoring points in a range of cell types 
(Biggs et al., 2007b, Yim et al., 2010, Chen et al., 2012).  
 
In view of larger focal adhesions being present in MSCs undergoing osteogenesis 
on NSQ (Tsimbouri et al., 2012), it is plausible that topographies that involve 
some disruption of FA formation may prevent the highly spread and flattened 
morphology associated with osteoblasts (McBeath et al., 2004), and additionally 
abrogate the onset of a high tension state. Indeed, ordered hexagonally 
arranged nanopits have been reported as reducing adhesion of fibroblasts, 
characterised by the number of focal contacts and adhesions in comparison to 
flat controls (Dalby et al., 2006a). The reduction of adhesion could be one 
reason for the effect of the SQ surface in promotion of self-renewal.  
 
Furthermore, the spacing between features or ligands is important in allowing 
formation of adhesion bridges (Malmström et al., 2011). This occurs when one 
adhesion is close enough to join to another and could be important in 
progression of osteogenic differentiation. Exploration of different 
nanotopographical features and spacings would reveal information regarding 
which dimensions would be best for optimisation of MSC self-renewal or 
osteogenesis.  
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